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Dr. George W. Gokel, Thesis Advisor

The study of proteins and natural molecules that transport cations and anions across
biological membranes has been a major focus of biochemistry and cellular biology for
more than a century. The function of ion transporters is vital for all known forms of life.
Natural and synthetic transporters can have applications as antimicrobial agents, in nerve
impulse transduction and cell signaling.
The current work was performed to further the understanding of a diverse array of
novel and previously-studied synthetic molecules as membrane-active ion transporters.
In the process, important facets such as ion binding capacity, aggregation behavior, ion
transport functionality, and antimicrobial activity are investigated. While these studies
yield structural and mechanistic insights into our own research group’s synthetic systems,
they may also aid in understanding both other synthetic ion transporters as well as natural
ion carriers and channels.
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Among the studies that are performed, is the design, synthesis and characterization
of members of the dipicolinic dianilide class of compounds as synthetic chloride
channels. In originating this project, an array of both known and novel synthetic chloride
receptors were modeled computationally.

These compounds were selected for their

synthetic accessibility and potential use as a chloride transporter. While some of the
dipicolinic dianilides or closely-related isophthalic dianilides have been previously
reported, few have been investigated for chloride-binding activity and none for chloride
transport activity.

Chloride binding and transport activity were correlated to the

structural variations within the family, which entailed variation of aromatic substituents.
This class of molecules are made in a one step synthesis from commercially-available
materials. Some members elicit rapid chloride transport activity (over 80% in 10 minutes
or less) at low micromolar concentrations. At least one of these select members displays
channel functionality in planar bilayers—one of the smallest family of compounds known
to do so. Molecular modeling and monitoring aggregation formation by fluorescence
spectroscopy reveals that a stack of transporter monomers presents a geometric
arrangement conducive of transmembrane pore formation.
This class of compounds, among others, is investigated for antimicrobial activity in
Gram negative E. coli. While no activity is present for these chloride transporters, coapplication with a known antimicrobial cation transporter diminishes the antimicrobial
activity of the latter in Gram positive S. epidermidis.
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CHAPTER 1

The Design, Synthesis and Characterization of Synthetic Ion
Receptors as Biologically Functional Ion Carriers and Channels

Background

Life and Compartmentalization
One of the seven pillars of life, as defined by Daniel Koshland,1 is
compartmentalization, or the separation of the other essentials of life from its environment.
Compartmentalization is important as it allows for the regulation of chemical
concentrations and, by proxy, regulation of chemical reactions. While in the simplest
forms of cellular life, like prokaryotic bacteria, one level of compartmentalization is
sufficient,2 in more advanced forms, this compartmentalization is further manifested in
cellular organelles such as the nucleus and mitochondria.3

Without doubt,

compartmentalization entails isolation, utilizing barriers to the ingress and egress of certain
chemical species, but it cannot be fully achieved without the selective and regulated
control of the transport of selected species.
To use a historical metaphor, the major cities of medieval and classical Eurasia
could almost certainly not have existed without thick walls to keep out bandits and deter
invaders. However, with the walls in place, there would have been no city at all without
gates and guards to allow merchants, soldiers and citizens to pass through freely.
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Phospholipid Membrane
In the most common forms of life, the isolation aspect of compartmentalization is
accomplished via cellular membranes composed mainly of phospholipids.4 Phospholipids,
such as the dioleoylphosphatidylcholine molecule seen in Figure 1.1, are amphiphilic
molecules with hydrophilic charged polar head-group moieties, a region of intermediate
polarity, and long, hydrophobic acyl tails. A phospholipid membrane is composed of two
leaflets or layers, a characteristic that gives rise to the alternate nomenclature of
“phospholipid bilayer.” Within a leaflet, the polar head-group of a phospholipid is aligned
with the polar head-groups of other directly adjacent monomers.

Likewise, the

hydrophobic tails are in close contact with the acyl tails of adjacent monomers.4 The
leaflets themselves are arranged in a tail-to-tail fashion with the polar head-groups of each
layer directed out toward the polar aqueous surroundings, minimizing the exposure of nonpolar hydrophobic moieties to the polar aqueous environment.5

If this bilayer were

extended into a spherical or other hollow 3-dimensional shape, a vesicle or compartment
would be formed. The end result is that a distinctly hydrophobic slab, located in the
interior of the bilayer, separates the aqueous intracellular domain from the aqueous
extracellular environment.

2

Figure 1.1 Cartoon representation of a phospholipid bilayer showing phospholipid
monomers (in box) aligning tail to tail, with hydrophilic head groups exposed to the
aqueous environment. A monomer here represents a molecule of a typical phospholipid,
dioleoylphosphatidyl choline (DOPC).
Membrane Permeability
While lipophilic molecules can pass freely from one leaflet of the bilayer to the
other, they cannot permeate into the aqueous surroundings. Conversely, for all but the
smallest uncharged molecules exhibiting a polar surface (water, molecular oxygen, etc.) or
densely-charged surface (sodium cation, chloride anion, adenosine triphosphate), the
energy barrier required to permeate the non-polar region of the bilayer is too high to pass
from aqueous phase to aqueous phase without assistance. However, these species can
associate into the aqueous milieu as well as with the hydrophilic head-group domain of the
phospholipid bilayer.6

A summary of these different chemical species can be seen in

Table 1.1.
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Type

Examples

Membrane
Permeable?

Non-polar

hexane

Yes

Large polar

glucose

No

Small polar

H2O

Yes

Dense Surface Charge

Na+, Cl¯, ATP4-

No

Hindered or Diffuse
I¯
Yes
Surface Charge
Table 1.1 Summary of the permeability of chemical species through
membranes.
Concentration Gradients
As previously stated, the impermeability of ions through the phospholipid
membrane imparts the ability to isolate aqueous environments from one another. Thus,
through either natural circumstances or (more often) directed effort by a cell, ion
concentrations can vary between the extracellular matrix and the cytosol. It is because of
this aspect—ion homeostasis—that many cellular processes function. The regulation of
intra- and extracellular ion concentrations is paramount to the maintenance of a fully
functional cell. Undesired disruption of this regulation can cause apoptosis—programmed
cell death—or in extreme cases, necrosis—immediate cell death. This latter event can
occur from disruption of osmotic balance and cytolysis, or rupturing of the cell membrane,
as water can move freely through the phospholipid bilayer.

The general intra- and

extracellular concentrations of common ions in mammals7 are presented in Table 1.2. This
relative trend in ion concentrations is seen throughout most biological systems, from
mammals to E. coli.

4

Ion

Intracellular
Concentration

Extracellular
Concentration

K+

139 mM

4 mM

Na+

12 mM

145 mM

Cl¯

4 mM

116 mM

Table 1.2 Intra- and extracellular ion concentrations of mammalian cells.7

Amphiphilic Molecules
The mixed hydrophobic-hydrophilic nature of amphiphiles theoretically allows
them, in an aggregated state, to permeate both the hydrophobic bilayer interior as well as
the aqueous bilayer exterior. In aqueous milieu, the amphiphilic monomers arrange in
such a way that their polar head-groups are directed externally into the polar aqueous
exterior. Hydrophobic tails are directed inward, minimizing the number and degree of
hydrophobic-hydrophilic contacts. Conversely, aggregates in a non-polar environment
would be composed of polar head-groups in proximity to one another in three dimensions
and lipophilic tails exposed to the similarly lipophilic surroundings.

However, the

formation of either of these types of aggregates is highly dependent on the geometric
constraints of the molecules, and not every type of amphiphile would be able to form each
type of aggregate.8
Either arrangement can result in (among others) flat bilayers or disks as with
phospholipid bilayers, large hollow, spherical aggregates called vesicles or small single
“layer” aggregates called micelles. The occurrence of each type of aggregate depends on a
number of factors, including shape of the monomer, monomer concentration and
temperature.

While phospholipid membranes are themselves formed by amphiphiles,
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many of the species that interact with them (or insert) in various ways are also
amphiphiles.9

Natural Ion Carriers and Channels
With a phospholipid bilayer creating an appropriate isolating structure for cells, a
mechanism for the selective transfer of ions and molecules into and out of a cell or
organelle completes the compartmentalization requirement of life. Most of the larger polar
species (sugars, membrane-impermeable proteins) pass into and out of the cell via
endocytosis and exocytosis, respectively.

While the transport of these species is of

extreme importance and is well-studied,10 the current work is concerned exclusively with
the transport of ions across membranes.
Along with endo- and exocytosis, the transport of ions across a phospholipid
membrane might have been one of the first processes developed in the evolution of life. In
these early stages it is likely that a small amphiphilic molecule would bind with the ion in
the aqueous media and ferry it through the membrane.
As evolution progressed, these simple molecules became more elaborate and
complex; a new mode of ion transport developed in the form of the ion channel—a
molecule or aggregate that spanned the lipid bilayer while forming a water-filled cavity
through which ions could pass. Natural ion channels are amphiphilic protein molecules
that insert into the membrane bilayer and span the distance between the separated aqueous
domains.11 In most cases, these ion channels present an outer hydrophobic surface to the
similarly non-polar domain of the bilayer, while forming an ion-conducting pore lined with
polar, hydrophilic residues.12 The presence of these polar residues effectively lowers the
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energetic barrier in the microenvironment of the pore for passage of the ion between
aqueous domains.
These ion channels have been perfected by eons of evolution, as by trial and error,
the best mix of amino acids in the best positions form pores of optimal geometry with
selectivity filters and gating mechanisms able to determine what is transported and what
conditions would be required for transport. Some channels evolved even further into
pumps—structures able to actively transport ions or molecules against the concentration
gradient. It is with these structures that cells are able to maintain ion homeostasis and
concentration gradients.

Receptors, Carriers and Channels

Carriers Versus Channels
The carrier mechanism is often likened to a boat ferrying passengers back and forth
across a river, while a channel is analogous to a bridge spanning the river, allowing the free
and continuous passage of anyone wishing to cross. The metaphorical comparison extends
to the rate of transport observed with the two separate mechanisms. An ion-carrying
molecule first binds an ion on one side of the membrane barrier, diffuses across the
membrane, and releases the ion on the far side of the barrier, repeating until equilibrium is
established.
Potassium transport by valinomycin, one of the best known ion carriers, reaches a
level of 104 ions per second13 while a functional pore may conduct ions at a rate of 107 or
even 108 ions per second.14 However, the size of the channel is another issue, as only a
certain number of ions can pass a confined space at any given time. Like a draw bridge,
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the channel may open and close at intervals, with no ions or current passing across the
barrier when the channel is closed. If two channels are open simultaneously in a cell or
other system, the current and ion transport rate will be double that of a single channel.

Synthetic Versus Natural Channels and Carriers
The extremely large sizes of natural ion channels make them impossible to create
without genetically-controlled biosynthesis. Protein crystallization,13,15 sequencing16 and
induced mutation17 has led to a wealth of discoveries about essential (conserved) residues
and their contributions to pore,18 gate18 and selectivity filter geometries.19 However, this
work is extremely resource-intensive and difficult to achieve.

Smaller synthetic

compounds can offer a viable, easily-modifiable, and less resource-intensive alternative to
research with natural ion channels. While such complexities as true ligand gating20 (as
opposed to pore blockage21) may be difficult or even impossible to achieve with smaller
synthetic systems, such fundamentals as pore geometry and ion selectivity can be
investigated.22
The work of chemical biologists is to create and utilize synthetic, often abiotic,
compounds to elicit a desired activity in biological or biological model systems or to
further the understanding of those systems. In the context of ion homeostasis and ion
channels, a simpler synthetic molecule can yield important insights into exactly what can
exhibit channel or carrier activity,23 what can exhibit ion selectivity24 and how channels
can form by folding,25 aggregation,26 membrane reorganization27 or some combination of
the three.28
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Measuring Carrier and Channel Activity
Both carriers and channels, by definition, must exhibit ion transport activity. An
assay in a biological model system is often the first step in characterizing a molecule as
such. Ion transport activity can be gauged by using a variety of biophysical techniques,
with some methods seeing more use recently.29
An octanol/water partitioning has often been used for determining the
hydophobicity of compounds (log P). Octanol provides a very rough approximation of the
polarity and character of a phospholipid bilayer. Likewise, the partitioning of chloroform
and water has been used in the same context to form discrete hydrophilic and hydrophobic
layers. The U-tube test uses a U-shaped container to separate two aqueous layers with a
layer of chloroform at the bottom of the “U.” A salt containing the transport target ion is
added to one of the aqueous layers along with a suspected transporter. After gentle stirring
of the system, the ion will be present in the second aqueous layer if a transporter is present,
as it has been carried through the hydrophobic layer by the transporting compound.30
While this system can impart important information, it is an extremely simplified
version of very complex natural cell membranes that can vary significantly from species to
species and even from cell type to cell type within the same species. Most importantly, the
U-tube test can only characterize a transporter as a carrier. If a compound acts solely as a
channel, it may not exhibit transport activity, as its ion transport dependence is based on
insertion into a membrane and transport across a distance of roughly 30Å, not diffusion
across a membrane. For a better assay, a better model of a natural system is required.
Liposomes, or phospholipid vesicles, are artificially created models of natural cells
with an internal volume of aqueous buffer surrounded by a phospholipid bilayer. In most
cases, these liposomes are formed exclusively with solutions of phospholipids, but
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different phospholipids could be used in varied proportions, and amphiphilic molecules
such as cholesterol can also be incorporated. After formation and purification, spherical
liposomes of uniform size can be isolated with an internal aqueous solution that can be
different from the external buffer. It is with these model systems that further investigations
can be made.
Three common methods have been used in measuring ion transport in vesicles—
NMR,31 ion-selective electrode,32 and fluorescent reporter.33

All three methods are

dependent on a reporter system that cannot cross the membrane and vesicles formed with
an internal aqueous solution that is different from the external solution. Most importantly,
all three methods use time-dependent measurements, allowing the characterization of not
only transport activity, but also transport rate.

Receptors: Ion Recognition
In all cases of ion transport, the transporter must interact in some way with the ion.
Thus, many synthetic ion transporters have their roots in supramolecular chemistry and ion
receptors.34 Most studies in the ion receptor field focus on solid-state binding geometries
and maximizing ion-binding strength (with values usually achieved in less competitive
non-polar solvents and counter-ions with diffuse charge densities). However, the field of
transmembrane ion transport is more subtle—stronger binding is not always better and
binding geometries in the solid state do not necessarily comport with binding in solution.
In aqueous solution, both direct transporter-ion interactions as well as indirect
interactions via organized water molecules can occur.

While direct transporter-ion

interactions would seem to be the preferred method of interaction energetically, this is not
necessarily the case.

Aquated ions are surrounded by a hydration shell—a three-
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dimensional array of water molecules with dipoles oriented toward the ion.

Cations

interact weakly with water’s oxygen lone pairs, while anions act as hydrogen bond
acceptors for water’s protons. While a single water-ion interaction is relatively weak, an
entire solvation shell as a whole is held tightly to the ion. Shedding a solvation shell or a
part thereof can be energetically expensive. Any favorable binding energy present with a
direct association of a transporter is counter-acted by this energy penalty.
Another aspect to consider is that an active transporter requires a dynamic
interaction with the transported ion. Exceptionally strong binding with the ion could result
in a binding equilibrium weighted heavily toward the complex, with ion uptake occurring
rapidly, but ion release occurring slowly. Essentially, this would impede the passage of
ions through the channel or preclude further uptake of ions by a carrier.
Considering this, a compound that orders water molecules or interacts with a
solvation sphere, rather than with the ion itself may be a more active transporter than one
that binds the ion directly. Therefore, while ion binding by a receptor and ion recognition
by a transporter may be rooted in the same principles, the goals for each field are distinctly
different when considering the design and implementation of an optimal set of compounds.

Supramolecular Interactions

Interactions of Receptors and Transporters with Ions
Reversible non-covalent interactions are of paramount importance in the fields of
both ion binding and transmembrane ion transport. Electrostatic interactions are among the
strongest non-covalent bonds, but depend significantly on the density of charge across the
surface of the ionic species. More diffuse charges, such as seen with iodide anions, or
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sterically-hindered charges lead to weaker electrostatic attractions. A chloride anion is
attracted more strongly to a charge-dense sodium cation than it is to a tetrabutylammonium
cation, which does not have a directly-accessible charge.
Solvent also has an effect on electrostatic attractions. The dearth of strong dipole
moments in non-polar solvents such as methylene chloride and hexanes translates to a noncompetitive environment. Assuming that both the anion and cation are completely soluble
in this non-polar milieu, the only significant interaction is between the two ions. However,
the strength of electrostatic attractions is greatly diminished in polar solvent as the dipoles
of solvent molecules (as previously described with aquated ions) interact with the charged
ions, forming solvation shells.
In either polar or non-polar solvent, host-guest interactions with these charged
species can occur, given proper host or transporter binding geometries and strengths. These
binding interactions, however, must at least be energetically and kinetically competitive
with the counter ion and/or solvation shell if either is displaced. Whereas in non-polar
solvents, binding competition comes mainly from the counter-ion, contact energies with
the counter-ion are nearly negated in polar solvents, with competition from the ion’s
solvation sphere dominating.

Membrane Insertion
Whereas most interactions in the cytosol or aqueous cell exterior are driven by
charge-charge, charge-dipole, or dipole-dipole contacts, the non-polar interior region of the
membrane bilayer is characterized by moieties that are energetically driven to minimize
contacts with polar and charged species. Other molecules that also have hydrophobic
substructures, such as alkyl chains or arenes with minimal dipole moments, can insert into
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membranes.

Amphiphilic compounds must insert and interact as the surrounding

phospholipids do, with polar or charged moieties directed outward and lipophilic residues
directed in toward the membrane interior.
The hydrophobic residues of a membrane monomer or other amphiphiles are not
inherently attracted to each other as cations are attracted to anions, but water is essentially
repulsed by them—membrane insertion is entropy driven. No favorable hydrogen-bonding
interactions exist between polar solvating water and non-polar substructures, so proximate
water molecules lose the energetic advantage of full hydrogen bonding capacity. These
water molecules, therefore, must maximize what favorable interactions are available to
them by forming more rigid, “ice-like” contacts with surrounding water molecules,
exacting a high entropic penalty in the process. When the quantity of rigid water contacts
is minimized, the entropic energy penalty is proportionately diminished.
The lipophilic-lipophilic forces themselves are extremely weak, allowing free
movement and lateral diffusion of amphiphilic and hydrophobic species laterally
throughout the bilayer, in much the same way that charged and polar species diffuse in
polar solvents. Given the proper conditions, amphiphiles that insert into one leaflet of the
bilayer can flip to the other leaflet. Gramicidin, a well-studied natural cation transporter,35
takes advantage of both of these characteristics in biological membranes. In fact, channel
functionality is elicited by two monomers in each leaflet of the bilayer, diffusing across the
face of its respective leaflet before aligning to form a transient pore.36

Self-Aggregation and Stacking
Another important aspect of weak-force binding that needs consideration is the
energetic favorability of receptor and transporter molecules to aggregate in solution.
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Aggregation of amphiphilic species in polar protic solvents is driven by the same forces
that drive membrane insertion—minimization of contacts between hydrophobic moieties
and solvent. In utilizing a molecule to elicit activity in a membrane, self-aggregation of
the molecule in solution can be counterproductive.37 Molecules that favor self-aggregation
are less likely to insert into bilayer membranes—by definition, a necessary process for
transmembrane ion transporters. While the compounds may be membrane active, the
concentration required to effect the desired activity may be significantly higher for those
that prefer self-aggregation.
One caveat to this self-aggregation concept is when the transporter is active
because of self-aggregation, either in solution or in the membrane.

For example,

molecules that are too small to span the membrane bilayer as a monomer would be more
likely to transport as a channel with increasing concentration.

Measuring Supramolecular Interactions
Both the association energies and geometries of these various supramolecular
interactions have been studied over the past several decades. Structural information can be
elucidated in the solid state by X-ray diffraction of grown crystals38 or in solution by
NMR.39

Structural information can also be accurately modeled using computational

methods.40 This technique is extremely useful when crystals are difficult to obtain, and
when NMR does not, or could not, yield sufficient structural information.
Relative binding strengths can also be modeled computationally41 and can yield a
significant amount of information relatively quickly, especially in the context of
optimizing leads (or targets) before synthesis and experimental analysis. Quantitative
characterization of interaction strengths, in the form of binding or association constants,
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can be obtained using a variety of techniques, each with differing degrees of relevance or
usefulness depending on the studied system and information gleaned.
For example, binding constants can be derived from the isotherms of host-guest
titrations, monitoring the change in chemical shift (Δδ) of binding protons by 1H NMR
spectroscopy.42 Whereas in the case of anions, a set of hydrogen-bond donors should be
present if any interaction exists, a cationic guest would not normally elicit a strong shift (if
any) in a neutral host molecule.

Thus, while 1H NMR binding constants would be

beneficial in measuring anion binding, it is often useless in measuring cation binding.

Summary of Dissertation Work

The following studies were performed to further the understanding of a diverse
array of novel and previously-studied synthetic molecules as membrane-active ion
transporters. In the process, important facets such as ion binding capacity, aggregation
behavior, ion transport functionality, and antimicrobial activity are investigated. While
these studies yield structural and mechanistic insights into our own research group’s
synthetic systems, they may also aid in understanding both other synthetic ion transporters
as well as natural ion carriers and channels.

Chapter 2: Synthetic Anion Receptors
After completing an in-depth review of the synthetic anion receptor literature, a
series of known uncharged anion receptors was modeled computationally to predict
chloride-binding strengths. Comparison with experimentally-derived values for the known
molecules aided in developing the calculation methods for later use with novel compounds
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designed to be chloride hosts.
Upon completion of the method development, the known families of molecules and
variations thereof, as well as novel families of uncharged molecules, were modeled and
chloride-binding strengths were calculated. These calculations were used as a predictive
tool for determining the best families of compounds to target and to better understand
structure-activity relationships within a family of compounds. Such characteristics as
number of hydrogen bond donors, proton acidity, and receptor flexibility were judged
based on the calculated complexation energies, host and complex electrostatic potential
maps, and analysis of host and complex geometries. Using the accrued data for the most
promising candidates, targets were determined for further study based on predicted activity
and synthetic accessibility.
Synthetic approaches were developed for all of the compounds studied, and efforts
were made toward some of the more promising candidates.

While one family of

compounds (dipicolinic dianilides) is detailed in Chapter 3, the synthetic work and
characterization for the remaining attempts are detailed in Chapter 2.

Chapter 3: Synthetic Anion Carriers and Channels
Dianilides of 2,6-pyridine dicarboxylic acid (dipicolinic acid), a family of
compounds modeled in Chapter 2, were synthesized, characterized, and studied for carrier
and channel activity in biological systems and biological model systems.
The first dipicolinic dianilides were made in a two-step synthetic process with
overall yields of 40-70% and covered a range of substituent character from the electrondonating para-methyl substituent to the electron-withdrawing para-nitro. Initially, the
compounds were investigated for chloride-binding activity in the context of chloride
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receptor utilization. 1H NMR binding constants were derived in both polar DMSO-d6 and
non-polar CD2Cl2, with the titrations showing that chloride binding activity was present
even in the polar milieu of DMSO-d6. These results were correlated with the previous
molecular modeling studies, as well as with competitive electrospray ionization-MS
studies performed by collaborators. The same trend in chloride binding strength was seen
across the studied range of substituents: with increased substituent electron-withdrawing
character comes increased chloride binding strength.
While elucidation of the solid-state structures of the host-guest complexes was
attempted, molecular modeling and experimental work involving the measurement of the
absorption spectra with increasing concentrations of a guest salt yielded significant insights
into both the energetics and the geometries associated with the complexation.
Favorable chloride binding results signaled that the compounds could conceivably
act as chloride carriers in biological model systems. Chloride influx into phospholipid
vesicles was studied using a chloride-quenched internal fluorophore as an indicator of
internal chloride concentration. Fluorescence intensity was monitored as a function of
time, showing fluorescence quenching and, by extension, chloride transport in a dynamic
setting. Again, the trend followed increased chloride transport activity with increasing
substituent electron-withdrawing character.
The rapid chloride transport rate seen in the vesicle study suggested that a channel
mechanism, not simply a carrier mechanism, may be present for at least some of the
transporters studied. As stated previously, the simplest method to distinguish between the
two mechanisms is the measurement of conductance between two aqueous environments
electrically isolated by a bilayer membrane. A colleague measured the presence of this
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electrical conductance using the planar-bilayer conductance technique. The results
indicated channel functionality in the form of distinct open-close behavior.
A dipicolinic dianilide transporter monomer at its widest is approximately 15Å and
is incapable of spanning the roughly 30Å of the hydrophobic region of the bilayer
membrane. Thus, unable to work alone, the monomers must somehow aggregate to elicit
the exhibited channel functionality. Using calculated geometries of stacked molecules,
along with the concentration-dependent fluorescence profiles of the transporters, a stacking
interaction was posited as the mechanism of channel formation.

Chapter 4: Solvent Dependence of Solid-State and Nanoscale Structure
Supramolecular interactions, are an extremely important part of understanding the
morphology of aggregates of compounds and predicting the possible interactions of both
monomers and aggregates in natural systems and biological model systems. The solvent
environment often plays a key role in how molecules aggregate and interact with other
species. Potential ion transporters, which are almost exclusively amphiphiles, can and will
form aggregates of different morphologies under different solvent conditions.
The work detailed in this chapter seeks to bring these solvent effects on aggregate
and crystal formation to the forefront in the context of understanding these molecules as
potential ion transporters. The work presented in this chapter focuses on the solid-state
and nanoscale morphologies of pyrogallol[4]arene macrocycles with branched sidechains.
These compounds were analyzed for solid-state or “Angstrom-scale” geometry and
morphology by X-ray crystallography and analyzed for nanoscale geometry and
morphology by cryogenic transmission electron microscopy (cryo-TEM).
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Both the crystallizations and EM sample preparations were performed in various
solvent conditions—polar, non-polar, protic, aprotic—and in mixed solvents.

While

crystallizations were unsuccessful in many cases, EM sample preparation by slow
evaporation generally yielded usable specimens. These specimens reveal that nanoscale
aggregates self-assemble in polar media. Under 50000x magnification, these aggregates
are shown to be formed from bundles of what appear to be short nanotubes of a diameter
congruent with measurements taken from X-ray crystal structures.

Chapter 5: Biological Activity of Synthetic Ion Carriers and Channels
As stated previously, a major goal of a chemical biologist is to elicit biological
activity from synthetic constructs. In this vein, assays of these constructs in biological
model systems are cursory studies leading to investigation in biological systems. Poreforming compounds, such as cation-conducting hydraphile channels,43 as well as anionconducting synthetic anion transporters (SATs),25a,44 and dipicolinic dianilide channels45
have the ability to conduct their respective ions rapidly across phospholipid membranes in
biological model systems such as vesicles and planar bilayers. If that activity is present in
biological systems such as bacterial and fungal cultures or human red blood cells,
therapeutic applications might emerge.
The first of three projects associated with this chapter is an exploration of the
antimicrobial activity for an array of novel ion transporters. In one part of this project, the
family of compounds, known as hydraphiles, was investigated for activity with variation of
growth culture pH. The subset of compounds tested had amide moieties present instead of
amines that are generally present in the family. Additionally, both cation and anion
transporters as well as suspected channel formers were studied using the minimum
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inhibitory concentration (MIC) method in Gram-negative Escherichia coli. Only newlystudied members of the hydraphile family of known antimicrobial agents exhibit any
biological activity in the studied bacterium.
The second project details the interaction between cation and anion transporters on
antimicrobial activity was measured in Gram-positive Staphylococcus epidermidis using a
co-application of two such compounds and comparing growth curves. While alone, the
diaza-18-crown-6 sodium transporter that is studied exhibits antimicrobial activity, when
co-applied with a dipicolinic dianilide chloride transporter these effects are completely
negated.
The third and final project explored the development of antimicrobial resistance in
E. coli to synthetic cation channel with known antimicrobial activity.

The antimicrobial

resistance was studied with regular application of sub-lethal concentrations of the
hydraphile cation channel over 12 days. While resistance did develop over the time period,
it plateaued after 6 days of growth, developing no further resistance.

20

1

D. E. Koshland, Jr.; Science 2002, 295, 2215-2216.

2 (a) Stanier, R. Y.; van Niel, C. B. Arch. Microbiol. 1962, 42, 17-35. (b) Whitman, W.
B. J. Bacteriol. 2009, 191, 2000-2005.
3

Vellai, T.; Vida, G. Proc. Biol. Sci. 1999, 266, 1571-1577.

4

Singer, S. J.; Nicolson, G. L. Science 1972, 175, 720-731.

5 McBain, J.W. Trans. Faraday Soc. 1913, 9, 99.
6

Parsegian, A. Nature 1969, 221, 844-846.

7 Darnell, J.; Lodish, H.; Baltimore, D.; Molecular Cell Biology, 1986; Scientific
American Books, New York; (2nd ed., 1990) p. 618 and 725.
8 Israelachvili, J. N.; Mitchell, D. J.; Ninham, B. W. J. Chem. Soc., Faraday Trans. 2,
1976, 72, 1525-1568.
9

Yeagle, P. The Structure of Biological Membranes. CRC Press: Boca Raton, 1992; p
1227.

10 Miaczynska, M.; Stenmark, H. J. Cell Biol. 2008, 180, 7-11.
11 Hille, B. Ionic Channels of Excitable Membranes. 3rd ed.; Sinauer Associates:
Sunderland, MA, 2001.
12 MacKinnon, R. Angew. Chem. Int. Ed. 2004, 43, 4265-4277.
13 Stark, G.; Ketterer, B.; Benz, R.; Lauger, P. Biophys. J. 1971, 11, 981-994.
14 Läuger, P. Biochim. Biophys. Acta 1973, 311, 423-441.
15 Dutzler, R.; Campbell, E. B.; Cadene, M.; Chait, B. T.; MacKinnon, R. Nature 2002,
415, 287-294.
16 (a) Edman, P. Acta Chem. Scand. 1950, 4, 283-293. (b) Noda, M.; Shimizu, S.;
Tanabe, T.; et al.; Nature 1984, 312, 121-127.
17 Labarca, C.; Nowak, M. W.; Zhang, H.; Tang, L.; Deshpande, P.; Lester, H. A. Nature
1995, 376, 514-516.
18 Planells-Cases, R.; Ferrer-Montiel, A. V.; Patten, C. D.; Montal, M. Proc. Nat. Acad.
Sci. USA 1995, 92, 9422-9426.
19 Yue, L.; Navarro, B.; Ren, D.; Ramos, A.; Clapham, D. E. J. Gen. Physiol. 2002, 120,
845-853.
21

20 Colquhoun, D.; Sivilotti, L. G. Trends Neurosci. 2004, 27, 337-344.
21 Kwon, D.-H.; Lu, C.-D. Antimicrob. Ag. Chemother. 2007, 51, 2070-2077.
22 (a) Gokel, G. W.; Mukhopadhyay, A.; Chem. Soc. Rev. 2001, 30, 274-286.
(b) Dieckmann, G. R.; Lear, J. D.; Zhong, Q.; Klein, M. L.; DeGrado, W. F.; Sharp, K.
A. Biophys. J. 1999, 76, 618-630.
23 (a) Sisson, A. L.; Shah, M. R.; Bhosale, S.; Matile, S. Chem. Soc. Rev. 2006, 35, 12691286. (b) Davis, A. P.; Sheppard, D. N.; Smith, B. D. Chem. Soc. Rev. 2007, 36, 348357. (c) Fyles, T. M. Chem. Soc. Rev. 2007, 36, 335-347.
24 (a) Schlesinger, P. H.; Ferdani, R.; Liu, J.; Pajewska, J.; Pajewski, R.; Mitsuyoshi, S.;
Shabany, H.; Gokel, G. W. J. Am. Chem. Soc. 2002, 124, 1848-1849. (b) Gokel, G. W.
Chem. Commun. 2000, 1-9.
25 (a) Prince, R. B.; Barnes, S. A.; Moore, J. S. J. Am. Chem. Soc. 2000, 122, 2758-2762.
(b) Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. Nat. Chem. Biol. 2007, 3,
252-262.
26 (a) Clark, T. D; Buehler, L. K.; Ghadiri M. R. J. Am. Chem. Soc. 1998, 120, 651-656.
(b) Bhosale, S.; Sisson, A. L.; Sakai, N.; Matile, S. Org. Biomol. Chem., 2006, 4,
3031. (c) Yang, J.; Dewal, M. B.; Sobransingh, D.; Smith, M. D.; Xu, Y.; Shimizu, L.
S. J. Org. Chem. 2009, 74, 102 (d) Helsel, A. J.; Brown, A. L.; Yamato, K.; Feng, W.;
Yuan, L.; Clements, A. J.; Harding, S. V.; Szabo, G.; Shao, Z.; Gong, B. J. Am. Chem.
Soc. 2008, 130, 15784.
27 Plank, C.; Zauner, W.; Wagner, E. Adv. Drug. Deliv. Rev. 1998, 34, 21-35.
28 Pajewski, R.; Ferdani, R.; Pajewska, J.; Djedovic, N.; Schlesinger, P. H.; Gokel, G. W.
Org. Biomol. Chem. 2005, 3, 619-625.
29 (a) Ashton, R.; Steinrauf, L. K. J. Mol. Biol. 1970, 49, 547-556. (b) Liu, C.; Hermann,
T. E. J. Biol. Chem. 1978, 253, 5892-5894.
30 (a) Yamnitz, C. R.; Gokel, G. W. Chem. Biodivers. 2007, 4, 1395-1412. (b) Gokel, G.
W.; Carasel, I. A. Chem. Soc. Rev. 2007, 36, 378-389.
31 Murray, C. L.; Gokel, G. W. Chem. Commun. 1998, 2477-2478.
32 (a) Koulov, A. V.; Mahoney, J. M.; Smith, B. D. Org. Biomol. Chem. 2003, 1, 27-29.
(b) Weber, M. E.; Schlesinger, P. H.; Gokel, G. W. J. Am. Chem. Soc. 2005, 126, 636664.
33 (a) Sakai, N.; Matile, S. J. Phys. Org. Chem. 2006, 19, 452-460. (b) Ferdani, R.; Li,
R.; Pajewski, R.; Pajewska, J.; Winter, R. K.; Gokel, G. W. Org. Biomol. Chem. 2007,
5, 2423-2432.

22

34 (a) Gatto, V. J.; Arnold, K. A.; Viscariello, A. M.; Miller, S. R.; Morgan, C. R.; Gokel,
G. W. J. Org. Chem. 1986, 51, 5373-5384. (b) Leevy, W. M.; Weber, M. E.; Gokel,
M. R.; Hughes-Strange, G. B.; Daranciang, D. D.; Ferdani, R.; Gokel, G. W. Org.
Biomol. Chem. 2005, 3, 1647-1652.
35 (a) Urry, D. W. Proc. Nat. Acad. Sci. (USA) 1971, 68, 672-676. (b) Gowne, J. A.;
Markham, J. C.; Morrison, S. E.; Cross, T. A.; Busath, D. D.; Mapes, E. J.; Schumaker,
M. F. Biophys. Chem. 2002, 83, 880-898. (c) Huang, H. W.; Novartis Foundation
Symposium: Gramicidin and Related Ion Channel-Forming Peptides, 1999, 225, 188–
206.
36 Urry, D. W.; Goodall, M. C.; Glickson, J. D.; Mayers, D. F. Proc. Nat. Acad. Sci.
(USA) 1971, 68, 1907-1911.
37 Elliott, E. K.; Daschbach, M. M.; Gokel, G. W. Chem. Eur. J. 2008, 14, 5871-5879.
38 Ladd, M. F. C.; Palmer, R. A. Structure Determination by X-Ray Crystallography;
Plenum Press: New York, 1985.
39 Pons, M., ed. NMR in Supramolecular Chemistry, Kluwer Academic Publishers:
Dordrecht, Netherlands, 1999.
40 Wu, Y.-D.; Wang, D.-F.; Sessler, J. L. J. Org. Chem. 2001, 66, 3739-3746.
41 Lybrand, T. P.; McCammon, J. A.; Wipff, G. Proc. Natl. Acad. Sci. USA 1986, 83,
833-835.
42 Connors, K. A. Binding Constants, 1st ed.; John Wiley & Sons: New York, 1987, 189215.
43 Gokel, G. W. Chem. Commun. 2000, 1-9.
44 Schlesinger, P. H.; Ferdani, R.; Pajewski, R.; Pajewska, J.; Gokel, G. W. Chem.
Commun. 2002, 840-841.
45 Yamnitz, C. R.; Negin, S.; Carasel, I. A.; Winter, R. K.; Gokel, G. W. Chem.
Commun. 2010, 46, 2838-2840.

23

CHAPTER 2

Design and Computational Investigation of Novel Synthetic
Anion Receptors for Use as Anion Transporters

Summary and Contributions to this Work

The work presented in this chapter focuses on the implementation of a
computational method to design and optimize families of molecules as potential anion
receptors with the goal of utilizing them as transmembrane chloride transporters. 40
potential receptors of 5 different types were modeled and studied computationally at the
density-functional level of theory. Structural variations within families include the number
and type of neutral hydrogen bond donor moieties, as well as substitutions in π-systems
that are in conjugation with the hydrogen bond donors.
After optimization of a computational method, the investigation yielded a number
of insights into the design of anion receptors. First, the use of urea or thiourea in the
binding cleft can lead to a significant complexation energy advantage over carbamates or
amides. In practical terms, however, the solubility of these compounds may limit their use
as receptors. Second, larger molecules with more hydrogen bond donor moieties may not
be advantageous when considering the design of an anion receptor or transporter.
Intramolecular hydrogen bonds would need to be broken to and complexation with an
anion may not be as energetically favored. Finally, electron-withdrawing substituents in a
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π-system including anion-binding moieties dramatically lowers the binding energy of those
systems due to increased proton acidity.
One family of these compounds studied, the dipicolinic dianilides, was investigated
further. They are shown in Chapter 3 to bind chloride in polar solvent, transport chloride
across phospholipid vesicles, and function as a synthetic anion channel.
I performed all of the computational work, synthesis, and characterization
described below.

Introduction

The essence of supramolecular chemistry has been, from its inception, weak force
interactions.1 While some early work was devoted to the complexation of anions,2 initial
studies focused primarily on host-guest interactions involving neutral hosts and cationic
guests. The field of anion binding remained only modestly active for many years, and
work did not gain momentum until recently. During the past decade, however, there has
been a burgeoning interest in both anion binding and transport.3 The anion-binding and
anion-transport fields have found utility in applications as diverse as the detection of
chemical weapons4 and therapeutic value in mitigating the symptomatic manifestations of
cystic fibrosis.5
The most common complexation mode for such anions as fluoride and chloride is
hydrogen bonding. Amides, ureas and thioureas, alcohols and protonated amines have all
proven to be effective hydrogen bond donor sources for these interactions,3b although the
latter has found more use in anion receptor studies than ion transporter studies.

A

successful ion carrier is dependent on at least three rates: the rate of binding the ion outside
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the cell, the rate of diffusion across the membrane into the cytosol, and the rate of
decomplexation—solvation of the ion by cytosolic water.6 Naturally, the former and latter
rates are inversely related, and the effectiveness of a transporting agent is held to a true
Goldilocks standard: a carrier that binds an ion too weakly prevents any meaningful hostguest interaction; a carrier that binds an ion too strongly will not release the ion once in the
cytosol. Logically, the best ion carrier is one that binds a target ion at an intermediate
magnitude of strength, being able to both bind an ion on one side of the membrane and
release it on the other side.
Incorporating a moiety with a charge opposite the target ion would render a carrier
host too strongly bound to its guest. The carrier must be uncharged but incorporate a series
of dipoles that favorably interact with the target ion. After such a molecule or aggregation
of molecules meets these criteria, it must pass the final test—permeate the lipid bilayer, ion
in tote.

Results and Discussion

Families of compounds modeled
As mentioned previously, numerous neutral and charged anion receptors have been
developed recently.3b Therefore, preliminary work consisted of identifying, as fully as
possible, the range of novel synthetic molecules already used as ion hosts, specifically
halide anion hosts. A development process, detailed below, followed to determine likely
combinations of anion-complexing moieties using readily available starting materials to
identify likely anion host targets.
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Figure 2.1 Examples of the five categories of transporter candidates modeled.

From this process, a number of candidates were determined. The candidate field
was winnowed down by eliminating structures that might present solubility problems, that
could not adopt a favorable complexation geometry, or were overly-large or complex to
target synthetically. The final candidates, therefore, were those that were synthetically
accessible, smaller, easier to model computationally and easily modifiable in order to
introduce a wide variety of compounds from a core or base structure. These candidates fell
into one of five distinct categories (examples given in Figure 2.1):

1. Dianilides of dipicolinic acid (compound 2) and of the structurally-similar
isophthalic acid—such as those discovered by Crabtree’s group7 and championed
by Gale and co-workers,8
2. Highly modified peptide chains akin to our group’s SCMTR9 (16),
3. Metal-chelating poly-acids that have been amidated to bind anions (29),
4. Alkyl and arylureas (35), and
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5. Macrocycles incorporating some combination of o-phenylenediamine, dipicolinic
acid and optional amino acids (38).

Dipicolinic and isophthalic diamides
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Figure 2.2 Synthetic anion receptors formed from the coupling of dipicolinic acid or
isophthalic acid and a substituted/unsubstituted aniline or benzylamine.
Method
Version

Conformer 1st Geometry 2nd Geometry
Energy
Search
Optimization Optimization Calculation
MMFF
I
AM1
B3LYP
10 of 10000
MMFF
II
PM3
B3LYP
10 of 10000
MMFF
III
RM1
B3LYP
B3LYP/MP2
20 of 10000
Table 2.1 Summary of the study methodology as developed over three versions

Using the set of molecules, 1-12 seen in Figure 2.2, the methodology for the study
was developed and perfected over three iterations, summarized in Table 2.1. In all three
iterations, a subset of lowest energy conformers (LECs) as determined from a set of up to
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ten thousand conformations generated at random and energy minimized using a low cost
molecular mechanics level of theory. Method versions I and II found ten such LECs, while
version III found twenty LECs. In all three versions, the optimized geometries of these
LECs were found using a slightly more computationally-expensive semi-empirical method
(AM110 in version I, PM311 in version II and RM112 in version III). Version III included a
further geometry optimization performed at the density functional level of theory (DFT)
using the B3LYP method13 with a 6-31G* basis set. B3LYP combines Becke's threeparameter function14 with the non-local correlation provided by the correlation function of
Lee, Yang and Parr,13 and finds common usage at this level of theory. Finally, the singlepoint energy was calculated for all versions using the B3LYP method and 6-31G* basis
set.

Version III also attempted an electron correlated Möeller-Plesset MP215 calculation

for most molecules, but a lack of computational resources prevented this calculation from
being performed on all but the smallest molecules and complexes. Thus, for comparison,
both sets of values are listed where appropriate.
The dipicolinic and isophthalic acid-derivatized receptors 1-12 were thus evaluated
using all three versions of methodology.

Version III’s use of a second geometry

optimization at the density functional level of theory proved worthwhile in evaluating the
receptors, as the calculated LEC of the semi-empirically-optimized molecules in versions I
and II were, at times, significantly inaccurate.

The calculated complexation energies of

receptors 1-12, using each version, are shown in Table 2.2. Of note is the significant
difference in the calculated energies of compounds 1, 3, and 6 from version to version, as
well as the comparatively high calculated chloride complexation energies of the para-nitro
compounds.
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Diacid

Amine

Aniline
2,6-Pyridine
Dicarboxylic
Acid
Benzylamine

Aniline
Isophthalic
Acid
Benzylamine

para
Substituent

Compound
Number

Version I
(kcal/mol)

Version II
(kcal/mol)

Version III
(kcal/mol)

H

1

-43.6

-9.8

-29.8

NO2

2

-45.8

-45.7

-50.7

OCH3

3

-14.7

-16.8

-32.6

H

4

-21.9

-18.6

-27.5

NO2

5

-44.3

-41.8

-45.6

OCH3

6

-2.6

-30.4

-33.6

H

7

-34.7

-33.2

-30.3

NO2

8

-48.9

-49.3

-49.7

OCH3

9

-33.5

-31.8

-35.0

H

10

-21.8

-34.0

-39.4

NO2

11

-39.6

-48.7

-48.5

OCH3
-25.8
-30.2
-35.8
12
Table 2.2 Calculated chloride complexation energies for compounds 1-12 as calculated by
each previously-described method. Of note are the inaccurate early-version calculations
of compounds 1, 3, and 6 (italicized in gray boxes) and the comparatively high calculated
complexation energies of the para-nitro compounds 2, 5, 8, and 11 (bolded typeface).

Figure 2.3 Left: Top-down view of geometry-optimized CPK structures of receptor 1 as
calculated by version I (top), version II (middle) and version III (bottom) of the calculation
method. Right: Geometry-optimized CPK structures of the chloride complexes
corresponding to the receptors on the left.
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Using compound 1 as an illustrative example of the limits of the first and second
calculation method version, it can be seen in Figure 2.3 that different geometry
optimizations can yield significantly different geometries. Superficially, the results seem
the same, as in all cases, the receptor adopts a syn-syn conformation as a native host and an
anti-syn conformation to bind the chloride anion guest with one amide N-H moiety. The
top-down view, however, allows us to see that using version I, shows a higher-energy LEC
host in a non-planar conformation (Figure 2.3 top left)—the amides are rotated 58° from
the plane of the central pyridine and 13° from the plane of the side arm phenyls,
eliminating any energy advantage gained from a fully planar, fully conjugated system.
However, in the chloride complex (top right), planarity and conjugation exist in the synconforming side arm. The chloride-binding anti-conforming side arm, however, is rotated
by 34° away from the central pyridine plane in order to favorably complex chloride.
The version II geometry also shows a rotation away from planarity in the native
host, though the rotation is less extreme than its version I counterpart. As a result, an
energy calculation yields a lower energy than that calculated with the former version. The
complexing host in version II, however, shows no amide-arene planarity in either the syn
or anti side arm resulting in a higher complex energy and a lower energy advantage for
complexation.
Version III, using two sets of geometry optimizations—the final at the density
functional level—predicts a low energy fully conjugated, fully planar conformation in the
native host and a 18° side-arm rotation in the chloride-binding host. The inclusion of the
density-functional level geometry optimization is the most important step in this 3rd
version. Other computational studies with anion receptors have used similar procedures
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with geometry optimization performed at the DFT level of theory,16 so its use here is
prudent.
The design of receptors 1-12 was based on a proposed syn-syn binding mode
making use of both amide protons for hydrogen bonding in an “internal cavity” between
the two side arms. The complex LECs for all receptors with substituted side arms show
this behavior using all calculation method versions. However, as seen in receptor 1 as well
as in others with unsubstituted side arms (4, 7) a one hydrogen bond syn-anti mode is
observed in the LEC optimized geometries of the first two calculation methods. However,
when geometry is optimized at the density functional level of theory as with Version III,
all of the receptors bind chloride in a syn-syn fashion. The dianilides, specifically, bind
chloride out of the central arene plane, requiring a rotation of the amide moieties out of this
plane as well.
A closer investigation of the aniline derivatives 1-3 and 7-9, show an interesting
relationship between the inductive strength of the para substituent and the chloride binding
strength of the amide. This trend, is explored more fully in Chapter 3 of this work,
including a wider breadth of substituents used. In addition, a computational investigation
is conducted that studies the energetic advantages and penalties for a rotation out of the
plane of the central arene to bind chloride.

Modified peptide chains
After optimization of the energy calculation process with compounds 1-12, method
version III was applied to the remaining receptor candidates, starting with C- and Ncapped peptide chains.

Taking experience and expertise from our similar, already-

established SAT anion transporters,9 such a synthetic thrust, involving peptide coupling
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and modification seemed

reasonable.

With adequate computational study, the

groundwork could be laid to properly direct such a foray.
The first issue studied in this category of carrier candidates was the effect of
substituting N-terminus capping moieties. In our SAT family of compounds, the N-termini
of the peptide chains are capped with a diglycolic acid anhydride derivative terminated
with a dialkylamine lipophilic membrane anchor. The C-termini are also protected and are
implicated in a secondary anchoring capacity.17 A new approach to these peptide chains
would be to reverse the function of the N- and C-termini, modifying the C-terminus with a
main hydrophobic anchoring moiety and availing the N-terminus for additional anion
complexation.
Structure

Compound

B3LYP
Ecomplexation
(kcal mol-1)

MP2
Ecomplexation
(kcal mol-1)

13

-27.3

-41.0

14

-26.2

-42.1

15

-40.4

-49.1

16

-45.9

-56.0

17

-40.4

-50.8

Table 2.3 Structures and calculated chloride complexation energies for Ala-Ala sequence
compounds varying the N-terminal moieties. Energies shown are calculated using the
B3LYP or MP2 method with the 6-31G* basis set.
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In order to study the effects of varying the N-terminus capping moiety, a simple
alanine-alanine dipeptide chain was modeled with an ethyl amidated C-terminus and a
variably-capped N-terminus. Compounds 13-17 include two commonly used N-protecting
groups, carboxybenzyl (CBZ) and tert-Butoxycarbonyl (t-BOC), a phenyl urea, a
phenylthiourea, and a phenylthiourea with an ortho-amino substituent.

The alanine-

alanine sequence was chosen to (1) preclude any backside amino NH···carbonyl O
hydrogen bonding in the native host, (2) introduce chirality leaving open the possibility for
a later chirality-based complexation study, and (3) produce models that are relatively easy
to calculate using the more stringent MP2 method. These structures, and the calculated
chloride complexation energies are seen in Table 2.3.

Figure 2.4 Top: Geometry-optimized space-filling structures of ortho-amino
phenylthiourea receptor 17 (left) and phenylthiourea receptor 16 (right). Bottom:
Corresponding geometry-optimized CPK structures of the chloride complexes of the
receptors above.
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The addition of a fourth potential hydrogen bond donor in a switch from
carbamates in 13 and 14 to ureas in 15, 16, and 17 lends an estimated 7 kcal mol-1 energy
advantage using the MP2 method for energy calculation. Substituting the urea for a
thiourea yields an additional 7 kcal mol-1 in 16. However, the addition of an ortho amino
substituent to the phenylthiourea cap in 17 reduces this energy advantage to one
comparable to the urea, 15.
As seen in Figure 2.4, this latter phenomenon may have to do with the fact that, at
most, only 4 N-H moieties bind the chloride anion in either geometry-optimized complex.
The extra amino substituent in 17 replaces the non-binding N-H moiety, the first alanine
backbone N-H which is geometrically unable to bind.
The interplay between the addition of anion-binding moieties and intramolecular hydrogen
bonding in the host is further investigated by lengthening the peptide to 3, 4 and 5 residues.
The urea and thiourea N-capping moieties were used in a study of the effect of peptide
length on chloride binding. A poly-alanine peptide sequence was thus used for this study
with extension out to 5 amino acid residues. Further extension of the chain would have
raised the computational costs significantly, and as the results imply (Figure 2.5),
additional amino acid residues past three would lend no significant change in complexation
ability.
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NTerminus
Cap
NH
O
NH

NH
S
NH

B3LYP
Ecomplexation
(kcal mol-1)

Ecomplexation
(kcal mol-1)

18

-37.1

2

15

3

Alanine
Chain
Length

Host

1

MP2

Intramolecular HBonds
Host

Complex

Complex
NHּּּCl¯
Contacts

-46.2

1

0

3 of 3

-40.4

-49.1

1

0

4 of 4

19

-50.9

-

2

0

5 of 5

4

20

-50.6

-

3

0

5 of 6

5

21

-51.0

-

4

3

4 of 8

1

22

-37.8

-46.7

1

0

3 of 3

2

16

-45.9

-56.0

1

1

3 of 4

3

23

-55.1

-

2

1

4 of 5

4

24

-54.8

-

3

0

5 of 6

5

25

-56.0

-

4

0

6 of 7

Figure 2.5 Tabular and graphical representations of complexation energies of urea (15,
18-21) and thiourea (16, 22-25) N-capped poly-Alanine peptides of various length. No
additional complexation energy advantage is expected past three alanine residues.
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The study suggests that for simplicity’s sake (both for calculations and synthesis), a
tripeptide is the optimal length for chloride binding via the peptide backbone.
Intramolecular hydrogen bonding is present in the smallest native hosts (18 and 22), and
increases proportionately with the addition of each hydrogen bond donor past a peptide
chain length of two.

The thiourea series shows an increasing degree of chloride

complexation with increasing length. In the 5-mer, 6 N-H···Cl¯ contacts are present of 7
possible. This compares to the same urea with 4 N-H···Cl¯ contacts of 7 possible and three
intramolecular hydrogen bonds in the host molecule. However, a closer examination of the
5 lowest energy conformations for these two hosts shows that in both cases, the higher
energy conformers (+ < 1.0 kcal mol-1) have variations in the amount of intramolecular
hydrogen bonding and chloride coordination.

The trade-off between intramolecular

hydrogen bonds and binding to the chloride guest is roughly the same when considering
the degree of intramolecular hydrogen bonding present in the host.
A final computational study in this area surveyed different amino acids used in
urea-terminated dipeptides. Once again, the compounds are compared to 15 as a standard
to compare across the three discrete studies performed. As seen in Table 2.4, four amino
acids have been studied in this capacity.

In compounds 27 and 28, two additional

hydrogen bond donors are present in the form of the serine and threonine residue side
chains, respectively. Compared to host 15, which contains only 4 hydrogen bond donors
instead of 6, the calculated chloride binding energy of 27 and 28 is 5 to 8 kcal mol-1 better.
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B3LYP
MP2
Ecomplexation Ecomplexation
(kcal mol-1) (kcal mol-1)

Amino
Acid

Host

H

Gly

26

-40.5

CH3

Ala

15

CH2OH

Ser

CH(OH)CH3

Thr

R=

Intramolecular HBonds

Complex
NHּּּCl¯
or
OHּּּCl¯
Contacts

Host

Complex

-47.1

1

0

4 of 4

-40.4

-49.1

1

0

4 of 4

27

-44.7

-

1

1

5 of 6

28

-47.7

-

1

1

5 of 6

Table 2.4 Structures and calculated chloride complexation energies for dipeptide
compounds varying the amino acid composition. Energies shown are calculated using the
B3LYP or MP2 method with the 6-31G* basis set.

Examination of the geometries of the 27·Cl¯ and 28·Cl¯ complexes reveals that
the geometries of the host peptides are essentially identical in the complex. Both of the
side-chain hydroxyl moieties bind the chloride guest along with both urea N-H protons and
the first amino acid amide proton. The N-H proton of the second amino acid residue is
hydrogen-bonded to the oxygen atom of the urea in both complexes.
The diglycine compound, 26, is predicted to be as good a host as the dialanine
compound. When compared to the dialanine compound, 15, it can be understood that the
presence of a methyl side-chain has no disruptive effect on the calculated binding energy.
Analysis of the host and complex geometries of 15 and 26 shows that they nearly overlap.
As with the other receptors modeled, the lowest energy conformer of 26 has one
intramolecular hydrogen bond present

in the native host.

When bound to chloride,

however, this interaction is broken in favor of a fourth interaction with the guest molecule.
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Amides of tri- and tetraacids

HN

X

O

X = CH3
O

29

N

H
N

NH

HN

O
O

O

34

N

N

H
N
O

X

N

H

31

CN

32

NO2

33

O

NH

NH
O

NH

30

X

HN

NH
O

O

Figure 2.6 Structures of the computationally-modeled amidated metal-chelates.
Compounds 29-33 are triamides of nitrilotriacetic acid, while 34 is the tetraethylamide
ethylene diamine tetracetic acid.
The third category of compounds (examples seen in Figure 2.6) studied are fullyamidated multi-carboxylates normally used for metal chelation. One of the most well
known of these metal chelates is EDTA, ethylenediaminetetraacetic acid. Amidation of the
four carboxylic acids yields a tetraamide—four covalently-bound moieties capable of
complexing a halide anion. When the ethyltetraamide, 34, is subjected to the established
calculation method, a tetracomplexation conformation is lacking in the twenty lowest
energy conformers (LECs), with only two halide-amide interactions present in the overall
LEC (Figure 2.7). Although other low energy conformers have three binding amide
moieties, presumably the energy-lowering backside amide to amide intramolecular
hydrogen bonding negates any advantage gained by extra complexing interactions.
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Host

Chelate
Acid

B3LYP
Ecomplexation
(kcal mol-1)

29

NTA

29·29
34

Host H-Bonds

Contacts in Complex

Intra-

Extra-

N-H···Cl¯

N-H···O

-44.2

2

-

3

0

NTA

-43.8

3

2

6

0

EDTA

-37.2

4

-

2

2

Table 2.5 H-bonds and complexation energies of modeled ethylamides of metal-chelating
agents nitrilotriacetic acid (NTA) and ethylenediaminetetraacetic acid (EDTA). 29 was
modeled as a dimeric host as well.
However, computational study of a tripodal receptor candidate, 29, shows that all
three amide N-H moieties are in close contact with the chloride anion (<2.31Å) with the
entire complex in C3 symmetry as seen in Figure 2.8. The clockwise or counter-clockwise
nature of the side chains (clockwise from the anion-binding face in Figure 2.8) could mean
induced chirality in aggregates of molecules with larger alkyl or aryl side chains. The
short-chained compound 29 was modeled not as a real-world synthetic target, but as a
computationally-friendly model of such targets. The core of the investigation of this
family of compounds is the central amide residues retained in all variations of this family.
With compound, 29, yielding a -44.2 kcal mol-1 complexation energy advantage, a
synthetic targeting of this receptor type seems prudent. Lack of similar structures used as
anion receptors and the relative ease of synthesis (see synthetic approach, below) further
argued for this synthetic target. Utilization of alkylamides can aid in optimization of the
solubility and membrane permeability of this class of compounds. The addition of amino
acid moieties or peptide chains with N-termini coupled to the triacids can yield additional
structural variability.
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Figure 2.7 (Left) Lowest energy conformer of 33 exhibiting 4 intramolecular N-H···O
contacts (Right) Lowest energy conformer of 33-Cl¯ complex. Two amide N-H moieties
bind chloride with close contacts as shown in the foreground, while the remaining amide
N-H moieties are in close contact with the carbonyl oxygen atoms of the former.

Figure 2.8 Lowest energy conformer of 29-Cl- complex. All three amide N-H moieties
bind chloride with close contacts on the same face of the receptor as the central nitrogen
lone pair (hidden behind the chloride ion).

During modeling and geometry calculations, an idea took hold for receptor 29 (and
by extension any similar nitrilotriacetamide) binding in a 2:1 host to guest ratio with
chloride. This possibility was modeled in the gas phase and the relevant host and guest
energies were calculated.

However, the drop in the complexation energy advantage

expected from the addition of three complexing amide N-H moieties was not seen in the
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final energy calculations. In fact, the energy advantage was statistically even with a slight
drop from -44.2 kcal mol-1 to -43.8 kcal mol-1.

Figure 2.9 Orthogonal views of the tube model of the lowest energy conformer of
29·29·Cl- complex with six amide N-H moieties binding chloride with close contacts. The
complex has a pseudo-octahedral geometry with an extended midsection. The angles of
the opposite N-H vertices, passing through the guest at the center average are offset
between 8° and 12° from linearity. Additionally, the central nitrogen atoms are offset 11°
from linearity through the central guest ion.
The optimized LEC of the 29·29·Cl- complex (Figure 2.9) shows, as expected, both
hosts complexing the chloride anion with a total of 6 amide N-H residues, but the NH···Cl¯ distances have increased from <2.31 Å to between 2.42 Å and 2.44 Å. In contrast,
the N-H···Cl¯ bond angles have decreased from 27° to about 24°. The marginal bond angle
decrease (3°) paired with a significant N-H···Cl¯ contact distance increase (>0.1 Å) leads to
no significant change if both host molecules are taken separately. Essentially, it is the
interactions within the host molecule dimer in the gas phase that leads to the lack of
change in the complexation energy. Apart from the two intramolecular hydrogen bonds
already present in the monomer, the two remaining non-interacting moieties on each
monomer hydrogen bond intermolecularly as seen in the center of Figure 2.10. This gasphase dimerization leads to an energy difference of -22.7 kcal mol-1 in the host dimer
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(compared to two monomers) and no net energy advantage to using a 2:1 host to guest
complex.

Figure 2.10 Tube representation of the lowest energy conformer of the 29·29 homodimer.
Extensive hydrogen bonding (3 intramolecular and 2 intermolecular) lowers the gas phase
energy of the host and negates any energy complexation advantage from the three
additional amide N-H moieties in the complex seen in Figure 2.9.
While the modeling of 29 as a 2:1 dimer does not yield an additional complexation
advantage, the geometry of the complex—which fully encapsulates the guest chloride
ion—is intriguing. This encapsulation strategy was used in the development of cryptands
as cation binding agents18 and synthetic cation carriers.19 The 2:1 host to guest complex
was modeled for para-substituted trinitrilotriacetanilides 30-34. As seen below in Figure
2.11, The rigid tris-anilide side-arms interdigitate in the complex at interatomic distances
as close as 3.7 Å. In all of the complexes, six N-H···Cl¯ are present at an average H···Cl¯
distance below 2.17 Å and a bond angle that does not exceed more than an 11° deviation
from linearity. This information is summarized in Table 2.6.
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Dimeric
Host

parasubstituent

B3LYP
Ecomplexation
(kcal mol-1)

Average
N-H-Cl¯ Bond
Angle (°)

Average
N-H···Cl¯
Distance (Å)

N-H
Electrostatic
Potential
(kcal mol-1)

30·30

CH3

-72.7

171.6

2.163

84.2

31·31

H

-77.8

171.7

2.163

87.7

32·32

CN

-104.3

171.1

2.160

113.4

33·33

NO2

-106.3

169.9

2.169

115.7

Table 2.6 Summary of the calculated energies and relevant geometric measurements of
the para-substituted trinitrilotriacetanilides, hosts 30-34 modeled as the 2:1 dimer
complex.

Figure 2.11 Orthogonal views of the 31·31·Cl¯ complex.
While the geometry of each of these complexes is essentially identical, the most
telling aspect gleaned from the calculations is the electrostatic potential of the chloridebinding cleft. The electrostatic potential is the measure of attraction or repulsion of a
positive charge on an isodensity surface.20 This potential is negative (energetically
favored) at more electron rich regions of the molecule such as the oxygen atom of a
ketone. Conversely, this potential is positive (energetically disfavored) at more electron
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poor regions of the molecule, such as the carbon atom of a ketone, or in the present case,
the hydrogen atom of an amide. This calculated prediction of localized proton acidity
correlates well with the calculated complexation energies.

Alkyl- and arylureas
The fourth of five categories of host candidates includes the urea non-peptidic
compounds shown in Figure 2.11. The favorable interactions of the urea and thioureacapped peptides led to the idea of extending the moiety to simple non-peptidic
compounds—a

4-nitrophenyl

alkyl

urea

(36)

and

an

ortho-phenylene

bis(4-

nitrophenyl)urea (35). Both compounds have been made previously, with the former
studied for antimicrobial activity21 and the latter used as an anion binding agent.22

O

O
NH HN

O2N

NH

HN

NO2

Compound

N-H Donor(s)

B3LYP
Ecomplexation
(kcal mol-1)

35

(2x) Urea

-83.6

36

Urea

-46.5

35
H
N
O2N

H
N
O
36

Figure 2.12 Structures of the p-NO2 urea compounds 35 and 36.
Compound 35, the chloride complex of which is seen in space-filling form in
Figure 2.13, produces the largest calculated energy advantage from a 1:1 complexation of
all of the compounds studied with -83.6 kcal mol-1.
Unlike the dipicolinic and isophthalic acid receptors, the geometry of the native
host is nearly planar while, upon rotation of one of the side arms, becomes completely
planar in the complex. The host forms four close contacts between urea N-H moieties and
the chloride guest. The anion receptor cleft is in such a geometry that the N-H···Cl¯
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hydrogen bonds are very close to linearity (169.2° and 162.9°) and in close contact (2.27Å
and 2.32Å) with no real deviation from the lowest energy conformation of the native host.
While Gale and co-workers have shown that this compound does bind chloride in DMSOd6, 22 it has a preference for trigonal planar anions.

Figure 2.13 (Left)Space-filling models of the lowest energy conformers of the native host
35 (top) and the 35-Cl¯ complex (bottom). The chloride-bound host is in a low energy
fully-planar and fully-conjugated system, while the host deviates by < 7° from planarity.
(Right) Structures of the lowest energy conformers of the native host 36 (top) and the 36Cl¯ complex (bottom).
The alkylurea compound, 36, contains only one urea moiety. Conjugation with the
electron-withdrawing p-NO2 substituent creates a more acidic urea moiety. The chloride
binding moieties deviate more from linearity than the interactions seen with 35 (N-H···Cl¯
angles = 164.9° and 156.2°), but are in closer contact (2.13Å and 2.28Å). Observed in the
lowest energy conformation of the complex, hydrogen atoms of the 3-,6-, and 8- carbons of
the octyl chain are in close contact with the chloride anion (H···Cl¯ distance = 3.02Å,
3.33Å and 3.00Å, for the 3-, 6-, and 8- carbons, respectively). These C-H···Cl¯ interactions
are normally seen with aromatic carbons (the hydrogen atom ortho to the urea substituent
in 36 is at a contact distance of 3.32Å). The limited energy that must be associated with
these C-H···Cl¯ interactions could be roughly equal to the energetic penalty of the
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methylene carbons rotating out of the all-gauche conformation. All of the twenty lowest
energy conformers have at least one non-gauche rotation, but the second lowest energy
conformer has only one, signifying that the all-gauche conformation is energetically
favorable as well.

Dipicolinic acid / ortho-phenylene diamine macrocycles
The fifth and final category of candidate receptors includes macrocycles
incorporating ortho-phenylenediamine and dipicolinic acid. The ortho-phenylenediamine
moiety was chosen as it presents 2 hydrogen bond donors in close proximity to one
another, as ureas and thioureas do. The dipicolinic acid residue was used as the lone pair
electrons of the pyridine nitrogen can pre-organize the amide N-H moieties to interact with
anions. The geometry of the two components also complement each other.
The macrocyclic compound, 37, was targeted for its structural rigidity, as preorganized receptors do not have significant energetic penalties associated with rotation into
the optimal guest-binding conformation. The leftmost half of Figure 2.14 shows the
geometry-optimized structure of the native host. The host is held rigidly in a puckered
geometry with two adjacent arenes related by a dihedral angle of 36°. The dihedral angle
between ortho-phenylenediamine and each amide C-N bond is approximately 23° while
the dihedral angle between each C-N bond and pyridine is approximately 13.°

The

geometry of the host in the calculated complex, however, reverses these angles, with the
amide moiety more closely aligned with the phenylene plane rather than the pyridine plane.
The chloride binding strength of macrocycle 37 is comparable to the other reported
hosts. The binding geometry is not ideal, as the average N-H···Cl¯ bond angle deviates
approximately 22° from linearity and the average H···Cl¯ distance is 2.57Å. The rigidity
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and pre-organization of the host is a key aspect in explaining the favorable chloride
complexation energies. However, a chloride ion of a diameter of 3.56Å is too large to fit
into the pre-organized binding cavity which is approximately 1.6Å in diameter, when
including the van der Waals radii of the binding amide protons. Fluoride (d = 3.02Å) may
be a better suited guest for this receptor.

Dihedral Angle
Structure

Average

Average

B3LYP

Pyridine/

Amide/

Pyridine/

H···Cl¯

N-H···Cl¯

Ecomplexation

Amide

Phenylene

Phenylene

Distance

Angle

(kcal mol-1)

37

13.1°

22.7°

35.8°

-

-

37·Cl

33.5°

-42.5
16.1°

50.6°

2.57Å

158.1°

Figure 2.14 Orthogonal views of the the lowest energy conformer of the 37 host (left) and
the 37-Cl- complex. “Puckering” of the ring allows for a better chloride binding geometry
in the complex, although the hydrogen bonds deviate by about 22° from linearity.
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Unfortunately, macrocycle 37 was reported in the literature during the initial phase
of this investigation.23 Therefore, a second type of macrocycle was envisioned that made
use of a repeating sequence of ortho-phenylenediamine, amino acid, dipicolinic acid, and
amino acid. This larger macrocycle may better complement larger anion guests with a
more favorable binding geometry.
This second design approach also allows for the incorporation of either D- or L-,
hydrophobic or hydrophilic, or natural or artificial amino acids to either aid in solubility or
anion binding or resist biodegradation. Only macrocycles incorporating four arenes and
four amino acids were modeled and binding energies were calculated.

Any larger

macrocycles would require greater computational and synthetic resources and were ruled
out. However, the macrocycles present, at a minimum, 8 hydrogen bond donors available
for chloride complexation.

Additional binding moieties can be integrated using

appropriate amino acids such as serine and threonine (used previously with compounds 27
and 28) or others such as asparagine, which have two hydrogen bond donors.
Three of the two-repeat macrocycles have been modeled and analyzed—the
tetraglycine version, 38, the tetraserine version, 39, and the tetraasparagine version, 40, all
seen in Figure 2.15. The latter two were modeled with the idea in mind of increasing the
available hydrogen-bonding moieties, and in turn increasing binding strength while the
former gives a good reference to the effects of adding different side chains into the mix.
Compound 40 also lends an increase in side arm flexibility (from the added length)
resulting in a high number of low energy conformers and increasingly difficult and
computationally-expensive geometries to optimize.
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Figure 2.15 Structures of the tetraarene, tetraamino acid macrocycles 38-40. In
compound 38, an array of 8 possible hydrogen bond donors are presented while
compounds 39 and 40 present 12 and 16 donors, respectively. Note that the amount of
hydrogen bond acceptors also increases from 10 for 38 to 14 for 39 and 40.
Focusing the discussion on the differences between compounds 38 and 39, we can
see in the orthogonal views of the two chloride complexes (Figure 2.16) that host 39 nearly
encapsulates the chloride ion from the back, front, and sides. Notably, in the front, relative
to viewpoints on the left-hand side of Figure 2.16, the serine side chain alcohol moieties
are binding and better encapsulating the chloride anion. Three of the four serine side
chains are binding the chloride anion, yet they replace the same number of amide hydrogen
bond donors, resulting in no net gain in close contacts. While an intramolecular hydrogen
bond is retained in the host molecule within the complex, host 39 starts out with eight
intramolecular hydrogen bonds in its native form and thus must sacrifice seven of them to
bind chloride.

In contrast, host 38 only has four intramolecular hydrogen bonds to

sacrifice and a binding event involves the same number of hydrogen bond donors. As a
result, host 38 has a greater net complexation energy advantage than its serine counterpart
(see Table 2.7 for full details)
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Figure 2.16 Orthogonal views of the CPK model of the tetraglycine compound 38, top, and
the tetraserine compound 39, bottom. In compound 38, six of eight amide hydrogen-bond
donors are in close contact (H···Cl¯ <2.75Å) at reasonable ion-dipole interaction angles
(>150°). Two hydrogen-bond donors are geometrically forbidden from anion binding. A
noticeable exposure to the outside environment is seen in the leftmost view. This exposure
is somewhat diminished with 39 as host molecule in which three of the amide-chloride
interactions are replaced with three serine side chain hydroxyl-chloride interactions,
forming a more octahedral binding domain as seen in chloride complex of the dimer of the
nitrilotriacetamide 29.
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Compound

Amino
Acid

Complexation
Energy
(kcal/mol)

38

Gly

39
40

Contacts in Complex

Intramolecular H-Bonds

N-H···Cl¯

O-H···Cl¯

Host

Complex

-58.0

6

-

4

0

Ser

-50.6

3

3

8

3

Asp

-52.3

4

-

9

9

Table 2.7 Comparison of compounds 38 and 39. 38 is predicted to complex chloride more
efficiently as the incorporation of the serine alcohol side chains in 39 affords no additional
chloride-dipole close contacts and results in the breaking of seven intramolecular
hydrogen bonds rather than four broken in 38 to bind chloride. Close contacts and
hydrogen bonds are defined as those with less than or equal to a 2.75Å hydrogenheteroatom or hydrogen-chloride distance, the presumed bifurcated hydrogen bonds
observed in the dipicolinic diamide system are not counted as binding with the pyridine
nitrogen lone pair.

Synthetic approaches and synthesis of selected modeled anion receptors
The receptors outlined in this study were designed and investigated for their
simplicity and ability to be structurally-modified. Both of these traits are highly desirable
in the context of new applications—the former for minimizing the use of resources and the
latter for optimizing a desired function. The families outlined above make use of amino
acid residues, alkyl or aryl moieties, or some combination of the three.
The use of alkyl substructures in a family of compounds allows for the optimization
of solubility and membrane permeability. Ethyl substituents were used as a stand-in for
any length alkyl chain in the modeling studies, as this minimized computational cost. The
exception to this is the octyl urea compound, 36. Utilization of substituted aryls allows for
the optimization of the strength of chloride interaction. Insertion of amino acids into
receptor molecules allows for further optimization of membrane permeability and chloridebinding characteristics with variation of the amino acid side-chains. With these key aspects
in mind, receptors 1-40 were targeted to both allow these structural variations and
minimize the synthetic steps (and resources used) to access these compounds.
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With 40 proposed synthetic receptors modeled computationally, the accessibility
for all of the families were assessed by the development of a synthetic approach for each.
The synthesis and characterization of the dianilides 1, 2, 7 and 8, as well as similar
compounds not enumerated here, are detailed in Chapter 3 in the context of the full
investigation of that family of compounds for anion binding, transport and channel
functionality.
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Scheme 2.1 Synthesis of modified peptides 13-16. Peptide length can be varied by the use
of extra peptide coupling steps while different amino acids can be used at any step to vary
the side-chains, giving access to the remainder of the modified peptides outlined above.
“EDCI” = 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; “HOBt” =
1hydroxybenzotriazole.
The protected peptides 13-28, are similar to the SAT molecules studied in the
Gokel lab, and are accessed through a similar synthetic approach. Standard solution
coupling methods would be used to prepare these modified peptides. Scheme 2.1 shows
the approach used to access the N-terminal-varied dialanine compounds 13-16. This same
approach can be used to access the remaining protected peptides, 17-28, and peptides of
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the same class. This is accomplished by variation of the amino acids used or the number
of amino acids coupled (for longer chains).
The approach consists of first coupling the alkylamine to the C-terminus of the
peptide, accomplished in the first step using EDCI or 1-ethyl-3-(3-dimethylaminopropyl),
a carbodiimide amide coupling agent24 and HOBt or 1-hydroxybenzotriazole, a
racemization suppressor. 25
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Scheme 2.2 Synthesis of nitrilotriacetanilides 30 and 31 and the proposed approach for the
synthesis of the N,N’,N”,N’”-alkyl tetrakis(ethylenediaminetetraacetic)acetamide,
(modeled by 34) from the corresponding tri- or tetraacid and the appropriate equivalents
of aniline or alkylamine. “DCC” = 1,3-dicyclohexylcarbodiimide.
A coupling agent is also used in the synthesis of nitrilotriacetanilides 30 and 31 as
shown in Scheme 2.2. DCC, or 1,3-dicyclohexylcarbodiimide, is an older variety of the
carbodiimide family of compounds. As no stereocenters are present in the proposed
receptors, a racemization suppressor is not utilized in this coupling interaction.
Unfortunately, the yields for these two compounds are relatively low, and a different
coupling reagent or different conditions may be used to optimize the synthetic efficiency if
future work were to progress with this type of anion receptor. Scheme 2.2 also shows a
synthetic approach for the tetraamides of EDTA. This methodology can be used for
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compounds in both classes. The poor solubility of the tri- and tetraacids in organic solvent
necessitates a reaction performed in an aqueous environment, and this is accomplished
using this procedure.
The N-(4-nitrophenyl)-N’-octylurea, 36,21 and bis(4-nitrophenyl)urea, 35,22 have
both been made previously. However, a synthetic method developed by Barbiou and coworkers26 was used to synthesize these receptors as seen in Scheme 2.3. The compounds
were made in one step from commercially available material in quantitative or nearquantitative yields. Variation of the substituents present on the phenyl isocyanate ring can
be used to optimize the chloride binding strengths of both 35 and 36 while variation of the
alkylamine (R) used in the synthesis of 36 can be used to optimize solubility and
membrane permeability of this type of receptor.
O2N

N
[2 equivs.]

C
O

+

O2N

NH

MeCN

HN

O
NH2

NO2

NH HN
O

Reflux, 5h
95%

NH2

O2N

N

+
H2N

35

C
O

H
N

MeCN
Reflux, 5h

O2N

H
N
O

36

quant.

Scheme 2.3 Synthesis of urea 36 and bis-urea 35 from 4-nitroisocyanate.
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Scheme 2.4 Synthetic approach to macrocycle 38 from dipicolinic acid, glycine benzyl
ester, and 2-nitroaniline. While the acyclic receptor 41 was accessed, the later coupling
with 2-nitroaniline was unsuccessful. “PyBrOP” = Bromo-tris(pyrrolidino)phosphonium
hexafluorophosphate; “DIPEA” = N,N-diisopropylethylamine.
The tetraarene / tetraamide macrocycle, 37, has been made previously,23 along
with a number of other similar compounds,27 so the synthetic approach to this molecule is
not outlined here. However, the macrocycles incorporating amino acid residues, 38-40,
have not, to our knowledge, been made previously. The synthetic approach to access the
tetraglycine compound, 38, is shown above in Scheme 2.4. The first two steps include the
coupling of dipicolinic acid to two equivalents of C-protected glycine through formation of
the dicarbonyl chloride to yield the acyclic bis-glycine dipicolinamide, 41. This compound
was studied in Chapter 5 for antimicrobial activity.
After hydrogenolysis of the benzyl esters, attempts were made to couple the
resulting diacid with 2-nitroaniline. However, the electron-withdrawing nature of this
substituent significantly decreases the nucleophilicity of the aniline amino moiety,
resulting in no reaction. While the coupling reagent, bromo-tris(pyrrolidino)phosphonium
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hexafluorophosphate, or PyBrOP, is shown in Scheme 2.4,

EDCI was also used

unsuccessfully as a coupling reagent.
A second strategy to access this class of compounds could make use of coupling Nprotected amino acid residues to 1,2-phenylenediamine through the C-termini.

After

deprotection, the N-termini could be coupled to a dipicolinic acid that has been
monobenzylated.

After hydrogenolysis and a cyclization coupling step, the desired

marocycle could be achieved. As detailed in Chapter 3, the success of the dipicolinic
dianilides as anion receptors and transporters precluded further synthetic exploration of the
tetraamino acid, tetraarene macrocycle family.

Conclusions

This survey of a vast number of novel structures has yielded better insight into
which anion-binding moieties and how many should be used in a successful anion
receptor. Modeling of the N-capped peptides has shown that the use of urea and especially
thiourea in the binding cleft can lead to a significant complexation energy advantage over
carbamates or amides.
The lengthening N-capped peptides, nitrilotriacetamide dimers, and the tetraamino
acid tetraarene macrocycles has shown that larger, more complex molecules with more
hydrogen bond donor moieties may not be advantageous when considering the design of an
anion receptor or transporter. Utilization of amides or ureas as hydrogen bond donors in a
binding motif also presents hydrogen bond acceptors in the native host. If a significant
amount of intramolecular hydrogen bonding exists in the host because of this, then
intramolecular host hydrogen bond would need to be broken and complexation may not be
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as energetically favored as one would anticipate. The best approach, therefore, would be
one that considers just a few amide or urea residues rather than many.
Modeling

of

the

2:1

host

to guest

complexes

of

4,4’,4’’-substituted

nitrilotriacetanilides and chloride has shown that that electron withdrawing substituents in
a π-system including anion-binding moieties dramatically lowers the binding energy.
Correlation with the calculated electrostatic potential maps reveals that this is caused by
increasing proton acidity. This characteristic is exploited more fully in the investigation of
the dipicolinic dianilide chloride transporters in Chapter 3.
These calculations give good predictions of actual molecules, yielding insight into
what substructures should be incorporated and how variations of those structures can
optimize the desired activity. However, once a family is designed and leads are made, they
must be correlated with experimental data to truly yield relevant information.

The

calculations performed for the dipicolinic dianilides are further expanded upon in Chapter
3 leading to work done with these compounds as synthetic ion channels. A few of the
other compounds modeled in this survey are approached synthetically, and the resulting
compounds are tested for antimicrobial activity as detailed in Chapter 5.

Experimental

General.
Reagents were the best (non-LC) grade commercially available and were distilled,
recrystallized or used without further purification, as appropriate. CH2Cl2 was distilled
from calcium hydride. Unless otherwise stated, all chemicals were purchased from SigmaAldrich (St. Louis, MO).
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Melting points were determined on a Thomas Hoover apparatus in open capillaries
and are uncorrected. All 1H NMR spectra were recorded on a Bruker Avance 300
spectrometer at 300 MHz and all chemical shifts are reported in ppm (δ), calibrated to
literature values for internal solvent with integrated intensity (X H) and multiplicity (b =
broad, s = singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, m = multiplet,
etc.) and coupling constants in Hz.

13

C-NMR spectra were obtained on a Bruker Avance

300 spectrometer at 75.4 MHz and referenced to solvent literature values for chemical
shifts. All Mass Spectrometry experiments were performed at high resolution on a JEOL
MStation, JMS-700, double focusing high-resolution instrument using the fast-atom
bombardment ionization technique in the positive ion detection mode. Calculations were
run using the Spartan 2006 software package on a Dell Dimension DXP061 desktop with a
2.40GHz Intel® Core™2 Processor and 2.00GB of RAM.

Molecular Modeling
The following calculation method is the third such version as described in this
method. All calculations and visualizations are performed using Spartan ’06 software from
Wavefunction Inc. The Monte Carlo simulated annealing method was used to determine
the twenty lowest energy conformations (LECs) from ten thousand conformations using
the Merck Molecular Force Field, a molecular mechanics level of theory. In some cases,
fewer than twenty LECs are generated when conformational flexibility is limited. The
geometry of these twenty LECs were then optimized first using the RM1 semi-empirical
method and then at the density functional level of theory using the B3LYP method with a
6-31G* basis set. The final single point, ground state energy calculations and electrostatic
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potential mapping were performed with the B3LYP method and the 6-31G* basis set. For
a specific set of final energy calculations, the electron-correlating MP2 method was used.
In every case, the conformer with the lowest calculated single point energy was
used for the calculation of the complexation energy. This calculation was performed by
adding the energies of the host and guest, then subtracting the energy of the complex. The
complexation energy is listed as a negative value if the interaction is favorable, the more
negative a value the more favorable an interaction.

N,N’,N’’-tris(phenyl)nitrilotriacetamide, 31
This compound was made previously by Greco and Schrock28 as an intermediate
for a metal coordination complex. The synthetic procedure from that work was used here.
No melting point was reported, but the spectral data agrees with what was determined
previously.
Aniline (1.84 g, 19.8 mmol) was added to a stirring suspension of nitrilotriacetic
acid (1.25g, 6.5 mmol) in water (14.0 mL) and stirred until a solution is formed (complete
proton exchange forming the salt).

To this solution is added a solution of 1,3-

dicyclohexylcarbodiimide (4.10 g, 19.9 mmol) in tetrahydrofuran (21.0 mL). The reaction
was stirred under N2 overnight. The resulting suspension was filtered over a glass frit,
retaining the crude product as a white solid.

This was suspended and filtered with

methanol (3x15mL) and diethyl ether (3x15 mL). The white solid was suspended in
dimethylformamide (4x25mL) and filtered over a glass frit, with the filtrate reduced in
vacuo to yield an off-white solid. This was suspended in a 2:1 mixture of diethyl ether and
chloroform (50 mL) before filtering, retaining the white solid. Trace solvent was removed
in vacuo to yield the pure product as a white solid (0.421 g, 16%, m.p. = 217°-220°C). 1H-
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NMR (DMSO-d6): 3.67 (6H, s, NCH2C(O)), 7.06 (3H, t, J = 7.3 Hz, Anil 4-H), 7.33 (6H,
dd, J1 = 8.0 Hz, J2 = 7.3 Hz Anil 3/5-H), 7.66 (6H, d, J = 8.0 Hz, Anil 2/6-H), 10.47 (3H,
s, C(O)NH-Anil).13C-NMR (DMSO-d6): 58.9 (NCH2C(O)), 119.4 (Anil 2/6-C), 123.7
(Anil 4-C), 129.2 (Anil 3/5-C), 139.2 (Anil 1-C), 170.4 (CH2C(O)NH). FAB-MS: m/z calc
for [M+H]+ 417.1926, found: 417.1926.

N,N’,N’’-tris(4-methylphenyl)nitrilotriacetamide, 30
The synthetic method for of this compound is similar to that used for N,N’,N’’tris(phenyl)nitrilotriacetamide, above, using an approach developed by Greco and
Schrock.28 p-Toluidine (2.18 g, 20.3 mmol) was added to a stirring suspension of
nitrilotriacetic acid (1.28g, 6.7 mmol) in water (25.0 mL), heated to 58°C and stirred until
a solution is formed. To this solution is added a solution of 1,3-dicyclohexylcarbodiimide
(4.21 g, 20.4 mmol) in tetrahydrofuran (15.0 mL). The reaction was stirred under N2
overnight. The remaining work-up is identical to above. Trace solvent was removed in
vacuo to yield the pure product as a white solid (0.562 g, 18%, m.p. = 216°-218°C). 1HNMR (DMSO-d6): 2.25 (9H, s, Anil-CH3), 3.63 (6H, s, NCH2C(O)), 7.12 (6H, d, J = 8.3
Hz, Anil 3/5-H), 7.53 (6H, d, J = 8.3 Hz, Anil 2/6-H), 10.21 (3H, s, C(O)NH-Anil).13CNMR (DMSO-d6): 20.4 (Anil CH3), 58.5 (NCH2C(O)), 119.1 (Anil 2/6-C), 129.1 (Anil
3/5-C), 132.2 (Anil 4-C), 136.3 (Anil 1-C), 169.7 (CH2C(O)NH). FAB-MS: m/z calc for
[M+H]+ 459.2396, found: 459.2379.

N,N’-(1,2-Phenylene)bis([4-Nitrophenyl]urea), 35
This compound was made previously by Gale and co-workers22 as a carboxylate
receptor. No melting point was reported, but the spectral data agree with what was
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determined previously. A synthetic procedure derived from the work of Barbiou and coworkers26 was used.
A solution of 1,2-phenylenediamine (0.2880g, 2.66 mmol) in acetonitrile (20 mL)
is added dropwise to a stirring solution of 4-nitrophenylisocyanate (1.0163 g, 6.19 mmol)
dissolved in acetonitrile (50 mL for 70 mL total). The reaction was heated to reflux and
stirred for 5 hours. After cooling, the resulting yellow suspension was filtered and washed
with acetonitrile (1 x 10 mL) and dichloromethane (2 x 10 mL) before drying under high
vacuum. The resulting yellow solid is retained as the pure product (1.1088 g, 95%, m.p. =
293°-297°C).

1

H-NMR (DMSO-d6): 7.19 (2H, m, o-Phen 4/5-H), 7.71 (2H, m, o-Phen

3/6-H), 7.78 (4H, d, J = 9.2 Hz, Isocyan 3/5-H), 8.19 (4H, d, J = 9.2 Hz, Isocyan 2/6-H),
8.83 (2H, bs, Urea N-H), 9.32 (2H, bs, Urea N-H).

N-(4-Nitrophenyl)-N’-octylurea, 36
This compound was made previously by Micich.21 The observed melting point
agrees with the literature value. A synthetic procedure derived from the work of Barbiou
and co-workers26 was used.
A solution of octylamine (0.32g, 2.5 mmol) in acetonitrile (10 mL) is added
dropwise to a stirring solution of 4-nitrophenylisocyanate (0.30 g, 1.8 mmol) dissolved in
acetonitrile (10 mL for 20 mL total). The reaction was heated to reflux and stirred for 5
hours. After cooling, the resulting yellow suspension was filtered and washed with
dichloromethane (2 x 10 mL) before drying under high vacuum. The resulting yelloworange solid is retained as the pure product (0.53 g, 97%, m.p. = 110°-113°C, Lit.21 =
113°-114°C).

1

H-NMR (DMSO-d6): 0.86 (3H, t, -CH3), 1.25-1.28 (10H, pseudo-s,

CH2CH2CH2), 1.55 (2H, m, -CH2CH3), 3.47 (2H, bdt, J = 5.7 Hz, NHCH2CH2), 7.84 (2H,

62

d, J = 9.2 Hz, Isocyan 3/5-H), 8.16 (2H, d, J = 9.2 Hz, Isocyan 2/6-H), 8.38 (1H, bt,
NHC(O)NHCH2), 10.21 (1H, bs, ArNHC(O)NH).

13

C-MR (DMSO-d6): 14.0 (CH2CH3),

22.1 (CH2CH2CH3), 26.5 + 28.1 + 28.7 + 28.7 + 31.3 (CH2CH2CH2), 43.9 (NHCH2CH2),
120.2 (Isocyan 2/6-C), 124.5 (Isocyan 3/5-C), 141.9 (Isocyan 4-C), 147.1 (Isocyan 1-C),
179.9 (NHC(O)NH).

N2,N6-bis(glycine benzyl ester)pyridine-2,6-dicarboxamide, 41
2,6-pyridinedicarbonyldichloride (3.24 g, 15.88 mmol) was dissolved in
dichloromethane (40 mL) and was added dropwise to a stirring solution of the tosyl salt of
glycine benzyl ester (12.81 g, 37.8 mmol) and triethylamine (20.0 mL, 143.6 mmol) in
dichloromethane (60 mL additional for 100 mL total) held at 0°C in an ice bath. Upon
completion of the addition, the system was returned to room temperature and stirred for 4
hours. The reaction was quenched with the addition of 100 mL of 5% (w/w) ammonium
chloride in water. The organic layer was washed with 5% sodium carbonate (2 x 50 mL)
and water (2 x 25 mL), dried over magnesium sulfate and filtered before removing solvent
in vacuo to yield the crude product as a dark red oil. The crude was chromatographed over
silica with 1:1 hexane to ethyl acetate  ethyl acetate  methanol to yield the pure
product as a light orange oil (7.18 g, 73%, oil). 1H-NMR (CDCl3): 5.18 (4H, s, OCH2Ar),
4.16 (4H, d, J = 5.9 Hz, NHCH2C(O)), 7.29-7.37 (10H, m, Bn-H) 7.89 (1H, t, J = 7.8 Hz,
Pyr 4-H), 8.16 (2H, d, J = 7.8 Hz, Pyr 3/5-H), 8.43 (2H, bt, J = 5.8 Hz, C(O)NHCH2). 13CNMR (CDCl3): 41.7 (NHCH2C(O)), 67.6 (OCH2Ar), 125.4 (Pyr 3/5-C), 128.7 + 128.9 +
129.1 (Bn 2/3/4/5/6-C), 136.0 (Pyr 4-C), 139.4 (Bn 1-C), 148.5 (Pyr 2/6-C), 164.1 (PyrCOCH2), 171.0 (CH2C(O)O). FAB-MS: m/z calc for [M+H]+ 462.1665, found: 462.1658.
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CHAPTER 3
Chloride Binding, Transport, and Channel Functionality of
Dianilides of Dipicolinic Acid and Isophthalic Acid

Summary and Contributions to this Work

Dianilides of 2,6-pyridine dicarboxylic acid (dipicolinic acid), a family of
compounds modeled in Chapter 2, were synthesized, characterized, and studied for carrier
and channel activity in biological systems and biological model systems.
The first dipicolinic dianilides were made in a two-step synthetic process with
overall yields of 40-70% and covered a range of substituent character from the electrondonating para-methyl substituent to the electron-withdrawing para-nitro. Initially, the
compounds were investigated for chloride-binding activity in the context of chloride
receptor utilization. 1H NMR binding constants were derived in both polar DMSO-d6 and
non-polar CD2Cl2, with the titrations showing that chloride binding activity was present
even in the polar milieu of DMSO-d6. These results were correlated with the previous
molecular modeling studies, as well as with competitive electrospray ionization-mass
spectrometry studies performed by collaborators.

Amide proton acidity and chloride

binding strength both increase with increasing anilide substituent electron-withdrawing
character.
A fluorescence-quenching assay was used to monitor chloride influx mediated by
this series of compounds into phospholipid vesicles over time. These studies show that
dianilides with more acidic protons attain approximately 80% of chloride transport, while
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those with less acidic protons elicit approximately 20% of chloride transport. In both
cases, the maximal chloride transport is achieved within 600 s of application.
Using the planar bilayer conductance technique, a collaborator, Saeedeh Negin,
confirmed channel functionality, showing that one of the highly-active chloride
transporters exhibits classic open-close behavior. A dipicolinic dianilide transporter
monomer at its widest is approximately 15Å and is incapable of spanning the roughly 30Å
of the hydrophobic region of the bilayer membrane. Thus, unable to work alone, the
monomers must somehow aggregate to elicit the exhibited channel functionality. Using
calculated geometries of stacked molecules, along with the concentration-dependent
fluorescence profiles of the transporters, a stacking interaction was posited as the
mechanism of channel formation.
I performed all calculations, syntheses and characterization, proton NMR binding
studies, chloride transport studies, and optical spectroscopy detailed here. A fellow Gokel
research group member, Alex Carasel of Washington University, along with Joseph
Kramer and Dr. Rudolph Winter of the University of Missouri-St. Louis, performed the
electrospray-ionization mass spectrometry studies. Saeedeh Negin, another member of the
Gokel research group and a graduate student at the University of Missouri-St. Louis,
performed the planar bilayer studies.
A portion of this work is included in a paper published in Chemical
Communications in 2010. 1

Introduction

The transport of anions is limited by the same constraints that are common to all
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transport processes.2 Similar to the demands of ion receptors, selectivity is dictated by a
binding or complexation interaction. These complexation forces must be strong enough so
that recognition can occur but, unlike receptors, weak enough to maintain a dynamic
system in order to effect transport. Once this dynamic characteristic is established, a
successful transporter may elicit functionality through one of two mechanisms—carrier or
channel.
The carrier mechanism is often likened to a boat ferrying passengers back and forth
across a river, while a channel is analogous to a bridge spanning the river, allowing the free
and continuous passage of anyone wishing to cross. The metaphorical comparison extends
to the rate of transport observed with the two separate mechanisms. An ion-carrier
molecule first binds an ion on one side of the membrane barrier, diffuses across the
membrane, and releases the ion on the far side of the barrier, repeating until equilibrium is
established. Potassium transport by valinomycin, one of the best known ion carriers,
reaches a level of 104 ions per second3 while a functional pore such as gramicidin may
conduct ions at a rate of 108 or even 109 ions per second.4
The roughly thousand-fold difference in transport rate is attributable to the ratelimiting diffusion process required of a carrier.5 Since a protein channel, at the very least,
spans the width of the hydrophobic bilayer domain, no diffusion is required for the channel
to elicit transport activity.
However, the size of the channel is another issue, as only a certain number of ions
can pass a confined space at any given time. Like a draw bridge, the channel may open and
close at intervals, with no ions or current passing across the barrier when the channel is
closed. If two channels are open simultaneously, the current will be double that of a single
channel.
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Many of the particulars of binding interactions for various anion hosts have been
obtained from binding constant determinations and X-ray crystal structure studies.6 While
the latter can yield valuable insights into static binding arrangements, the geometries and
stabilizing interactions of the solid-state may be altered in the presence of solvent
molecules. Binding constants can gauge the strength of the interactions in solution, but ion
transport is a dynamic process that cannot truly be verified without the use of dynamic
tools in biological model systems.
Several techniques have been developed over the past decades to assess ion
transport functionality. These methods range from the U-tube technique using a waterorganic partitioning to gauge carrier functionality7 to vesicle-based systems that monitor
intra- or extravesicular ion concentration levels.8
The complexation of anions was explored nearly concurrently with the
development of cation complexation by crown ethers.9 Examples include studies reported
by Simmons,10 Schmidtchen,11 Lehn,12 de Mendoza,13 Newcomb,14 and others.6 Great
interest and activity in this area burgeoned only recently, however. By far, the most
common complexation mode for such anions as fluoride and chloride has been hydrogen
bonding, particularly by amides or protonated amines. Characterization of anion complexes
has often been accomplished by X-ray crystallographic methods, although solution
studies15 and much more rarely, dynamic transport studies16 have also been reported.
In 1999, Crabtree and coworkers reported a much emulated isophthalic acid
dianilide anion host.17 This isophthalic dianilide bound Br¯ in the solid state and Cl¯ in
CHCl3 solution. Since these first reports, the family of studied isophthalic acid dianilides
has been greatly expanded by Gale and coworkers,18 the receptor has been incorporated as
an anion-binding subunit into ion-pair hosts,19 while isophthalamides have been reported

69

that replace the aniline subunit with other aromatics such as aminoindoles20 or with
alkylamines.16e Numerous pyridine-2,6-dicarboxylic acid dianilides are known as well
although most were prepared for study in a context other than anion complexation.21
Dipicolinamides have been incorporated as subunits into structures such as Lehn's helices22
and Anslyn's cyclophane receptor for trigonal planar anions.23
For a potential new chloride channel or carrier to transport its quarry, either must
recognize and bind chloride or at least organize solvent molecules to indirectly bind the
anion. For the most part, compounds that are thought to form channels or pores are of a
length at sufficient to penetrate a single leaflet of a bilayer membrane, while most span
both leaflets of the bilayer. An exception exists in the system developed by Sakai, Matile
and coworkers that appears to stack dendritic folate rosettes within the bilayer.24 Using
planar bilayer conductance studies, transport of various cations was demonstrated for this
assembly. The arrangement of multiple individual elements in an organized membranespanning stack seems unlikely from an energetic point of view but essential in the light of
the experimental evidence. That transport occurs is unequivocal, so some type of organized
assembly that mediates transport must form.
While several synthetic chloride ion channels have been prepared,25 only one
example of channel function by an isophthalamide, and none by a dipicolinamide, has
appeared before completion of the current work.1

Li et al. showed that a bis(α-

aminoxyamide) derivative of isophthalic acid can form Cl¯-conducting channels in
phospholipid bilayers.26

This is remarkable because the isophthalamides are small

molecules that seem incapable of spanning a bilayer membrane and would require both
aggregation and organization to function as a channel. Li et al. have offered no structural
suggestion to account for pore formation.
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Recent work published by Yang and co-workers26b has expanded upon the
biological and biophysical effects of their chloride channels in living cells, but have yet to
offer an explanation for the mechanism of chloride channel formation. The goals of this
study of the dipicolinic dianilides were therefore twofold: to compare the chloride-binding
abilities of these dipicolinamide compounds, and to determine the efficacy and mechanism
of chloride transport activity.

Results and Discussion

Compounds prepared for the current study
Compounds 1-4, 7 and 8 were prepared as outlined in Scheme 3.1 by converting
2,6-pyridinedicarboxylic acid into the corresponding dichloride using SOCl2, followed by
coupling with two equivalents of amine in the presence of triethylamine.27 Compounds 912 were prepared in one step from the commercially-available 2,6-pyridinedicarbonyl
dichloride. The well known isophthalamide, 5,17b was used as a control in the ion-binding
studies. Previously-unstudied 628 was prepared as a comparison to the deeply-investigated
compound 4. Both of these compounds were prepared in one step from commerciallyavailable isophthaloyl dichloride. All products were characterized by 1H- and

13

C-NMR

and mass spectrometry. Structural data were as expected, and agreed with published
values where available.
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Compound

Y=

X=

Yield

m.p. (°C)

1

N:

4-CH3

42%

223-224

2

N:

H

86%

277-278

3

N:

4-CN

34%

304-306

4

N:

4-NO2

52%

> 330

5

CH

H

67%

291-294

6

CH

4-NO2

40%

> 330

7

N:

4-NHC(O)CH3

72%

195-196

8

N:

4-C(O)CH3

76%

>330

9

N:

3- CH3

78%

211-214

10

N:

3-CN

37%

260-261

11

N:

3- CF3

41%

288-291

N:
3-Cl
70%
245-247
12
Scheme 3.1. Synthesis of compounds 1-12 with yields reported over one or two steps as
appropriate. Compounds 5, 6, and 9-12 were made in one step from the appropriate
commercially-available dicarbonyl chloride. Compounds 1-4 and 7-8 were made in two
steps.
Comparison of calculated and solid state structures
Much of the work with dipicolinamides and isophthalamides has focused on solidstate structures and anion binding. Accordingly, there are a number of crystal structures
and binding constants of these hosts or closely related molecules available in the literature.
To give us a sense of chloride-binding strength we can model these hosts and their
complexes and calculate their associated energies (see the “Calculated gas-phase chloridebinding energies” section below), but the structures themselves yield insights into host and
complex geometries outside of the solid-state and the influence of crystal-packing forces.
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Comparison of solid-state and calculated gas-phase structures, therefore, seemed a
necessary step in developing of our binding models.
Figure 3.1 shows calculated gas-phase structures for the related isophthalic and 2,6dipicolinic acid dianilides. The geometries of the unbound host molecules are significantly
different from one another. The dipicolinamide adopts a syn-syn conformation of sidearms, with amide protons directed inward, while the isophthalamide host adopts a syn-anti
side-arm conformation with only one amide proton directed inward. All of the dipicolinic
dianilide hosts were calculated to be planar in their unbound forms, maintaining an
extended conjugated π-system while minimizing molecular dipoles. The pyridyl lone pair
offers little or no steric hindrance of the type the 2-hydrogen does in isophthalic acid.
While the solid-state structure of the 4-CH3 isophthalamide (CSD:ATIQAV) reported by
Nimmanpipug

et

al.29

confirms

this syn-anti

conformation, the unsubstituted

isophthalamide (CSD: PULHUZ)27b adopts the syn-syn conformation seen in the calculated
gas-phase and experimental solid-state structures of dipicolinamides. This difference may
be attributable to a more favorable crystal packing geometry arising from the syn-syn
conformation.
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Figure 3.1. Structural comparison of dianilides of isophthalic acid (left) and dipicolinic
acid. Space filling models are of the DFT energy-minimized conformer of the unsubstituted
dianilides

Figure 3.2.Orthogonal depictions of the solid-state structure of the DMSO pseudopolymorph of 4, as determined by X-ray analysis.
Solid-state structures of 1 (CSD: RABZUK),30 2 (CSD: PULJAH), 27b and of 4 have
previously been reported. The latter was crystallized by Yin et al.31 from several different
solvents but not in the presence of Cl¯. The study rather described the formation of
pseudo-polymorphs in which 4 was solvated by DMSO (CSD: NEDSAR), DMF (CSD:
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NEDRUK), or MeCN (CSD: NEDROE). In that work, the oxygen atom of a single DMSO
molecule in 4DMSO was coordinated to the amide hydrogen atoms of the dipicolinamide.
Along with the original report by Kavalleratos et al. of the isophthalamideBr¯
complex,17b structures have been reported by Gale and coworkers32 of compounds related
to 4, namely N1,N3-bis(3-nitrophenyl)isophthalamide co-crystallized with Bu4NPF6 (CSD:
QAGFAG)

and

N1,N3-bis(3,5-dinitrophenyl)isophthalamide

with

Bu4NF

(CSD:

QAGFEK). The existence of these structures led to our desire to deduce a complex of the
more biologically-relevant chloride ion with receptor 4. Numerous attempts to cocrystallize 4 as a chloride complex (in DMSO with NBu4Cl or NaCl) afforded only the
uncomplexed receptor. Therefore, the previously published structure with DMSO (CSD:
NEDSAR)31 was compared with the calculated host 4 geometry. No direct solid-state
comparison could be made with the calculated 4 Cl¯ complex.

Figure 3.3. (A) Solid state structure of 4 viewed from above, derived from the work of Yin
et al.31 The top molecule is represented as sticks and the lower in the space-filling
metaphor. The two molecules are offset by ~60o and the interplanar distance is ~3.4 Å. (B)
The gas-phase calculated electrostatic potential map (DFT/B3LYP/6-31G*) of receptor 4
with a capped-stick structural overlay depicting the underlying geometry. The more
electronegative portions (amide and nitro oxygen atoms) are shown in red on the map with
the electropositive chloride-binding cleft (amide protons) shown in darker blue. Regions
of intermediate potential are shown spanning the spectrum from red to blue.
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Of particular interest is the orientation of the adjacent (i.e. stacked) molecules of 4.
The left panel of Figure 3.3, derived from the crystal structure of 4 by Yin et al.31 shows
that two receptors in the unit cell are stacked at van der Waals distances (~3.4 Å) and
rotated by ~60o with respect to one another. The DMSO molecules have been omitted for
clarity. The right panel of Figure 3.3 shows the calculated electrostatic potential map for 4.
The color scale runs from blue (most positive) to red (most negative). Four areas that are
relatively negative owing to the presence of electronegative oxygen are found at the
termini of the inverted V and proximate to pyridine’s 2- and 6-positions. The most
electropositive regime is comprised of two amide protons surrounding the pyridyl nitrogen.
A comparison of the calculated electron densities and the crystal structure (above) suggests
that the orientation of the two molecules of 4 is determined primarily by the overlap of this
most electropositive region with one of the electronegative carbonyl oxygen atoms.
However, in agreement with crystal structures of similar complexes,17b,33 the
geometry-optimized dipicolinic dianilide hosts adopt a non-planar conformation with
rotation about the pyridine-CO bond to bind chloride and other anions above the pyridine
plane. This rotation leads to an energetically unfavorable conformation that breaks the πconjugated system. Thus, an energy trade-off is required to maximize chloride binding and
minimize the energy of the complex. Calculations investigating this energetic relationship
are detailed below.

Calculated gas-phase proton acidities, chloride-binding energies and complex
geometries
As seen in the left panel of Figure 3.4, an analysis of electrostatic potential maps
calculated at the density-functional level of theory reveal that the electrostatic potential at
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the amide protons closely correlate (R2 =0.881) to the Hammett σp and σm constants for the
substituents modeled. The electrostatic potential is the measure of attraction or repulsion
of a positive charge on an isodensity surface.34 This potential is negative (energetically
favored) at more electron rich regions of the molecule such as the oxygen atom of a
ketone. Conversely, this potential is positive (energetically disfavored) at more electron
poor regions of the molecule, such as the carbon atom of a ketone, or in the present case,
the hydrogen atom of an amide.
This measure of acidity can also be correlated to experimentally-derived data. In
the right panel of Figure 3.4, the calculated electrostatic potentials are plotted against the
observed chemical shifts (ppm) of the amide protons of dipicolinic dianilides 1-4 and 7-10
in DMSO-d6. The straight line fit to these data shows a good correlation (R2 =0.897)
between calculated and experimental values.

Figure 3.4: (Left) Linear correlation (R2 =0.881) between Hammett  values35 of
dipicolinic dianilide substituents and the DFT-calculated electrostatic potential at the N-H
amide protons. (Right) Linear correlation (R2 =0.897) between the calculated N-H
amide electrostatic potential and the observed chemical shift of the same moiety in DMSOd6.
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Binding energies were also calculated for chloride complexation by nine of the
para-substituted dipicolinic dianilides at the density-functional level of theory (DFTB3LYP)36 using the 6-31G* basis set. Likewise, the calculated binding energies (1:1
host:Cl¯) obeyed a Hammett relationship,37 with the strongest Cl¯ binding calculated to
occur when the 4,4’-substituents were most electron withdrawing. The plot shown in
Figure 3.5 includes data for compounds 1-4 (black dots), which were examined
experimentally as well as by computational methods. The calculated energies for those
compounds that were not further studied are shown as gray, rather than black, points. The
range of substituents and their Hammett p constants35 were CH3, -0.14 (1); OCH3, -0.12;
H, 0.00 (2); F, 0.15; Br, 0.26; COCH3, 0.47; CF3, 0.53; CN, 0.70 (3); and NO2, 0.81 (4). A
graph of the calculated data produced a straight line having R2 =0.96.
Two phenomena are observed with increasing substituent electron withdrawing
nature: increased acidity (and H-bond donor ability) of the amide proton as well as better
facilitation of rotation away from planarity and full conjugation with decreased electron
density over the rotating π-bonds. The latter observation was investigated by measuring
the energy penalty associated with rotating away from co-planarity in the unbound host.
The energetic effects of this non-planarity were studied in further computational
detail for the p-NO2 variant 4 by incrementally and symmetrically rotating the pyridine-CO
bond in the unbound host, freezing the host geometry and optimizing the geometry of the
complex with an unconstrained chloride guest, calculating energies at each step. With no
rotation, there is no direct N-H···Cl¯ interaction, so a rotation must occur to yield a binding
event.
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Figure 3.5: DFT-calculated binding energies plotted against the Hammett para35 for each
para-substituent modeled in the survey (R2 =0.965).

Figure 3.6 Energy penalty of rotation away from the central arene plane in host 4 (“Opt
Rot”), compared to the rotation of each bond. The significantly higher energy penalty of
rotating the C-N amide bond precludes any rotation of this angle above 11°.
In rotating away from the central arene, two of the three interarene bonds (those
proximal to the central arene) result in decreased steric repulsion and better geometry for
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binding chloride by the amide hydrogen bond donors. However, rotation of the distal
Namide-Carene bond has no effect on geometry of the amide proton moieties and yields little
to no steric advantage. Thus, this distal bond is neglected in considering the rotation of the
side-arm arenes to bind halides.
For compound 4, the optimum bond angles for the two proximal bonds were
established by calculating the DFT energy of the host resulting from each 5° rotation (up to
90°) of either the Carene-Camide (proximal) bond or the Camide-Namide (middle) bond. These
energy distributions were fit to polynomial functions then related to predict the lowest
energy combination of rotations for both bonds to yield a total 5° rotation from the central
arene plane. The energy of each optimized rotation was then calculated and compared to
the lowest energy conformation of 0° rotation. These results are graphically summarized
in Figure 3.6.
After these host geometries were established at each 5° interval, the host was
frozen and an unfrozen chloride anion was added to the structure before geometry
optimization (essentially optimizing the host-guest interactive distances and geometry).
The energy for each optimized complex was calculated by comparing the energy of the
host and guest separately to the energy of the complex. Finally, the total relative energy
was calculated by adding the energy advantage from complexation to the energy penalty
from bond rotation.
As summarized graphically in the relative energy profile seen in Figure 3.7, this
conformational change incurs an energetic penalty (squares) to the unbound host, but
yields an optimized binding geometry. Whereas the energetic penalty is due primarily to
the disruption of the conjugated π-system, steric interactions and the intramolecular
pyridine nitrogen—amide hydrogen bonds play minor roles. The advantage of binding Cl¯
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ion is greatest at between a 50° and 60° rotation (circles). Closer examination of the
calculated geometries of the host-guest complexes show that with increased pyridine-CO
bond rotation, the N-H···Cl¯ angle gradually approaches 180° while simultaneously
shortening the H···Cl¯ distance until only one amide proton can bind the guest chloride ion.
However, the summation of the rotation energy penalty and the binding energy advantage
(diamonds) shows that a shallow energy trough between 20° and 40° yields the best
combination of minimized π-system disruption and optimized N-H···Cl¯ binding geometry.

Figure 3.7 Total relative energies for each conformation of host 4 rotated at 5° intervals
from the central arene plane. The energy penalty arises from the breaking of planar
conjugation in the π-system whereas the energy advantage is gained from more favorable
halide complexation geometry. Note that the overall greatest energy advantage occurs at
around 55°, but is negated by a higher energy penalty. As a result, the lowest total relative
binding energy is present at around 30°.
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Figure 3.8 Energy advantage for conformation of host 4 optimally rotated at 5° intervals
from the central arene plane compared with the N-H…Cl- bond distance (top panel) and
N-H…Cl- bond angle (bottom panel). The increased energy advantage appears more
dependent on a lower angle of deviation from linearity in the H-bond, as the conformation
with the smallest such angle corresponds to the conformation with the greatest energy
advantage.
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While the energy penalty of rotation increases as rotation away from the central
arene plane occurs, a large energy advantage is gained by creating a better complexation
geometry through a closer N-H···Cl- contact and a bond geometry closer to 0° through the
three atoms. A survey of these interactions (Figure 3.8) in these optimized geometries
show that, while close contact reaches its peak at 40° with a 2.27Å H-bond distance (upper
panel), optimum bond geometry occurs at 55° with a bond angle of 8.6° (lower panel).
The energy calculations show that indeed it is at this latter angle that the lowest energy is
achieved (greatest energy advantage), predicting that bond geometry trumps contact
distance when considering a difference of less than 0.1Å.

Binding constants determined by 1H-NMR.
The chloride association constants (Ks) of compounds 1-6 and were determined by
1

H NMR spectroscopy in DMSO-d6 and CD2Cl2 by titration of a solution of 10:1 Bu4NCl

guest to dianilide host into a solution of host only, monitoring the chemical shift change
(Δδ) of the amide N-H peak. In all cases, the amide N-H peak shifts downfield upon
addition of chloride guest. Donation of electron density from the anionic guest to the
unfilled N-H σ* antibonding orbitals leads to less N-H bonding character and a downfield
shift. Job plots38 were constructed for each determined binding constant and with a
maximal N-H amide shift at χHost= 0.5, a 1:1 binding stoichiometry is indicated for all
complexes.

Using this 1:1 host to guest complex stoichiometry, constants were

determined at [host] = 1.8 mM. The data points, derived from three independent titrations
each, were fit to eq. 1,17b where “[H]0” is the initial host concentration, “[G]0” is the initial
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guest concentration, “Δδ” is the change in chemical shift of the proton peak of interest, and
“Ka” is the association constant.

(Eq. 1)

No.

Host
Y=

DMSO-d6
-1 a

CD2Cl2

X=

Ks (M )

Ks (M-1)a

1

N:

p-CH3

NBb

63 ± 5

2

N:

H

26 ± 8

222 ± 14

3

N:

p-CN

50 ± 7

Insolc

4

N:

p-NO2

44 ± 4

Insolc

5

CH

H

16 ± 1

NPd

6

CH

p-NO2

46 ± 8

NPd

Table 3.1: Chloride association constants Ks (M-1) and maximal amide N-H shifts for 1-6.
a
[Host] = 1.8 mM. Guest Cl¯ (as NBu4Cl) up to 18.0mM in DMSO-d6 and CD2Cl2 at 298
K. bNB = no binding cInsol = the host is insoluble. dNot Performed.
Direct comparison of binding by 1-4 was complicated by differing solubilities.
Compounds 1 and 2 were soluble in CD2Cl2, but hosts 3 and 4, were not. Although 1-4
were all soluble in DMSO-d6, its polarity diminishes the binding to such an extent that an
encompassing comparison could not be completed in that solvent. As shown in Table 3.1,
the isophthalamide receptor 5 bound chloride significantly better than its dipicolinamide
counterparts 1 and 2 in non-polar CD2Cl2. However, in the more polar milieu of DMSOd6, 3 and 4 bound chloride more strongly than 2 and far more strongly than 1, which did
not yield a fittable curve.
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Job Plots and titration curves leading to the values seen in Table 3.1 can be seen in
Appendix A of the dissertation.

Figure 3.9: Representative 1H NMR spectra showing the shift of the amide proton peak of
4 upon addition of Bu4NCl guest. The uppermost panel is the spectrum with no guest
present (δ NH = 11.438 ppm). The lower panel is the spectrum acquired with 16
equivalents of guest present (δ NH = 11.933 ppm).

Competitive chloride binding assayed by electrospray mass spectrometry
As noted above, our desire to directly compare binding in a single solvent was
thwarted. Alex Carasel, Joseph Kramer, and Dr. Rudolph Winter thus undertook an
electrospray ionization mass spectrometry (ESI-MS) study that would permit comparison
of all of the compounds under similar conditions. Although mass spectrometry is a gas
phase technique, the electrospray method gives data that are reflective of the solution at the
time of ionization and limits or eliminates fragmentation.39 The electrospray study of 1-6
was conducted in CH3OH, using Bu4NCl as the Cl¯ source. Methanol is not identical to
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either solvent system used in the 1H NMR studies, but it permits a uniform evaluation for
all of these receptors.
In each experiment, competing hosts were present in equimolar concentrations (50
µM) and chloride (as NBu4Cl salt) was kept sub-stoichiometric (5 µM) so that competition
for the guest would be obvious. The excess neutral host molecules are not observed in
mass spectrometry unless they are complexed by Cl¯, so excess neutral host could be
ignored. The ratios shown in Table 1 were calculated from the total integration of relevant
M/z peaks for host-Cl¯ adducts. Five charged adducts were observed at significant
abundances:

[hostACl]¯,

[hostBCl]¯,

[(hostA)2Cl]¯,

[(hostB)2Cl]¯,

and

[hostAhostBCl]¯. In each case, the lowest relative abundance was normalized to 1.
Errors are the calculated standard deviations of ratios from at least three independent
experiments.

No.
1
2
3
4
5
6

Host
Compound
Dipic p-CH3
Dipic unsub
Dipic p-CN
Dipic p-NO2
Isophth unsub
Isophth p-NO2

1

H NMR Ratio
vs. Control (5)a
NBc
1.63 ± 0.56
3.13 ± 0.44
2.75 ± 0.25
1.00
2.88 ± 0.51

ESI-MS Ratio
vs. Control (5)b
0.14 ± 0.01
0.13 ± 0.02
3.27 ± 0.26
2.82 ± 0.07
1.00
5.44 ± 0.65

Table 3.2: Comparison of ratio of chloride association constants to ESI-MS competitive
ratio. aKA (M-1) in DMSO-d6 at 298 K normalized to KA of 5 bCompetitive complexation
with host 5 [Host] = 50 µM, 10% DMSO in MeOH. cNB = no binding.
Table 3.2 shows that Cl¯ binding by dipicolinamides 3 (p-CN) or 4 (p-NO2) was
similar. The KS values obtained in DMSO-d6 were 50.2 ± 7.3 and 44.0 ± 3.8, respectively
with a ratio of binding constants equal to 1.14:1. The results of mass spectrometric
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competition experiments for these two hosts were similar, with a ratio of 1.2:1 obtained by
ESI-MS.
When 3 and 4 were used as hosts, they behaved in a relatively similar manner
showing roughly equal abilities to bind chloride. When either 3 or 4 was compared with
control 5, each showed a much higher affinity for chloride. When all three compounds
were mixed together, again 3 was slightly better than 4, and both were much better than 5
with a ratio of the adducts of 3 to 4 (~1.2:1) preserved, even in the presence of 5. When 3,
4 or 5 were compared all at once with compounds 1 and 2, no chloride adducts of 1 and 2
were observed, indicating very weak binding. These data are in accordance with the
calculated binding energies and provides further support for our findings.

Chloride transport through vesicular phospholipid bilayers
Compounds 1-4 and 6 as well as the control 5 were tested for mediation of chloride
influx into dioleoylphosphatidylcholine (DOPC) vesicles as indicated by quenching of a
vesicle-entrapped chloride-sensitive fluorescent indicator.
NO3
N
O
N
O

S

O

O
N

6-Methoxy-N-(3-sulfopropyl)quinolinium
SPQ

NO3
N,N'-Dimethyl-9,9'-bisacridinium nitrate
Lucigenin

Phospholipid vesicles were prepared as previously described40 to obtain liposomes
of a uniform 200 nm size. The indicator 6-methoxy-N-(3-sulfopropyl)quinolinium, or SPQ,
has been used in previous chloride-transport studies using synthetic transporters26a but was
unsuitable in the present context because the excitation and emission bands of 4 were
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found to overlap with SPQ. While the fluorescence and absorption profiles of 4 were
further investigated (see the “Absorbance and fluorescence of the p-NO2 derivative”
section), an alternative chloride-sensitive dye, N,N’-dimethyl-9,9’-bisacridinium nitrate, or
lucigenin, was used. This fluorescent probe was also used in previous transport studies40,41
and was found to be optimal with no excitation and emission overlap with any of the
compounds to be tested. Lucigenin’s use requires it to be trapped in the Cl¯-free interior
of vesicles where it fluoresces (λexc = 368 nm, λem = 506 nm). However, if an agent
mediates the passage of Cl¯ through the bilayer from the external buffer, the fluorescence
intensity decreases due to collisional quenching. After a specified time, Triton X-100 is
added to lyse the vesicles, and a baseline intensity for complete quenching is established.
This baseline fluorescence intensity value is subtracted from the raw fluorescence intensity
data and fractionally normalized to F0, the unquenched fluorescence value. Thus, a value
of 0.2 indicates 80% chloride influx.
Figure 3.10 compares Cl¯ transport mediated across dioleoylphosphatidyl choline
(DOPC) vesicles over the course of 600 s by 1-6 at a host concentration of 10 µM.
Transport mediated by weak chloride binders 1 and 2, was far less effective than transport
mediated by the stronger binders 3 and 4.

In direct correlation with the molecular

modeling predictions, the experimental binding constants and the mass spectrometry
competition experiments, receptors 3, 4, and 5 exhibited the highest levels of chloridetransport activity with ~80% chloride influx after 600 s, respectively. Receptors 1 and 2
and the control, 5, showed diminished activity under the same conditions. The ideal
chloride transporter (carrier or channel) needs to bind the ion strongly enough for
recognition to occur but weak enough to maintain a dynamic system. While 1, 2, and 6
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can be considered to bind chloride too weakly in a polar environment, the stronger
interactions observed for 3, 4 and 5 are weak enough that a dynamic system is maintained.

Figure 3.10. Chloride transport through DOPC vesicles mediated by dianilides 1-4 and
isopthalamides 5 and 6 as determined by lucigenin quenching.42 All hosts are added as
DMSO solutions with a final concentration of 10 µM. Maximal quenching is reached
within 10 minutes in all cases. Data points for all replications are within 7% of the mean.
The relatively rapid chloride influx rate, observed at low micromolar
concentrations of receptors 3 and 4, suggests that a channel mechanism versus a carrier
mechanism is responsible for transport. Thus, a definitive test for channel activity, a
planar-bilayer conductance study, was performed to confirm the theory (see the “Planar
bilayer conductance” section).
While the lucigenin quenching experiment characterizes chloride transport activity
at a given transporter concentration, variation of the transporter concentration can yield
insights into the aggregation mechanics of transport activity. Systems using vesicles at a
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fixed lipid concentration of 0.31 mM and transporter 4 in a range of concentrations from
20 µM to 50 nM were used to study the concentration dependence of chloride transport
activity. The results, shown in Figure 3.11, can be used to construct a Hill Plot43 (Figure
3.12) to determine the concentration dependence of the active channel or carrier.

Figure 3.11. The concentration dependence of the p-NO2 dianilide, 4, on
chloride transport.
Originally used in the study of enzyme kinetics, Hill plots are constructed to
analyze the velocity of a measurable reaction or activity (in the present case, the initial rate
of chloride transport) at different concentrations of enzyme or other agent (our chloride
transporter).

As these velocities are limited to some maximum value (Vmax) at a

theoretically infinite concentration of activity-inducing agent, an asymptotic relationship is
observed. The data are linearized by plotting on a log-log scale for the Hill plot with a line
of slope 1 indicating a direct ideal linear relationship between activity-inducing agent and
activity velocity. If the slope is greater than 1, a cooperative relationship is indicated, as
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the activity velocity increases at a greater than linear rate. If the slope is less than 1, a
competitive or non-cooperative relationship is indicated, as the presence of more activityinducing agent leads to less activity per molecule of agent present.
F0/F = 1 + KD [Q]

(Eq. 2)

Application of the Stern-Volmer equation (Eq. 2)44 to the acquired fluorescence
data yielded chloride concentrations for each half-second recording. Using the literature
Stern-Volmer quenching constant for lucigenin with chloride (KD = 390 M-1) and the
experimentally-determined F0/F values (the inverse of the dependent values in Figure
3.10), intracellular chloride concentrations are derived for each observed point in time,
ultimately yielding ion transport velocities.

Figure 3.12. A Hill plot derived from the data
presented in Fig. 3.11 (variation of [4]) via
application of the Stern-Volmer equation.
Examination of the Hill plot seen in Figure 3.12 shows that when plotted on a loglog scale to linearize the transport velocity and concentration terms, a non-linear
dependence is observed.

If all 5 points were fit to a single straight line (full line), as
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normally done with a Hill plot, a slope of 0.66 is the result, indicating a competitive
concentration dependence. However, if the plot were divided into two parts, the first with
the two lowest concentrations and the second with the three remaining, two straight lines
result: the first half yielding a slope of 0.13 and the second a slope of 1.98, indicating a
competitive and cooperative concentration dependence, respectively. Presumably, these
two straight lines are a simplification, and a non-linear relationship is truly at work (dashed
curve), but with only 5 data points, this is an assumption at this time.
However, while measuring membrane potential polarization rate in their work,
Yang and co-workers also observe a non-linear concentration dependence with their αaminooxyacid class of synthetic chloride transporters.26b These observations with other
synthetic chloride transporters incapable of spanning a membrane may complement our
own studies with similar compounds. The non-linear dependence may be based on a
minimum concentration threshold that is required for these transporters to function as
anion channels. At any given concentration, both the carrier and channel mechanism may
be active, with more channel character present at higher concentrations.

Planar bilayer conductance
The planar bilayer conductance technique45 (KCl, 0.45 M, pH 7.0, soybean
asolectin) was used to probe for channel formation in experiments conducted by Saeedeh
Negin. In this experiment, two potassium chloride buffer solutions (0.45M, pH 7.0) were
separated by a phospholipid membrane (asolectin from soybean) painted onto a ~200 μm2
aperture between the two buffer chambers. To this system, a DMSO solution of 4 was
added to one buffer chamber (the cis chamber) yielding a final transporter concentration of
7 μM. A potential difference was then applied across the membrane and channel activity
was observed by measurement of current in the trans buffer chamber. The distinctive open92

close behavior exhibited by the current measurements seen in Figure 3.13 is indicative of
functional ion-channel formation in the bilayer.45

Figure 3.13. (Left) The current observed at applied voltages of (Top) -60 mV and (Bottom)
60 mV elicited upon the addition of transporter 4 at 7 μM. (Right) I-V Plot, a plot of
observed current vs. applied potential correlating to the major conductance state.
When the experiments were conducted for durations as long as 3 hours after
addition of transporter, a variety of “open” currents could be observed at the same voltage,
meaning that multiple conductance states are present. Data for the major conductance state
are shown in Figure 3.13. The conductance value determined from the graph in Figure 3.13
is 117 pS.
To estimate the pore diameter of this channel, Hille’s equation45 can be applied to
the derived conductance value. A channel exhibiting a conductance of 117 pS in a 35Å
thick bilayer has an estimated pore diameter of ~8Å. An unsolvated Cl- ion with a 1.81Å
van der Waals radius46 ion would need a pore with a diameter of at least 3.6Å to transport
ions and the calculated structures of the dipicolinamides show a binding cavity in a single
receptor with a diameter of ~4.1Å. A pore of ~8Å would mean that at least two of these
receptors would form the sides of the pore with their binding cavities directed inward.
Unsolvated Cl¯ has a diameter of ~3.6 Å47 but fully aquated Cl¯ is estimated to be ~6.5
Å,48 which is close to the calculated pore size
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Unsubstituted dipicolinamide, 2, and isophthalamide, 5, were also tested for
channel functionality using the same procedure shown above.

Tests were run for

durations of 3 hours showing no conductance behavior for either of these compounds at a
final transporter concentration of 7 μM.

Absorbance and fluorescence of the p-NO2 derivative, 4
The formation of a transmembrane channel by 4 would require aggregation of
the monomers. One possibility is that the triarenes self-assemble, stacking upon one
another. To span the 30-35 Å insulator regime of a bilayer membrane, 8-10 molecules
would be required to stack at the van der Waals distance of 3.4 Å. Such an arrangement
would have a significant entropic cost in the bilayer but this type of stacking is
apparent in the solid state structure.31
Inferential evidence for stacking was obtained from fluorescence studies. Nitrosubstituted dipicolinamide (4) showed no fluorescence emission when excited at various
wavelengths in DMSO solution. Compound 4 is soluble in DMSO but not in water.
However, when a small amount of a concentrated DMSO solution of 4 is added to an
aqueous solution (1% DMSO v/v), fluorescence is readily observed. The emission spectra
seen in Figure 3.14 are from an excitation wavelength of 280 nm. The only peak observed
at a receptor concentration of 50 μM was the peak having a maximum near 400 nm as
seen in Figure 3.14. In subsequent studies varying the excitation wavelength (270-600 nm
in 10 nm increments), it was determined that an excitation wavelength of 280 nm yielded
the highest fluorescence intensity.
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Figure 3.14. Fluorescence in 4 in 1% DMSO / water at (Top) 2-20 µM host concentration
(Center) 10-90 µM concentration and (Bottom) 10-90 µM with 0.17mM DOPC vesicles.
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The top panel of Figure 3.14 shows the fluorescence spectra obtained for 4 in 1%
DMSO/H2O over a concentration range of 2-20 µM, in 2 µM increments—concentrations
relevant to eliciting chloride transport, from concentration dependence studies (Figure
3.11). Molecules of 4 aggregate under these conditions and the fluorescent emission is
presumably due to the formation of excimers. Similar, but more intense spectra, were
obtained at concentrations between 10-90 µM as shown in the middle panel of Figure 3.14.
As the concentration increases, the peak intensifies while shifting from its first observable
maximum of 372 nm to a final maximum of 403 nm.
The maximal emission intensity fluorescence excitation wavelength of 280 nm
does not correlate with the maximal absorbance wavelength of 338 nm seen in Figure 3.15
(uppermost curve). However, when the same DMSO-water solution of 4 is titrated with a
10 equivalent mixture of NaCl and host 4, an isosbestic point in the absorbance spectrum is
observed near the aforementioned 280 nm wavelength.
The lower absorption at the longer wavelength (338 nm) upon addition of NaCl is
most likely attributable to the disruption of the extended conjugated π-system of the planar
receptor molecule. We speculate that with increasing NaCl concentration, the receptor
anilide side-arms rotate to bind its Cl- guest as seen previously in the calculated structure
(Figure 3.15). While the absorbance at this higher wavelength is decreased, the absorbance
intensity at 275 nm (and presumably lower wavelengths) increases proportionally.
Unfortunately, the absorbance spectra below 275 nm is not able to be obtained due to
instrumental limitations.
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Figure 3.15. (Top) Absorbance of host 4 in 1% DMSO/water at a concentration of 10mM.
NaCl guest is added (0-70 equivalents) resulting in the lowered absorbance at the
maximum at 338 nm and an increased absorbance for a species with a maximum below
275nm. (Bottom) The calculated geometry of a 4·Cl¯ complex. Presumably, the species
absorbing at 338 nm is the planar host whereas the species absorbing at the shorter
wavelength is a combination of the three discrete π-systems present in the complex.

Conclusions
In this study, we have examined the chloride binding properties of hosts 1-4 using
three independent methods—DFT-level gas-phase calculations, 1H NMR binding constants
in both polar DMSO- d6 and non-polar CD2Cl2, and electrospray ionization MS in a polar
methanol microenvironment. We observed the same general trend across the methods: the
more electron-withdrawing p-NO2 and p-CN dianilides (4 and 3, respectively) were better
chloride binders than the unsubstituted and electron-donating p-CH3 dianilides (2 and 1,
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respectively). 3 and 4’s chloride binding capabilities—even in polar environments—
proved a boon in their ability to transport chloride across phospholipid membranes, an
ability not displayed by their more weakly-binding counterparts. The rapid chloride
transport evidenced by 4 was explored more fully, with its open-close behavior exhibited
in planar-bilayer conductance tests proving its channel functionality.
The observation that compound 4 exhibits channel behavior may be surprising at
first glance. While each molecule of 4 is at most 14.5 Å in length, the hydrophobic
insulator regime of a bilayer is ~35 Å thick49 meaning 4 and members of its structural
family, 1-3, would not span the bilayer in a typical unimolecular fashion as would natural
ion channels45 or many designed single-molecule synthetic channels.50 Certainly, other
channel modalities could be in play, such as a two-molecule, two-leaflet modality seen in
gramicidin.51 However, a vertically-stacked assembly of receptors such as seen in cartoon
form in Figure 3.16 could be another possible mechanism. The formation of channels from
stacked monomers has been proposed previously for cyclic peptides,52 rosettes,53 cyclic
ureas54 and for oligoamide macrocycles55 even though π-π stacking has been the subject of
controversy in recent years.56
Observation of the fluorescence of 4 in water leads us to believe that this stack is
rapidly organized in the aqueous milieu by exclusion of water contacts at the hydrophobic
arene faces. Examination of calculated gas-phase models argues that this pre-organized
stack most likely organizes solvent water, binding the electronegative water oxygen. The
exposed water protons in turn weakly (but dynamically) complex chloride in a water-andion filled pore.
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Figure 3.16. (Left) CPK representation of a stack of molecules of receptor 4 with solvent
water molecules in light blue and chloride ions in green. (Center) DFT-calculated
structure of host 4 with two molecules of water. (Right) DFT-calculated structure of host 4
with four molecules of water and a chloride anion.
The multiple conductance states seen in the planar-bilayer tests show that different
channel sizes are possible. While a minimum of 8 to 10 transporters would be needed for a
single stack, further lateral aggregation over time might form larger and larger pores
leading to those of the size seen in the planar-bilayer conductance studies. The formation
of channels by such small molecular species may have implications in the design of drugs,
especially since the aminoxyisophthalamides described recently alter biological
function.26b
The regulation of ion concentrations—maintaining gradients across ionimpermeable cellular membranes—is of paramount importance in living, functioning cells.
Disruption of the regulation of the chloride ion gradient is implicated in the symptomatic
manifestation of cystic fibrosis in humans,57 a result of malfunctioning natural chloride
channels.58 While many commercially successful synthetic therapeutics are small, limiting
the costs in an industrial process, they are tailored to interact with naturally-occurring
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proteins, rarely affecting activity on their own. However, compounds such as transporters 3
and 4 that are small and easily made while independently eliciting a desired effect at a low
concentration, could find many potential therapeutic uses.

Experimental

General.
All NMR spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz
and all chemical shifts are reported in ppm (δ), calibrated to literature values for internal
solvent in reference to TMS with integrated intensity (X H) and multiplicity (b = broad, s
= singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, m = multiplet, etc.), and
coupling constants in Hz.
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C-NMR spectra were obtained at 75.4 MHz and calibrated to

literature values for chemical shift in reference to TMS. Melting points were determined on
a Thomas Hoover apparatus in open capillaries and are uncorrected. Reagents were the
best (non-LC) grade commercially available and were distilled, recrystallized or used
without further purification, as appropriate. CH2Cl2 was distilled from calcium hydride.
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (St. Louis,
MO).
All Mass Spectrometry experiments were performed on a JEOL MStation, JMS700, double focusing high-resolution instrument using either the fast-atom bombardment
ionization technique in the positive ion detection mode at high resolution (FAB-MS), or
the elesctrospray ionization technique in the negative ion detection mode (ESI-MS). All
fluorescence spectra and fluorescence quenching data were recorded on a Perkin Elmer
LS50B Luminescence Spectrometer. Planar bilayer conductance measurements were
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performed with a Warner bilayer clamp instrument. All UV-Vis absorbance spectra were
recorded on a Beckman Coulter DU 7400 Spectrophotometer. Calculations were run using
the Spartan 2006 software package on a Dell Dimension DXP061 desktop with a 2.40GHz
Intel® Core™2 Processor and 2.00GB of RAM.

Gas-phase binding calculations and molecular modeling.
A lowest energy conformation search was performed using the Monte-Carlo
simulated annealing method with the MMFF force field to yield the ten lowest energy
conformers for each host and complex modeled. The geometry of each of these conformers
were optimized by the density-functional B3LYP method using the 6-31G* basis set.
Single-point energy calculations were performed using the same method and basis set to
determine the overall lowest energy conformer (LEC). Binding energies were determined
for each complex by adding the calculated energies of the host LEC and guest then
subtracting the calculated energy of the complex LEC.

Synthesis and characterization of hosts 1-12, general procedure.
All solvents used were freshly distilled and all reactions were performed under an
inert nitrogen or argon atmosphere and vapor condenser.
The commercially-available diacid (2,6-pyridinedicarboxylic acid for 1-4,
isophthalic acid for 5 and 6) was dissolved in acetonitrile or dichloromethane (~2mmol in
7mL) and added drop-wise to a stirring solution containing an excess of the appropriate
aniline in the same solvent (~7mmol in 7mL in acetonitrile or dichloromethane) and
triethylamine (3mL) held at 0°C in an ice bath. After addition, the mixture was returned to
room temperature and then heated to reflux for 3h. After returning to room temperature,

101

the solid was filtered and washed with the reaction solvent (acetonitrile or
dichloromethane) and dried under high vacuum yielding the final product.

2,6-Pyridinedicarbonyl dichloride
The commercially-available diacid, 2,6-pyridinedicarboxylic acid (4.00 g) was
added to a stirring mixture of thionyl chloride (15.80 g) and 1,4-dioxane (24.0 mL) and
heated to reflux for 4 hours. After cooling to room temperature, solvent, excess thionyl
chloride and hydrogen chloride gas are removed in vacuo. Toluene (2 x 50 mL) is added
to the concentrate and removed in vacuo to ensure removal of all traces of thionyl chloride
and hydrogen chloride. The resulting brown solid (4.88 g, quantitative, mp = 61-62 °C, lit.
59

= 60 °C) is used immediately in the subsequent amide coupling reactions. 1H-NMR

(CD2Cl2): 8.18 (1H, dd, J1 = 8.3 Hz, J2 = 7.3 Hz Ar 4-H), 8.38 (2H, d, J = 7.8 Hz Ar 3/5H), 13C-NMR (CD2Cl2): 129.9, 140.3, 149.7, 169.8.

N2,N6-bis(4-Methylphenyl)pyridine-2,6-dicarboxamide, 1
This compound was made and reported previously. Spectral data and the melting
point match literature values.60 2,6-Pyridinedicarbonyl dichloride (0.44 g, 2.2 mmol) was
dissolved in acetonitrile (5.0 mL) and was added dropwise to a stirring solution of 4toluidine (0.82 g, 7.7 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (7.0 mL
additional for 12.0 mL total) held at 0°C in an ice bath. Upon completion of the addition,
the system was returned to room temperature and stirred for 24 hours. The resulting white
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10
mL) and refiltered after each suspension before drying under high vacuum. The resulting
white solid is retained as the pure product (0.33 g, 42%, mp = 223-224 °C, lit.60 = 224 °C).
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1

H-NMR (DMSO-d6): 2.32 (6H, s, Anil-CH3), 7.25 (4H, d, J = 8.4 Hz, Anil 3/5-H), 7.80

(4H, d, J = 8.4 Hz, Anil 2/6-H) 8.29 (1H, dd, J1 = 8.6 Hz, J2 = 6.9 Hz, Pyr 4-H), 8.38 (2H,
d, J = 7.6 Hz Pyr 3/5-H), 11.03 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 20.6 (AnilCH3), 121.2, (Anil 2/6-C), 125.2 (Pyr 3/5-C), 129.1 (Anil 3/5-C), 133.4 (Anil 4-C), 140.2
(Pyr 4-C), 135.6 (Anil 1-C), 149.0 (Pyr 2/6-C), 161.5 (Pyr-C(O)NH). ESI-MS: m/z calc for
[M+Cl]¯ 380, found: 380.

N2,N6-bis(Phenyl)pyridine-2,6-dicarboxamide, 2
This compound was made previously. Spectral data and the melting point match
literature values.61 2,6-pyridinedicarbonyl dichloride (0.42 g, 2.1 mmol) was dissolved in
acetonitrile (5.0 mL) and was added dropwise to a stirring solution of aniline (0.63 g, 6.8
mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (7.0 mL additional for 12.0
mL total) held at 0°C in an ice bath. Upon completion of the addition, the system was
returned to room temperature and stirred for 24 hours. The resulting white suspension is
filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 mL) and
refiltered after each suspension before drying under high vacuum. The resulting white
solid is retained as the pure product (0.56 g, 86%, mp = 277-278 °C, lit.61 = 278 °C). 1HNMR (DMSO-d6): 7.19 (2H, t, J = 7.4 Hz, Anil 4-H), 7.45 (4H, t, J = 7.9 Hz, Anil 3/5-H),
7.94 (4H, d, J = 7.5 Hz, Anil 2/6-H) 8.31 (1H, dd, J1 = 8.7 Hz, J2 = 6.6 Hz, Pyr 4-H), 8.41
(2H, d, J = 7.7 Hz Pyr 3/5-H), 11.09 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 121.1
(Anil 2/6-C), 124.4 (Anil 4-C), 125.3 (Pyr 3/5-C), 128.8 (Anil 3/5-C), 138.1 (Anil 1-C),
140.0 (Pyr 4-C), 148.9 (Pyr 2/6-C), 161.7 (Pyr-C(O)NH). ESI-MS: m/z calc for [M-H]¯
316, found: 316; m/z calc for [M+Cl]¯ 352, found: 352.
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N2,N6-bis(4-Cyanophenyl)pyridine-2,6-dicarboxamide, 3
This compound was made previously. Spectral data and the melting point match
literature values.62 2,6-Pyridinedicarbonyl dichloride (0.42 g, 2.1 mmol) was dissolved in
acetonitrile (5.0 mL) and was added dropwise to a stirring solution of 4-aminobenzonitrile
(0.82g, 6.9 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (7.0 mL
additional for 12.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition,
the system was returned to room temperature and stirred for 24 hours. The resulting white
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10
mL) and refiltered after each suspension before drying under high vacuum. The purified
product is isolated as a white powder (0.26 g, 34%, mp = 304-306 °C, lit.62 = 304-306 °C).
1

H-NMR (DMSO-d6): 7.92 (4H, d, J = 8.6 Hz, Anil 3/5-H), 8.19 (4H, d, J = 8.6 Hz, Anil

2/6-H) 8.34 (1H, t, J = 7.7 Hz, Pyr 4-H), 8.43 (2H, d, J = 8.0Hz Pyr 3/5-H), 11.34 (2H, s,
C(O)NH-Anil).
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C-NMR (DMSO-d6): 106.0 (Anil 4-C), 119.0 (Anil-CN), 120.7 (Anil

2/6-C), 126.0 (Pyr 3/5-C), 133.2 (Anil 3/5-C), 140.3 (Pyr 4-C), 142.3 (Anil 1-C), 148.3
(Pyr 2/6-C), 162.1 (Pyr-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 366, found: 366; m/z calc
for [M+Cl]¯ 402, found: 402.

N2,N6-bis(4-nitrophenyl)pyridine-2,6-dicarboxamide, 4
This compound was made previously. No spectral data were recorded, but the
melting point matches the literature value.63 2,6-Pyridinedicarbonyl dichloride (1.65 g, 8.1
mmol) was dissolved in acetonitrile (20.0 mL) and was added dropwise to a stirring
solution of 4-Nitroaniline (2.44g, 16.2 mmol) and triethylamine (9.0 mL, 64.6 mmol) in
acetonitrile (25.0 mL additional for 45.0 mL total) held at 0 °C in an ice bath. Upon
completion of the addition, the system was returned to room temperature and stirred for 24
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hours. The resulting yellow-brown suspension is filtered, resuspended with acetonitrile (2
x 25 mL) and diethyl ether (1 x 10 mL) and refiltered after each suspension before drying
under high vacuum. The resulting yellow-beige solid is retained as the pure product (1.70
g, 52%, mp > 330°C, lit.63 >300°C). 1H-NMR (DMSO-d6): 8.13 (4H, d, J = 9.2 Hz, Anil
3/5-H), 8.24 (4H, d, J = 9.6 Hz, Anil 2/6-H) 8.23 (1H, [buried], Pyr 4-H), 8.34 (2H, d, J =
8.1 Hz Pyr 3/5-H), 11.48 (2H, s, C(O)NH-Anil).13C-NMR (DMSO-d6): 120.4, (Anil 2/6C), 124.9 (Anil 3/5-C), 126.2 (Pyr 3/5-C), 140.4 (Pyr 4-C), 143.0 + 144.3 (Anil 4-C +Anil
1-C), 148.2 (Pyr 2/6-C), 162.3 (Pyr-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 406, found:
406; m/z calc for [M+Cl]¯ 442, found: 442.

N1,N3-bis(phenyl)isophthalamide, 5
This compound was made previously. Spectral data64 and the melting point65
match literature values. Isophthaloyl chloride (0.498 g, 2.45 mmol) was dissolved in
acetonitrile (7.0 mL) and was added dropwise to a stirring solution of aniline (0.780 g, 8.38
mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (8.0 mL additional for 15.0
mL total) held at 0 °C in an ice bath. Upon completion of the addition, the system was
returned to room temperature and stirred for 24 hours. The resulting white suspension is
filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 mL) and
refiltered after each suspension before drying under high vacuum. The resulting white
solid is retained as the pure product (0.521 g, 67%, mp = 280-281 °C, lit.65 = 279-281 °C).
1

H-NMR (DMSO-d6): 7.13 (2H, t, J = 7.3 Hz, Anil 4-H), 7.38 (4H, t, J = 7.2 Hz, Anil 3/5-

H), 7.70 (1H, t, J = 7.7 Hz, Isophth 5-H), 7.81 (4H, d, J = 8.1 Hz, Anil 2/6-H), 8.15 (2H,
d, J = 7.7 Hz, Isophth 4/6-H), 8.54 (1H, s, Isophth 2-H), 10.44 (2H, s, C(O)NH-Anil). 13CNMR (DMSO-d6): 120.4 (Anil 2/6-C), 123.8 (Anil 4-C), 127.0 (Isophth 2-C), 128.4

105

(Isophth 5-C), 128.7 (Anil 3/5-C), 130.6 (Isophth 4/6-C), 135.2 (Isophth 1/3-C), 139.1
(Anil 1-C), 165.1 (Isophth-C(O)NH). FAB-MS: m/z calc for [M+H]+ 317.1290, found:
317.1285. ESI-MS: m/z calc for [M+Cl]¯ 351 found: 351.

N1,N3-bis(4-Nitrophenyl)isophthalamide, 6
This compound was made previously. No spectral data were recorded, but the
melting point agrees with the literature value.66 Isophthaloyl chloride (1.199 g, 5.90 mmol)
was dissolved in acetonitrile (15.0 mL) and was added dropwise to a stirring solution of 4nitroaniline (2.478g, 17.94 mmol) and triethylamine (10.0 mL, 71.7 mmol) in acetonitrile
(15.0 mL additional for 30.0 mL total) held at 0 °C in an ice bath. Upon completion of the
addition, the system was returned to room temperature and stirred for 24 hours. The
resulting brown-yellow suspension is filtered, resuspended with acetonitrile (2 x 25 mL)
and diethyl ether (1 x 10 mL) and refiltered after each suspension before drying under high
vacuum. A yellow-beige solid is isolated as the pure product (0.951 g, 40%, mp > 330°C,
lit.66 = 377°C). 1H-NMR (DMSO-d6): 7.76 (1H, t, J = 7.4 Hz, Isophth 5-H), 8.13 (4H, t, J
= 7.7 Hz, Anil 2/6-H), 8.22 (2H, d, J = 7.8 Hz, Isophth 4/6-H), 8.30 (4H, d, J = 7.7 Hz,
Anil 3/5-H), 8.67 (1H, s, Isophth 2-H), 11.22 (2H, s, C(O)NH-Anil). 13C-NMR (DMSOd6): 119.9 (Anil 2/6-C), 124.8 (Anil 3/5-C), 127.8 (Isophth 5-C), 131.5 (Isophth 4/6-C),
134.4 (Isophth 1/3-C), 139.5 (Isophth 2-C), 142.6 (Anil 4-C), 145.3 (Anil 1-C), 165.6
(Isophth-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 405, found: 405; m/z calc for [M+Cl]¯
441, found: 441.

N2,N6-bis(4-Aminoacetylphenyl)pyridine-2,6-dicarboxamide, 7
2,6-Pyridinedicarbonyl dichloride (1.10 g, 5.4 mmol) was dissolved in acetonitrile
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(20.0 mL) and was added dropwise to a stirring solution of 4-aminoacetanilide (1.78 g,
11.9 mmol) and triethylamine (9.0 mL, 64.6 mmol) in acetonitrile (20.0 mL additional for
40.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition, the system
was returned to room temperature and stirred for 24 hours. The resulting white suspension
is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 mL) and
refiltered after each suspension before drying under high vacuum. The resulting off-white
(slight pink) solid is retained as the pure product (1.77 g, 76%, mp > 330°C).

1

H-NMR

(DMSO-d6): 1.49 (6H, s, C(O)CH3), 7.08 (4H, d, J = 8.9 Hz, Anil 3/5-H), 7.25 (4H, d, J =
8.9 Hz, Anil 2/6-H) 7.73 (1H, dd, J1 = 8.8 Hz, J2 = 6.5 Hz, Pyr 4-H), 7.82 (2H, d, J = 7.5
Hz Pyr 3/5-H), 10.00 (2H, s, Anil-NHC(O)), 10.98 (2H, s, C(O)NH).13C-NMR (DMSOd6): 24.0 (COCH3), 119.3 (Anil 3/5-C), 121.8, (Anil 2/6-C), 125.2 (Pyr 3/5-C), 133.08
(Anil 1-C), 136.0 (Anil 4-C), 139.4 (Pyr 4-C), 148.9 (Pyr 2/6-C), 161.5 (Pyr-C(O)NH-),
168.2 (NHC(O)CH3). FAB-MS: m/z calc for [M+H]+ 462.1665, found: 462.1658.

N2,N6-bis(4-Acetylphenyl)pyridine-2,6-dicarboxamide, 8
2,6-Pyridinedicarbonyl dichloride (0.44 g, 2.2 mmol) was dissolved in acetonitrile
(7.0 mL) and was added dropwise to a stirring solution of 4’-aminoacetophenone (0.92 g,
6.8 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (5.0 mL additional for
12.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition, the system
was returned to room temperature and stirred for 24 hours. The resulting white suspension
is filtered, resuspended and refiltered with acetonitrile (2 x 25 mL) and diethyl ether (1 x
10 mL) before drying under high vacuum. The resulting off-white (slight pink) solid is
retained as the pure product (0.63 g, 72%, mp = 195-196 °C). 1H-NMR (DMSO-d6): 2.58
(6H, s, C(O)CH3), 8.04 (4H, d, J = 8.7 Hz, Anil 3/5-H), 8.18 (4H, d, J = 8.7 Hz, Anil 2/6-
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H) 8.32 (1H, dd, J1 = 8.6 Hz, J2 = 6.7 Hz, Pyr 4-H), 8.42 (2H, d, J = 7.2 Hz Pyr 3/5-H),
11.33 (2H, s, C(O)NH).13C-NMR (DMSO-d6): 26.5 (COCH3), 120.2, (Anil 2/6-C), 125.8
(Pyr 3/5-C), 129.3 (Anil 3/5-C), 132.5 (Anil 4-C), 140.1 (Pyr 4-C), 142.6 (Anil 1-C), 148.7
(Pyr 2/6-C), 162.2 (Pyr-C(O)NH), 196.7 (Anil-C(O)CH3). FAB-MS: m/z calc for [M+H]+
402.1454, found: 402.1448.

N2,N6-bis(3-Methylphenyl)pyridine-2,6-dicarboxamide, 9
2,6-Pyridinedicarbonyl dichloride (0.426 g, 2.09 mmol) was dissolved in
dichloromethane (6.0 mL) and was added dropwise to a stirring solution of 3-toluidine
(0.743 g, 6.93 mmol) and triethylamine (5.0 mL, 35.9 mmol) in dichloromethane (9.0 mL
additional for 15.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition,
the system was returned to room temperature and stirred for 24 hours. The resulting white
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10
mL) and refiltered after each suspension before drying under high vacuum. The resulting
white solid is retained as the pure product (0.564 g, 78%, mp = 211-214 °C).

1

H-NMR

(DMSO-d6): 2.34 (6H, s, Anil-CH3), 7.01 (2H, d, J = 7.5 Hz, Anil 4-H), 7.31 (2H, t, J =
7.8 Hz, Anil 5-H), 7.65 (2H, d, J = 8.0 Hz, Anil 6-H), 7.70 (2H, s, Anil 2-H), 8.28 (1H,
dd, J1 = 8.7 Hz, J2 = 6.6 Hz, Pyr 4-H), 8.37 (2H, d, J = 7.3 Hz Pyr 3/5-H), 11.00 (2H, s,
C(O)NH-Anil). 13C-NMR (DMSO-d6): 21.5 (Anil-CH3), 118.9 (Anil 6-C), 122.2, (Anil 2C), 125.2 +125.6 (Pyr 3/5-C + Anil 4-C), 129.0 (Anil 5-C), 138.0 + 138.4 (Anil 1-C +
Anil 3-C), 143.5 (Pyr 4-C), 149.2 (Pyr 2/6-C), 162.1 (Pyr-C(O)NH). FAB-MS: m/z calc
for [M+H]+ 346.15555, found: 346.1555. ESI-MS: m/z calc for [M+Cl]¯ 380, found: 380.
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N2,N6-bis(3-Cyanophenyl)pyridine-2,6-dicarboxamide, 10
2,6-Pyridinedicarbonyl dichloride (0.423 g, 2.07 mmol) was dissolved in
acetonitrile (7.0 mL) and was added dropwise to a stirring solution of 3-aminobenzonitrile
(0.785g, 6.64 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (11.0 mL
additional for 18.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition,
the system was returned to room temperature and stirred for 24 hours. The resulting white
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10
mL) and refiltered after each suspension before drying under high vacuum. The resulting
white solid is retained as the pure product (0.311 g, 41%, mp = 288-291 °C).

1

H-NMR

(DMSO-d6): 7.62-7.68 (4H, m, Anil 4-H + Anil 5-H), 8.21 (2H, dt, J1 = 6.5 Hz, J2 = 2.5
Hz Anil 5-H), 8.32 (1H, dd, J1 = 8.8 Hz, J2 = 6.6 Hz, Pyr 4-H), 8.37 (2H, s, Anil 2-H),
8.42 (2H, d, J = 7.4 Hz Pyr 3/5-H), 11.31 (2H, s, C(O)NH-Anil).

13

C-NMR (DMSO-d6):

111.9 (Anil 3-C), 118.8 (Anil-CN), 124.1 (Anil 2-C), 126.1 + 126.2 (Anil 6-C + Pyr 3/5C), 128.3 (Anil 4-C), 130.6 (Anil 5-C), 139.2 (Anil 1-C + Pyr 4-C), 148.6 (Pyr 2/6-C),
162.5 (Pyr-C(O)NH). FAB-MS: m/z calc for [M+H]+ 368.1148, found: 346.1132. ESI-MS:
m/z calc for [M+Cl]¯ 402, found: 402.

N2,N6-bis(3-Trifluorophenyl)pyridine-2,6-dicarboxamide, 11
2,6-Pyridinedicarbonyl dichloride (0.423 g, 2.07 mmol) was dissolved in
acetonitrile (7.0 mL) and was added dropwise to a stirring solution of 3trifluoromethylaniline (1.083 g, 6.72 mmol) and triethylamine (5.0 mL, 35.9 mmol) in
acetonitrile (11.0 mL additional for 18.0 mL total) held at 0 °C in an ice bath. Upon
completion of the addition, the system was returned to room temperature and stirred for 24
hours. The resulting white suspension is filtered, resuspended with acetonitrile (2 x 25
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mL) and diethyl ether (1 x 10 mL) and refiltered after each suspension before drying under
high vacuum. The resulting white solid is retained as the pure product (0.346 g, 37%, mp
= 260-261 °C). 1H-NMR (DMSO-d6): 7.55 (2H, d, J = 7.7 Hz, Anil 4-H), 7.71 (2H, t, J =
7.8 Hz, Anil 5-H), 8.19 (2H, d, J = 7.9 Hz, Anil 6-H), 8.34 (1H, t, J = 7.9 Hz, Pyr 4-H),
8.44 (4H, m, Anil 2-H + Pyr 3/5-H), 11.25 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6):
117.0 (Anil 2-C), 120.7 (Anil-CF3), 124.6 (Anil 4-C), 125.7 (Anil 6-C), 129.3 (Pyr 3/5-C),
130.8 (Anil 3-C + Anil 5-C), 138.9 (Anil 1-C), 140.3 (Pyr 4-C), 148.4 (Pyr 2/6-C), 162.1
(Pyr-C(O)NH). FAB-MS: m/z calc for [M+H]+ 454.0990, found: 454.0995. ESI-MS: m/z
calc for [M+Cl]¯ 488, found: 488.

N2,N6-bis(3-Chlorophenyl)pyridine-2,6-dicarboxamide, 12
2,6-Pyridinedicarbonyl dichloride (0.426 g, 2.09 mmol) was dissolved in
acetonitrile (5.0 mL) and was added dropwise to a stirring solution of 3-chloroaniline
(0.861 g, 6.75 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (10.0 mL
additional for 15.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition,
the system was returned to room temperature and stirred for 24 hours. The resulting white
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10
mL) and refiltered after each suspension before drying under high vacuum. The resulting
white solid is retained as the pure product (0.561 g, 70%, mp = 245-247 °C).

1

H-NMR

(DMSO-d6): 7.25 (2H, d, J = 7.9 Hz, Anil 4-H), 7.48 (2H, t, J = 8.1 Hz, Anil 5-H), 7.90
(2H, d, J = 7.9 Hz, Anil 6-H), 8.16 (2H, s, Anil 2-H), 8.31 (1H, t, J = 7.7 Hz, Pyr 4-H),
8.41 (2H, d, J = 8.2 Hz Pyr 3/5-H), 11.19 (2H, s, C(O)NH-Anil).

13

C-NMR (DMSO-d6):

119.5 (Anil 6-C), 120.4 (Anil 2-C), 124.1 (Anil 4-C), 125.7 (Pyr 3/5-C), 130.5 (Anil 5-C),
133.0 (Anil 3-C), 139.6 (Anil 1-C), 140.1 (Pyr 4-C), 148.6 (Pyr 2/6-C), 161.9 (Pyr-
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C(O)NH). FAB-MS: m/z calc for [M+H]+ 386.0463, found: 386.0463. ESI-MS: m/z calc
for [M+Cl]¯ 420, found: 420.

Chloride binding constants from 1H-NMR titrations.
Solutions of the receptor molecule in DMSO-d6 or CD2Cl2 were prepared at a
concentration of 1.8 mM. A 1 mL solution thus prepared was transferred to a glass NMR
tube and titrated with a solution containing both 1.8 mM of host and 18 mM solutions (10
equiv.) of NBu4+Cl-. The chemical shifts of the NH protons were monitored as a function
of the anion concentration until saturation was reached. Using data accrued from a
minimum of three independent determinations, the association constants were calculated
using a nonlinear regression analysis (GraphPad) with a curve fit for 1:1 binding originally
used by Kavallieratos et al.17b

Competitive chloride binding assayed by electrospray mass spectrometry, as
performed by I. Alexandru Carasel, Joseph Kramer and Dr. Rudolph Winter.
In each experiment, competing hosts were present in equimolar concentrations (50
μM) and chloride (as NBu4Cl salt) was kept sub-stoichiometric (5 µM) so that competition
for the guest would be obvious. The excess neutral host molecules are not observed unless
complexed by Cl¯, so excess host could be ignored. The ratios shown in Table 3.2 were
calculated from the total integration of relevant m/z peaks for host-Cl¯ adducts. Five
charged adducts were observed at significant abundances: [hostACl]¯, [hostBCl]¯,
[(hostA)2Cl]¯, [(hostB)2Cl]¯, and [hostAhostBCl]¯, and total relative abundances were
calculated for both hosts. In every case, the total relative abundance of the unsubstituted
isophthalamide, 5, was normalized to 1, with a value established for the competing
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compound. Errors are the calculated standard deviations of ratios from at least three
independent experiments.

Preparation of phospholipid vesicles.
3.6 mL of a 25 mg mL-1 chloroform solution of dioleoylphosphatidylcholine
(DOPC, from Avanti Polar Lipids; Alabaster, AL), was distributed equally to 6 test tubes
before evaporating the solvent in vacuo for 4 hours to yield dry films of 15 mg each. For
each vesicle preparation, a dry film sample was dissolved in a mixture of Et2O (375 μL)
and aqueous 1 mM lucigenin – 225mM NaNO3 (375 μL). The combined mixture was
sonicated for 30 s yielding a yellow suspension. The diethyl ether was removed under low
vacuum at 30 °C for 2 to 2.5 hours. The resulting mixed micellar, vesicular, and aggregate
aqueous suspension was extruded through a 200 nm pore-size membrane filter 5 times.
The filtered suspension was passed through a Sephadex G25 size exclusion column that
was previously equilibrated with a 225 mm NaNO3 external buffer, collecting the first
translucent fractions. This process effectively eliminated undesired extra-vesicular
lucigenin as well as micelles and vesicles of a smaller-than-desired size. The size of the
resulting purified vesicles was confirmed by light-scattering analysis, and the sample was
diluted to the appropriate concentration using the 225 mm NaNO3 external buffer.

Lucigenin quenching assay.
A 1900 μL aliquot of 0.31 mM vesicles in external buffer was placed in a quartz
cuvette to be used for the lucigenin quenching experiment. The excitation wavelength was
set to 368 nm and the emission wavelength to 506 nm, with both slits set to 5 nm. After a
brief initial equilibration phase, 100 μL of a 4 M NaCl solution were added in order to
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create a chloride gradient between the outside (190 μM) and the inside (0 μM) of the
vesicles. When the fluorescence intensity stabilized, 2 μL of the desired compound at the
appropriate concentration (10 mM stock solution for studies with 10 μM concentrations) in
DMSO were added. At the end of each experiment the vesicles were lysed with 100 μL of
a 2% Triton X-100 solution to establish the level of baseline fluorescence. The traces
shown are an average of at least 3 independent trials.

Planar bilayer conductance as performed by Saeedeh Negin.
Membranes were formed by painting lipid solutions (asolectin from soybean
dissolved in n-decane, 25mg mL-1, from Avanti Polar Lipids; Alabaster, AL) over a 200
m aperture separating two chambers containing 3.000 mL buffer solutions (450 mM KCl,
10 mM HEPES, pH = 7.00). 21L of a DMSO solution of the appropriate transporter was
then added into the cis chamber (the side of the membrane that hosts the input electrode) to
yield a final concentration of 7 M. Working in a Faraday cage (Warner Instruments) at
room temperature, specific potentials were applied between two electrodes immersed in the
two buffer solutions. The resulting currents were amplified (amplifier BC-525 D, from
Warner Instruments), filtered with a 4-pole Bessel filter at 1 kHz, digitized by Digitizer
(Digidata 1322A from Axon Instruments), sampled at 100 Hz amplifier filter frequency
and collected using Clampex 9.2 (Axon Instruments). The data were analyzed later using
Clampfit 9.2 (Axon Instruments).

Fluorescence of compound 4.
Fluorescence emission intensity was found to be maximal for all wavelengths with
λex = 280 nm when both slits were set to 5 nm. The fluorescence emission spectrum was
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recorded while titrating a solution of host in 1% DMSO/Water into a solution of either 1%
DMSO/Water or 1% DMSO/Water with 0.31 mM DOPC vesicles.

In all cases, the

recorded spectra are the average of 10 scans per concentration per trial with a minimum of
three independent trials totaling a minimum of 30 scans.
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CHAPTER 4
Solvent Dependence of Solid-State and Nanoscale Structures of
Branched-Chain Pyrogallol[4]arenes

Summary and Contributions to this Work

The work presented in this chapter focuses on the solid-state and nanoscale
morphologies of pyrogallol[4]arene macrocycles with branched sidechains.

These

compounds were analyzed for solid-state or “Angstrom-scale” geometry and morphology
by X-ray crystallography and analyzed for nanoscale geometry and morphology by
cryogenic transmission electron microscopy (cryo-TEM).
Solid-state

structures

show

that

within

a

family

of

branched-chain

pyrogallol[4]arenes, one in particular self-assembles into unique hexameric nanotubes.
Further analysis reveals that while the phenolic “head-group” is identical for all
pyrogallol[4]arenes, sidechain-sidechain interactions dominate the self-assembly, and a
unique intermolecular hydrogen bonding motif exists.
Both the crystallizations and electron microscopy sample preparations were
performed in various solvent conditions—polar, non-polar, protic, aprotic—and in mixed
solvents. While crystallizations were unsuccessful in many cases, EM sample preparations
by slow evaporation generally yielded usable specimens. These specimens reveal that
nanoscale aggregates self-assemble in polar media. Under 50000x magnification, these
aggregates are shown to be formed from bundles of what appear to be short nanotubes of a
diameter congruent with measurements taken from X-ray crystal structures.
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The solid-state X-ray crystal structures of these compounds were solved at the
University of Missouri – St. Louis by Dr. Nigam Rath using crystals grown by Dr.
Kulikov.

My contributions to the solid-state work are confined to the analysis of the

structures and the associated DFT-level calculations.
With the exception of the first set of specimens examined (seen in Figure 4.8,
below), I prepared samples of compound 2 for analysis by transmission electron
microscopy, which was performed with the assistance of Dr. Dan Zhou and David Osborn
at the University of Missouri – St. Louis.
A portion of this work is included in a paper1 published in Chemical
Communications in 2009.

Introduction

While covalent and ionic bonds are the strongest of interatomic forces and are thus
key factors in the formation of structures on the nanometer scale, weaker forces such as
hydrogen bonding, dipole-dipole, and van der Waals’ (or London dispersion) forces can
play prominent roles as well.

Solid-state and nanoscale morphologies are of utmost

importance when considering the activity of a compound in a biological membrane.
Aggregates visible on the nanoscale using techniques such as transmission electron
microscopy (TEM) may be indicative of a propensity for a compound to self-aggregate.
Self-aggregation may preclude membrane insertion in some cases or may lead to
unexpected characteristics in other cases.

This paradox is seen in the two synthetic

chloride channels that have been developed in our lab—the peptidic SAT transporters and
the dipicolinic dianilide triarenes detailed in Chapter 3.
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With the SAT molecules, self-aggregation of those family members with long alkyl
chains at either the N- or C-terminus anchors leads to a decrease in chloride transport
activity at a given applied concentration.2 A large proportion of these specific SAT
molecules form large, stable aggregates in the aqueous media. As a result, the effective
concentration—the fraction of the total concentration that inserts into the membrane and
transports chloride—is decreased. Generally, with increasing alkyl chain length and, by
extension, hydrophobic character, the effective concentration decreases and overall
chloride transport activity decreases.
Hydrophobic character was designed into the amphiphilic SAT system, as it was
believed that it was necessary for membrane insertion. Indeed, it is true that for SAT
molecules with alkyl chains that are too short, chloride transport rate is significantly
diminished due to lack of membrane insertion and a lowered effective concentration.
Thus, the hydrophobic character of a potential ion transporter must be balanced to both
allow membrane insertion and minimize unwanted self-aggregation.
With dipicolinic dianilides, however, self-aggregation in aqueous solution leads to
increased chloride transport activity as, with higher concentration, more aggregation
occurs.

A stacked aggregate is capable of spanning the phospholipid bilayer and

transporting chloride via a channel mechanism.3 This aggregation is explored in full detail
in Chapter 3 of this work.
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Figure 4.1. Structures of branched-chain pyrogallol[4]arenes 1-4, investigated in this
work. As variation is present only in the aldehyde-derived side chains, they can be
distinguished in future reference as 2-propyl (compound 1), 3-pentyl (2), 4-heptyl (3) and
5-nonyl (4). In the same crystallization conditions, 1, 3 and 4 form the bilayer (example in
bottom left panel) while 3 forms a unique hexameric nanotube (bottom right).
Another family of compounds known as pyrogallol[4]arenes have been made and
characterized by a colleague in our research group, Oleg Kulikov. The hydroxyl-rich
tetrarenes are formed from the 4+4 condensation of pyrogallol (1,2,3-trihydroxybenzene)
and an aldehyde under acidic conditions.4 The reaction proceeds through an electrophilic
aromatic substitution at the 4 and 6 positions of the arene, ultimately resulting in
cyclization. Variation of the aldehyde used in the condensation allows for modification of
the four “legs” or “sidechains” of the macrocycle. Pyrogallol[4]arenes with sufficiently
lipophilic sidechains are amphiphilic in nature, owing to the hydroxyl-rich “upper rim” of
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the macrocycle seen in Figure 4.2.

Work performed by another colleague, Megan

Daschbach, indicates that this amphiphilic behavior extends to pyrogallol[4]arenes with
sidechains as short as three carbons.5

Figure 4.2. Orthogonal perspectives of the calculated lowest energy gas-phase
conformation of the 3-pentyl branched chain pyrogallol[4]arene, 2.
The pioneering work of Atwood and collaborators with these pyrogallol[4]arenes
has explored a wide variety of straight-chain alkane and alkene sidechains, among
others.4,6 While many of the solid-state structures of these macrocycles exhibit a bilayer
morphology that is typical of amphiphiles,7 a number of these compounds have been
shown to self-assemble under the proper solvent conditions to form hydrogen-bonded
dimeric8 and hexameric9 nanocapsules. Additionally, one pyrogallol[4]arene has been
shown to assemble, in the presence of an ancillary molecule, into a solid-state nanotube
formed from stacks of hydrogen-bonded rings of four macrocycles each.6b
In the present work, Dr. Kulikov was able to isolate crystals of compounds 1-4
grown from the polar solvent systems 1:1 ethanol to ethyl acetate and 1:1 acetonitrile to
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ethyl acetate.

These crystals were characterized by X-ray analysis and the resulting

structures were studied further to elaborate structural detail and solid-state geometry.
One pyrogallol[4]arene, the 3-pentyl compound, 2, was found to form nanotube
structures in the solid state, while the remainder form a typical bilayer morphology. The
nanotubes formed by 2 appear to pack tightly with one another, leaving open the
possibility of forming nanostructures, which are shown to form on a carbon coated copper
grid after slow evaporation of solvent.
The nanoscale characterization is extended in the current work to investigate the
variation in nanoscale morphologies based on the evaporation of solvent, as well as to
determine the presence of and analytically compare the crystallinity and order in the
solvent-evaporated specimen. If different solvents yield different nanoscale morphologies,
and if diffraction patterns are present, a comparison of patterns can be made. If the same
diffraction pattern and lattice spacings arise from different nanoscale morphologies, it
supports the argument that both morphologies form from the same supramolecular
structure—the nanotube, for example. If the diffraction patterns are different, it lends
credence to the argument that different nanoscale morphologies arise from different
supramolecular structures.
Diffraction patterns of soft materials—most notably carbon nanotubes10—have
been acquired and used to differentiate varying molecular structures from similar or nearlyidentical nanostructure morphologies. In another previous study, calix[4]arenes, which are
similar in structure to the pyrogallol[4]arenes used in this study, were deposited on a
particular face of a gold crystal, self-organizing into a flat crystalline overlayer.11 This
supramolecular organization was determined by the combined use of scanning tunneling
microscopy and low-energy electron diffraction.

124

In both of these previous studies, low

energy-electron diffraction (LEED) was used to garner structural information on the
molecular level—a strategy that may be used with normal energy electron diffraction to
simply reveal differences in molecular/supramolecular structure, if not the structures
themselves. Unfortunately, these techniques were not available for our efforts, so TEM
visualization of nanostructures and analysis of polycrystalline diffraction rings are the
techniques used to garner as much information as possible herein.

Results and Discussion

Solid-state structure of branched-chain pyrogallol[4]arenes
The synthetic efforts of Dr. Kulikov, further characterized as presented here, were
targeted at understanding the effects of branched sidechains on the self-assembly of
pyrogallol[4]arenes in solution and in the solid-state.

Four branched-chain

pyrogallol[4]arenes were prepared for the present study. The acid-catalyzed reaction of
pyrogallol with isobutyraldehyde, 2-ethylpropanal, 2-propylbutanal, or 2-butylpentanal
gave, respectively, pyrogallol[4]arenes 1, 2, 3 and 4 shown in Figure 4.1. With one of
these sidechain variations, macrocycle 2, a self-assembled hydrogen-bonded nanotube has
been shown to form in the solid-state. The nanotube consists of an infinite stack of rings
of six hydrogen-bonded macrocycles. Conversely, under identical crystallization
conditions, pyrogallol[4]arenes 1, 3, and 4 crystallize in the more common bilayer
morphology.
Samples suitable for X-ray crystal structure determination were obtained for
compounds 1, 2, 3, and 4 by crystallization from 20:19:1 (v/v/v) EtOAc:EtOH:H2O. Solidstate structural analysis confirmed the bilayer structures for 1, 3, and 4. In all three cases,
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the pyrogallol[4]arene molecules align face-to-face with the phenolic hydroxyls
participating in a significant amount of intermolecular and interfacial hydrogen bonding.
Simultaneously, the branched hydrocarbon sidechains align tail-to-tail, maximizing polar
solvent exclusion and minimizing void space. Although none of these bilayer structures
had been previously described, the observed bilayer organization is similar to that reported
for related compounds with straight alkyl chains.

Figure 4.3. Orthogonal perspectives of a single hydrogen-bonded hexameric ring of
molecules of compound 2 formed in a 20:19:1 (v/v/v) EtOAc:EtOH:H2O solvent mixture.
Molecules directly opposite one another in the ring are related by Ci symmetry, with the
inversion point located on the tube axis. Solvent molecules and side-chains are omitted for
clarity.
In contrast, when 3-pentylpyrogallol[4]arene, 2, was crystallized, either from
20:19:1 (v/v/v) EtOAc:EtOH:H2O (“form A”) or 1:1 (v/v) EtOAc:MeCN (“form B”),
identical structures of the hexameric nanotube morphology were obtained. The
organization of a single hexameric ring is shown in Figure 4.3 as a cross-section of the
solid-state structure obtained from the ethanol-ethyl acetate solvent system.
Form A, which crystallized from 20:19:1 (v/v/v) EtOAc:EtOH:H2O, has an
empirical formula C152H238O52 and a molecular weight of 2897.4 g/mol that is consistent
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with half of a hexameric ring (i.e., a trimeric “half-ring”). This corresponds to 3
pyrogallol[4]arene subunits, 4 EtOH, and 12 H2O molecules. This repeating structure
comprises one half of a hexameric nanotube ring, with the other half-ring related by
reflection through a single inversion point that lies on the nanotube axis (Ci symmetry). A
full ring is held together by two direct hydrogen bonds between each neighboring subunit
and direct solvent-bridging interactions involving 2 EtOH and 6 H2O molecules. Rings are
linked by 18 subunit-to-subunit hydrogen bonds — 2 per subunit plus 6 additional H-bonds
between specific subunits. These interactions are shown in Figure 4.4. Note that no solvent
molecules participate in direct ring-to-ring bridging, and no organized ethyl acetate
molecules are present.
Form B of 2, crystallized from 1:1 (v/v) EtOAc:MeCN and has the empirical
formula C162H229N5O43 (mw 2934.5 g/mol). The molecular weight corresponds to 3 units
of 2, 3 EtOAc, 5 MeCN, and 3 H2O molecules. As in form A, this comprises half of the
hexameric ring. The internal and external dimensions of Forms A and B are not identical
but differ by less than 1 Å in any direction. The direct subunit-to-subunit hydrogen bond
network is identical in Forms A and B, although additional interactions occur with either
EtOH (Form A) or EtOAc (Form B).
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Figure 4.4. A depiction of the supramolecular interactions involved in a hexameric ring
derived from the ethanol-ethyl acetate system (Form A). The depiction is a “Mercatorlike” projection from the outside of the tube looking towards the tube axis running
vertically and is not drawn to scale. The sixth subunit (C’) is not shown as its interactions
are identical to those between the C subunit and its neighbors B and A’. The A’ subunit of
the ring below and the B subunit of the ring above are shown for clarification of inter-ring
interactions. Bridging waters are shown as red spheres while bridging ethanol molecules
are shown as red spheres connected to black ellipses. Relevant hydrogen bonds are
depicted as blue dashed lines.

Figure 4.5. (Top) Side view of a stack of six hexameric rings composed of
pyrogallol[4]arene 2. For clarity, the 3-Pentyl side chains and solvent molecules are not
depicted. (Bottom) A cartoon representation of tube formed by the stacked rings, showing
the tube axis and the cylinder formed. The dimensions of the elliptical tube are measured
within the plane that is normal to the tube axis.
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Analysis of Form A shows that the hexameric rings that form the nanotubes are
elliptical and tilted by about 30° with respect to the tube axis normal, as presented in
Figure 4.5. Using measurements of atoms that are coplanar with the tube axis normal, the
nanotubes themselves are shown also to be elliptical with short and long axis internal
dimensions of 16 Å x 22 Å between hydroxyl oxygen atoms and external dimensions of 26
Å x 33 Å measured between distal side-chain carbon atoms.
The nanotube formed in this structure is much larger than related predecessors.
Approximately 60% of the crystal's volume is an intra-annular, solvent-filled void. This
compares

with

previously

reported

internal

volumes

of

38%

for

Atwood’s

pyrogallol[4]arene tetrameric ring nanotubes,6b and 6% for the resorcin[4]arene inverted
hexameric ring nanotube characterized by Rissanen and co-workers.12 The larger void
volume in the present case may explain the higher R-factor (R1) of 16.5% (form A) and
18.2% (form B) compared to R1 values of 9.4%,6b 11.8%,6b and 9.0%12 for the previously
reported nanotubes. These void volumes are compared visually in Figure 4.6.
In the previous cases of nanotube formation from resorcin[4]arene or
pyrogallol[4]arene, a compound such as pyrene, 1-bromopyrene,6b or a diammonium salt12
was present as an ancillary to the nanotube. In the current work, ordered solvent molecules
appear in the crystal lattice, but the H-bond network does not appear to require them. In
contrast to the previous nanotubes and the other branched-chain solid-state structures, the
3-pentyl sidechains appear to interlock like the teeth (or cogs) of gears to tightly join
adjacent nanotubes and exclude solvent from the interannular domain. This interaction and
the excellence of the fit are apparent in the top panel of Figure 4.7, which shows a topdown view of three closely packed nanotubes.
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Intertube side-chain carbon-carbon distances are often between 3.5Å and 4.5Å – at
or near the sum of the van der Waals radii. These contacts have been measured and
enumerated for all four of the solid-state structures derived from branched chain molecules
crystallized from 20:19:1 (v/v/v) EtOAc:EtOH:H2O. When normalized to the unit cell
composition (crystals of 1, 3 and 4 have two pyrogallol[4]arenes present in the unit cell,
while 2 has three monomers), a direct comparison of contact distances can be made. The
counts are portrayed in relation to carbon-carbon distances, with values binned to
maximum cut-off points (0.05 Å, 5 pm). The data binning is cumulative, meaning that a
contact of 3.71 Å would be included in the 3.75Å count and counts for all higher values
(3.80Å, 3.85Å, etc.).
The number of close contacts present in these solid state structures suggests that the
unique hexameric nanotube morphology formed by 2 is energetically advantageous. The
high number of close contacts (< 3.75 Å) formed in the solid-state as well as the high
number of total contacts less than 4.10 Å is a manifestation of this energetic advantage,
underscoring the possibility that these structures form spontaneously in polar
environments.
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Figure 4.6. Comparison of tube size and volume of Rissanen’s trimeric ring
resorcin[4]arene tube (Panel A), Atwood’s tetrameric ring pyrogallol[4]arene tube
(Panel B), and the current hexameric ring pyrogallol[4]arene tube (Panel C). All
projections are along the tube axis, and no ordered intraannular solvent molecules are
shown. Polar interannular solvent molecules (present only in the resorcinarene nanotube,
Panel A) are depicted in blue, macrocycle oxygen atoms are depicted in red, macrocycle
carbon atoms in yellow, and lipophilic solvent molecules/co-crystallents shown in orange.
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Figure 4.7. (Top) End-on perspective of three rings of three adjacent nanotubes (carbon
atoms in green, blue or orange for each ring) showing the cogged or interlocked nature of
the branched side chains in the interannular space. (Bottom) Cumulating histogram of
interannular carbon-carbon contacts binned to the maximum contact distance.
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Nanoscale morphologies of 3-pentyl pyrogallol[4]arene, 2
The tight interlocking of pyrogallol[4]arene sidechains between nanotubes provides
a mechanism for bundling of nanotubes and formation of discrete identifiable
nanostructures. Previous transmission electron microscopy (TEM) work by Oleg Kulikov
shows that when specimens are prepared by evaporation of solutions or sonicated
suspensions of these pyrogallol[4]arenes, nanoscale morphologies are evident.

His

specimen was taken from a sample of 2 that had crystallized as form A and was
resuspended in 20:19:1 (v/v) EtOAc:EtOH:H2O. When this mixture was evaporated on a
copper-continuous carbon support, nanowires composed of what are presumably bundles
of tens to thousands of nanotubes are seen by transmission electron microscopy. The
specimen, as seen in Figure 4.8, exhibits small bundles forming in amorphous areas of the
sample and larger bundles in the more ordered areas of the sample. As the solvent
evaporates, the nanotube bundles could form more quickly or thoroughly in one area
versus another.
Detailed examination of TEM images acquired for the sample of compound
2 revealed that the smallest dark lines typically have a width of 9-10 nm. The
thinnest lines that are visible have a width of 6-7 nm. If the microfiber bundles are
exclusively nanotubes, then each individual nanotube is a cylinder of approximate
dimension 30 Å. Four coaxial tubes would have an external dimension of 60-70 Å
(6-7 nm).
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Figure 4.8: Bright-field images of a single specimen prepared by Dr. Oleg Kulikov from
the evaporation of a solution of pyrogallol[4]arene in a 1:1 mixture of ethyl acetate and
acetonitrile. Images are taken at a magnification of 2500x. Larger, thicker rhomboidal
cylinders with diameters between 270 nm and 13 nm are seen in panel A in a more
amorphous, thicker “field” of presumably disordered pyrogallol[4]arene. Panel B shows
a more extensive and numerous “web” of nanotube bundles with fewer areas of
amorphous “fields.”
Dr. Kulikov’s work has proven that these compounds can form nanostructures
when evaporated from solution. However, only one solvent system—a 1:1 mixture of
ethyl acetate and acetonitrile has been used to form nanostructures. Variation of the
solvent systems used to prepare the specimen may yield different nanostructures.
Four solvent systems were investigated for the current work—the original 1:1 ethyl
acetate to acetonitrile mixture, a 1:1 ethyl acetate to ethanol mixture, a 99:1 water to
ethanol mixture, and a pure ethanol mixture. The 99:1 water to ethanol mixture yielded the
most interesting results and will be discussed at length. Nanostructures derived from the
other solutions were all varied, and comparisons will be made following the discussion on
the specimen prepared from the 99:1 water to ethanol suspension.
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Particle size analysis of the post-sonication 99:1 water to ethanol suspension by
dynamic light scattering showed that aggregates were non-spherical, with a wide
distribution of average diameters. Using the TEM at 2500x magnification, large particles
of what appeared to be crystalline powder were seen, as shown in Figure 4.9. However,
under higher magnification (10000 x) the large aggregates appeared as large cylinders of
diameters varying from 900 nm to 150 nm. These large cylinders displayed ordered
texture, spaced at about 25 to 26 nm, running the length of the cylinder, as seen in Figure
4.10.

Also evident at this magnification were smaller nanowire-like structures that

appeared to emanate from the surface of the larger cylinders, as seen in Figure 4.11. These
also varied in diameter with a range of about 80 nm to 20 nm, and may have been
deposited by solvent in an ordered manner at the cylinder surfaces during the evaporation
process. As thickness cannot be easily judged using phase-contrast imaging, it is unknown
whether these structures are 3-D nanowires or 2-D nanobelts.

Presumably, a large

proportion of the pyrogallol[4]arene monomers in the sonicated solution remained as the
large cylindrical aggregates that form, immediately.

However, a smaller proportion

becomes solvated in the sonication process and the solvated monomers deposited at the
ordered cylinder surfaces.

135

Figure 4.9: Phase contrast image (2500x magnification) of the specimen, taken from an
evaporated, sonicated solution of pyrogallol[4]arene in 99:1 water to ethanol. The larger,
thicker cylinders are between 900 nm and 150 nm in diameter, while the smaller
nanowires are between 80 nm and 20 nm in diameter.
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Figure 4.10: Phase contrast image of a large cylindrical aggregate taken at 10000x
magnification. Ordered texture is seen running the length of the cylindrical aggregate,
with thickness, and thus transmission loss, increasing near the center of the cylinder.
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Figure 4.11: Phase contrast image (10000x magnification) of the same cylindrical
aggregate seen in Figure 4.10. Bundles of nanotubes (8-20 nm diameter) are seen
radiating from the circular edge, or “top,” of the cylinder. This phenomenon is seen
throughout the specimen.
This ethanol-water post-sonication specimen was investigated further for possible
crystallinity and order. When a large cylindrical aggregate is isolated by the selective-area
aperture, a polycrystalline-like diffraction ring is seen, but the wide bands indicate that the
nanostructure is too amorphous to be considered polycrystalline. Polycrystalline can be
differentiated from crystalline in that the latter is organized into a single crystal lattice (or
relatively few crystal lattices) while the former consists of crystallites that can be of
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various sizes and different orientations. Rings are formed in the diffraction patterns of
polycrystalline materials due to their random orientations, while crystalline materials
diffract at distinct points.

Figure 4.12: (Top left) Phase contrast image taken at 2500x magnification of three larger
cylindrical aggregates. The area of the image under the beam-stop tip is selected for using
the SAD aperture to produce the diffraction rings (top right). Image (bottom left) and the
derived ring pattern (bottom right) of a “web” of smaller bundles of nanotubes not
associated with a large aggregate.
The aggregate examined and the resulting diffraction pattern can be seen in the
upper left and upper right panels of Figure 4.12, respectively. The observed ring pattern is
the same when examining a “web” of smaller bundles of nanotubes as seen in lower left
panel of Figure 4.12. A direct comparison can be made between the rightmost panels.
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Nanostructures formed from the evaporation of the other three solvents were
dramatically different. The 1:1 ethyl acetate to acetonitrile solution originally used to
prepare the specimen seen in Figure 4.8 was used once again, nearly three months later, to
determine if the nanostructures morphology remains stable over time. The more recent
transmission electron micrograph, seen in Figure 4.13, is dramatically different. The
sample exhibits the same “fields” of presumably amorphous disordered pyrogallol[4]arene,
yet the visible nanostructures formed are spherical outcroppings, or “buds,” from the
amorphous fields. Attempts to examine fine structure at higher magnification showed that
no fine structure was apparent (Figure 4.13, Right)

Figure 4.13: (Left) Phase contrast image (5000x) magnification of spherical “buds” or
outcroppings from the amorphous pyrogallol[4]arene fields present in this specimen,
prepared from evaporation of a solution of monomer in 1:1 ethyl acetate to acetonitrile.
(Right) An image (10000x) magnification revealing no additional insights into fine
structure or nanostructure order.
The nanostructures seen in the specimens prepared from evaporation of absolute
ethanol and 1:1 ethyl acetate to ethanol possessed the most similar nanostructure
morphologies. Side-by-side comparison of the two—seen on the left and right panels,
respectively—was made at 25000x magnification (Figure 4.14) and 50000x magnification
140

(Figure 4.15). The similarities were striking at both magnifications, particularly at 50000x,
and one can reasonably assume that these solvent systems form the same nanostructures
upon evaporation. This observation, coupled with the observation that crystallization of
this pyrogallol[4]arene from 1:1 ethyl acetate to ethanol shows no ordered ethyl acetate
molecules in the solid-state crystal structure, supports the argument that even though there
is a difference in polarity between the two solvents, ethyl acetate has no effect in both
supramolecular and nanoscale structure formation when ethanol is involved.

Figure 4.14: (Left) Phase contrast image (25000x magnification) of a specimen prepared
from evaporation of a solution of monomer in 1:1 EtOAc to EtOH. (Right) An image
(25000x magnification) of a specimen prepared from absolute EtOH.
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Figure 4.15: (Left) Phase contrast image (50000x magnification) of the same 1:1 ethyl
acetate to ethanol specimen seen in the left panel of Figure 4.14. (Right) An image (50000x
magnification) of the absolute ethanol specimen seen in the right panel of Figure 4.14.
Evident at the higher magnification (50000x) seen in Figure 4.15, are distinct
rectangular and ordered “tiles” measuring about 25 to 35 Å in diameter. This is roughly
the size of a single nanotube in the solid state structures. These “tiles” are closely packed
in 2-D space, as one sees in the solid-state crystal structure. These nanostructures could
perhaps be large aggregates or bundles of short nanotubes, but the amorphous environment
of the surrounding material and the difficulty in studying a given particle at high
magnification for long periods of time makes this statement a supposition.
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Figure 4.16: (Left) Phase contrast image
taken at 100000x magnification of the same
absolute EtOH specimen seen in the right
panels of Figure 4.14 and 4.15.
Attempts to image the material at high magnification were made, but were futile.
As seen in Figure 4.16, specimen drift and degradation of the sample prevented the capture
of a high-resolution image, and no additional information could be gleaned. Unfortunately,
at high magnifications (>50000x), specimen degradation and shift is significant in all of
the studied samples.

Conclusions

The formation of the hexameric nanotube morphology by compound 2 is
surprising. No ancillary or solvent molecules are present to aid in ordering the sidechains
or filling void space in the hydrophobic domain of the crystal. Enthalpically, the only
energetically favorable supramolecular interactions exist at the interfaces of the
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hydrophilic phenolic regions of the macrocycle. As the pyrogallol[4]arenes are structurally
identical in this region, one would expect the supramolecular interactions to also be
identical in solution and the solid-state. As with the “hydrophobic interactions” mentioned
previously, the variation in solid-state morphology is derived from the geometry that
minimizes supramolecular hydrophobic-hydrophilic contacts and increases solvent
entropy.
This entropy is easily exemplified in the void space that is present in the crystal.
The interannular portion of the crystal is roughly 60% of the crystal lattice by volume. A
layer of polar protic solvent molecules (water and ethanol) are organized by the phenolic
hydroxyls lining the nanotube interior (or pore). However, significant disorganization of
the space between this first layer of solvation signifies that a favorable solvent entropic
situation exists.
The tight interlocking between the 3-pentyl sidechains of pyrogallol[4]arene 2
appears to be the dominant force in the crystal lattice.

This “gearing” interaction

completely excludes water or other solvent molecules from the hydrophobic region of the
crystal and perfectly minimizes void space in this intraannular domain.

The larger

branched-chain pyrogallol[4]arenes 3 and 4, have 12 and 24 extra methylenes per
macrocycle, respectively. In an extended geometry, the extra carbon atoms expand the
radius of the hydrophobic domain beyond the radius encompassed by the phenolic upper
rim of the macrocycle. With too much steric bulk to accommodate between the rings, the
cogged, hexameric ring geometry of 2 is not the entropically-preferred morphology and a
bilayer is formed. Presumably, the shorter-chained pyrogallol[4]arene 1 would yield too
much void space in the cogged nanotube morphology, as the steric bulk of 12 methylenes
per macrocycle would be absent. While studies at the air-water interface1,5 suggest that
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some entropically-favored interaction occurs between macrocycle monomers, only the
bilayer morphology is observed in the solid state.
Specimens prepared by evaporation of pyrogallol[4]arenes in four different solvent
systems were studied and imaged by transmission electron microscopy.

The

nanostructures morphologies were different for each solvent system, indicating that the
solid-state crystallized nanotubes of compound 2 can form different nanostructures out of
different solutions. However, all nanostructures appear to be spontaneously-formed in
polar solution, with the 1% ethanol in water solution yielding the only structures formed
from evaporation.
The specimens formed from solutions of pyrogallol[4]arene 2 in ethanol or 1:1
ethanol to ethyl acetate show ordered aggregates that exhibit fine structure. At 50000x
magnification, these aggregates are shown to be composed of structures approximately 25
to 35 Å in diameter, the same dimensions as the nanotube observed in the solid state. This
observation confirms the nanotube supramolecular morphology. In this solvent system,
however, the rings do not form into infinite stacks—a trait which may only be present in
the sonicated 1% ethanol in water specimens.

Experimental

Compounds Studied

Compounds 1-4
These compounds were synthesized by Dr. Oleg Kulikov and were used as received.
Synthetic details are reported in the literature.1
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X-Ray Analysis
Crystallographic data for compound 2 crystallized from the mixture 20:19:1 (v/v/v)
EtOAc:EtOH:H2O in nano-tubular motif (form A). C152H238O52, M = 2897.42, triclinic, a =
12.5581(17), b = 29.097(5), c = 30.504(7) Å, U = 9743(3) Å3, µ = 0.074 mm-1, T = 100(2)
K, space group P-1, Z = 2, GOF = 1.129, final R-indices (R1 = 0.1645, wR2 = 0.3740),
103521 reflections collected, 33806 unique (Rint = 0.186), CCDC 729499.
Crystallographic data for compound 2 crystallized from the mixture 1:1
(v/v)EtOAc:MeCN in nano-tubular motif (form B). C162H229N5O43, M = 2934.50,
triclinic, a = 12.546(2), b = 29.291(6), c = 29.804(5) Å, U = 9564(3) Å3, µ = 0.073
mm-1, T = 100(2) K, space group P-1, Z = 2, GOF = 1.619, final R-indices (R1 =
0.1820, wR2 = 0.4672), 155193 reflections collected, 32525 unique (Rint = 0.1644),
CCDC 729498.
Data for both crystal structures were collected on a Bruker Kappa Apex II CCD
detector single crystal X-ray diffractometer.

Transmission Electron Microscopy
Four solvent systems were investigated for this study—the original 1:1 ethyl
acetate to acetonitrile mixture, a 1:1 ethyl acetate to ethanol mixture, a 99:1 water to
ethanol mixture, and a pure ethanol mixture. The 99:1 water to ethanol specimen yielded
large extended aggregates that were easily visible with the naked eye and thus too large for
TEM work. This mixture was sonicated for 15 minutes to give a stable suspension usable
for specimen preparation. In all cases, a copper/continuous carbon support grid was
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dipped in a given pyrogallol[4]arene solution with a concentration of 600µM and left to air
dry for 30 minutes.
Specimens were examined and imaged primarily with the JEOL 2000 FX
microscope with an electron acceleration voltage of 120kV. CryoTEM conditions are
achieved using a suitable specimen holder that cools the specimen using liquid nitrogen.
A digital CCD camera was used to capture all images with this microscope. However, for
the images and associated diffraction patterns shown in Figure 4.12, the more powerful
Phillips EM 430 microscope (acceleration voltage of 300kV) was used with a film camera
for image/pattern collection. The film negatives were developed and digitized by David
Osborn.
Images were taken primarily at 25000 x magnification or lower, as the
nanostructures of interest were easily visible at these magnifications. However, in a few
cases, images were taken at 50000 x and 100000 x magnifications in an attempt to
investigate the fine structure of nanostructures. In many cases, specimen degradation and
drift under the electron beam rendered images of low clarity and resolution, though these
are examined.
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CHAPTER 5
Antimicrobial Activity and the Development of Antimicrobial
Resistance to Synthetic Ion Carriers and Channels in Bacteria

Summary and Contributions to this Work

The work presented in this chapter focuses on the characterization of antimicrobial
activity of novel compounds as well as an investigation into the development of
antimicrobial resistance to a known novel synthetic cation channel in Escherichia coli. 27
compounds were tested for their activity in Gram negative E. coli, revealing that only
cation transporters of the known hydraphile family of compounds1 are active in the
bacterium. The other compounds studied, including known cation and anion transporters,
did not elicit growth inhibition in E. coli.
Growth curve measurements of Gram-positive Staphylococcus epidermidis were
used to study the effects of co-application of a diaza-18-crown-6 antimicrobial cation
transporter with one of two dipicolinic dianilide (Chapter 3) anion transporters. The
activity of the diaza-crown was monitored at both lethal and sub-lethal concentrations.
While alone, the diaza-18-crown-6 that is studied affects antimicrobial activity, when coapplied with a dipicolinic dianilide chloride transporter the effects are completely negated.
The third and final project explored the development of antimicrobial resistance in
E. coli to synthetic cation channel with known antimicrobial activity.

The antimicrobial

resistance was studied with regular application of sub-lethal concentrations of the
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hydraphile cation channel over 12 days. While resistance did develop over the time period,
it plateaued after 6 days of growth, developing no further resistance.
Compounds 1-12 (structures below) were made and chemically characterized by
Dr. Wei Wang, a former collaborator. Compounds 13 and 14 were made and chemically
characterized by Dr. Lei You, compounds 15-17 were made and chemically characterized
by Dr. Oleg Kulikov, and compounds 18-27 were made and chemically characterized by
me, as outlined in Chapters 2 and 3. The 24-hour growth curves were measured for the last
6 hours by an undergraduate researcher, Jason Atkins. Otherwise, I performed all of the
sample preparation, specimen storage, and microbiological assays reported here.
A portion of this work is included in a paper published in Heterocycles in 2007.2

Introduction

The development of resistance to first-, second-, and even third-line antibiotics is
an alarming upward trend, prevalent in both the developing and developed world.3
Overuse and misuse of antibiotics—antibacterial soaps for the general population,
prophylactic antibiotic use in livestock, doctors wrongly prescribing antibiotics for the flu,
patients not completing their prescribed regimen after they feel healthy—can all further the
development of resistance.4 Application of antibiotics at sub-lethal concentrations—an
end result of scenarios such as these—inevitably kills the weakest, least resistant
phenotypes of a given bacterial strain, while the strongest and most resistant survive.5 This
acceleration of evolution, coupled with the twenty minute average generation time for E.
coli, exacerbates a problem (from a human perspective) that arises naturally, without
antibiotics.6
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Resistance to antibiotics can develop for many different reasons and through many
different mechanisms.7 Eons before the pharmaceutical industry existed, a molecular arms
race began between organisms small and large, simple and complex. Over the millennia,
multi-cell eukaryotic organisms have developed a myriad of defenses against their distant
prokaryotic relatives. Whereas humans have their own immune systems to fight off
infection, other organisms have developed their own methods and molecules to do the
same.
At the same time, the prokaryotes have developed ways to circumvent these
eukaryotic defenses, as well as put themselves at an advantage against other prokaryotes.
As evolution continues, the organisms that can exploit their genetic advantages will go on
to procreate and multiply—while those that cannot go by the wayside.
While modern science has allowed us to isolate, characterize, improve, and use
what antibiotic defenses nature has provided, we are only now beginning to see the effects
of harnessing and improving nature on the organisms that we target for elimination. Many
of these natural molecules and synthetic analogues, such as the β-lactam antimicrobial
agents, that have been cornerstones in antibiotic regimens, have been showing a marked
increased of tolerance in pathogenic organisms.8 Only in the past few decades have we
come to understand the many mechanisms and modes of antibiotic resistance.9 Once we
are able to fully elucidate all of these mechanisms, efforts to target antibiotics in order to
circumvent these prokaryotic defenses can come about at full steam.
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Figure 5.1 Common drugs of “last resort” include the glycopeptide, vancomycin, the first
oxazolidinone, linezolid, and the broad-spectrum beta lactam, imipenem.
The third-line of antibiotic defense, or “drugs of last resort,” include antibiotics
such as vancomycin, imipenem, and linezolid that are prohibitively expensive, broadspectrum (adversely affecting ones natural gastric flora), relatively toxic to the host, or
some combination of the three.10 While these have been used quite successfully against
bacterial strains such as methicillin-resistant Staphylococcus aureus (MRSA)11 that are
resistant to older drugs, some of these newer antibiotics are inciting resistance themselves,
as evidenced by the appearance of vancomycin-resistant S. aureus (VRSA).12
At some point in the future, medical practitioners facing an outbreak of bacterial
infections resistant to multiple antibiotics may have to release these drugs of last resort for
broad use.

If this nightmare scenario comes to pass time and time again, our existing

stockpile of novel antibiotics may run out. To circumvent this future problem, an obvious
solution is better handling and use of the antibiotics already in the field. However, it might
also be wise to find a proverbial über-drug—an antibiotic that is not only active against
drug-resistant strains, but is immune to the development of resistance in bacteria. 13
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This über-drug may be found in the realm of novel synthetic molecules that have
no significant structural basis in natural materials and do not interact directly with enzyme
active sites or genetic material—areas where mutations could quickly lead to the
development of resistance.14 Compounds derived from abiotic materials may be less likely
to be metabolized by either the host or the target organisms. “Foreign” structures and
uncommon chemical moieties may have no “molecular predators”—enzymes with active
sites that can bind with and break down the molecule. Such a substance has a two-fold
therapeutic advantage in vivo: (1) molecules that have diffused to the infection site will be
broken down only slowly by the bacterial colonies, if at all and (2) bioavailability, or the
proportion of the original dosage available where needed, is higher if the host cannot
metabolize the substance. This second advantage could be a drawback if the host cannot
eliminate the foreign substance, inevitably becoming toxic if a build-up occurs. Such
considerations must be weighed during pre-clinical in vivo testing with mammals, but this
is beyond the scope of knowledge gleaned in a chemical biology laboratory.
The application of sub-lethal concentrations of antimicrobial agents has been
employed previously to understand what fraction of the total may survive contact with the
agent, and what changes may take place.15 However, it is now well known that the
presence of sub-lethal concentrations of antimicrobial agents leads to multi-drug
resistance, 16 specifically in nosocomial infections where both different strains of bacteria
and different antimicrobial agents are present.
Our group’s studies in the biological realm consist primarily of assaying
functionality in both natural and biological model systems.

In this regard, we have

developed a number of membrane-active ion transporters, many of which display channel
functionality. Earlier work with diaza-18-crown-6 synthetic cation carriers showed that
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channel functionality is not a requirement for antimicrobial activity.17 Therefore, a broad
range of ion transporters—anion or cation transporters with carrier or channel
mechanisms—have been assayed for antimicrobial activity in the present work.
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Previous work in our laboratory group has yielded a well-studied membranespanning, ion-conducting family of compounds known as hydraphiles.18

Aside from

showing ion channel activity, many of the hydraphiles have exhibited antimicrobial
activity, with efficacy against Gram negative Escherichia coli, Gram positive Bacillus
subtilis, and eukaryotic Saccharomyces cerevisiae.17 The best characterized, and one of
the most biologically-active members of this family is the C12 benzyl channel hydraphile,
compound 1, used for a further study into the development of antibiotic resistance in E.
coli.

Results and Discussion

Antimicrobial activity of novel compounds
Drawn from various research projects carried out in our group, a collection of
known, membrane-active ion transporters and suspected transport agents was gathered and
assayed for antimicrobial activity.
Minimum inhibitory concentration (MIC) assays are performed in liquid culture
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with bacteria grown over time in a liquid nutrient-rich growth media. A set of cultures
with varied concentrations of the compound of interest is grown in an incubator-shaker at
37°C for 24 h. Cultures with low enough concentrations of an antimicrobial compound
show growth in the form of visual turbidity. Cultures in the presence of high enough
concentrations of an antimicrobial compound show no visual turbidity and thus no growth.
The lowest concentration at which no growth is seen is the MIC.
antimicrobial agents would therefore have a lower MIC.

More active

This method yields quick

quantitative results that are sufficient for this broad-range study.
For the sake of comparison, many common antimicrobial agents, such as penicillin
and erythromycin, are active at concentrations less than 20 μM.19 Novel compounds that
prove to be inactive in a bacterial species at concentrations of 100 μM or lower are deemed
inactive and in most cases not worthy of further study in the use against the respective
organism.
The first set of compounds tested for antimicrobial activity was a subset of the
previously mentioned hydraphile family of synthetic cation channels. This subset was
synthesized and chemically characterized by a collaborator, Wei Wang, and is unique in
that they feature amide moieties at specific diazacrown-alkyl chain interfaces (outlined in
Figure 5.2) rather than tertiary amines which are typical for the hydraphile family. Due to
the predicted variation of nitrogen basicity and molecular geometry in tertiary amides and
tertiary amines, it was believed that pH could play a determining role in the cation
transport effectiveness and antimicrobial activity of the hydraphile channels.
Dr. Wang’s work with the compounds focused on the cation transport activity of
the hydraphiles in phospholipid vesicles, while my portion of the project entailed
characterizing variations in antimicrobial activity in E. coli at various pH conditions.
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Under normal circumstances, the pH of the unadulterated growth media is around 7.0.
When used for all microbiological tests, the pH of the media is maintained using HEPES
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), a common, biologically-inert buffer.
For the more acidic growth cultures, malonic acid was added until a pH of 6.5 was
indicated by a pH meter.
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Figure 5.2 Amide hydraphile channels tested for microbial activity at pH 7 and 6.5.
Compounds 3-9 containing amide moieties have a gray shaded box at the appropriate
position, highlighting the presence of the carbonyl moiety.
Compound

X=

Y=

Z=

Hydraphiles 2-9 were dissolved in ethanol and serially-diluted in two-fold steps to
yield a range of concentrations from 32 to 0.5 μM. While ideally ranges up to 100 μM are
desired, solubility issues prevented exploration of activity at these higher concentrations.
Therefore, as seen in Figure 5.2, where an MIC is reported as >32, no activity is seen in the
culture with the highest concentration of hydraphile present. Note that this is distinct from
a reported MIC of 32 μM (Compound 4 at pH 7).
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A second set of compounds that were made and characterized by Wei Wang, called
aplosspan or “simple span,” were found to elicit sodium transport and channel activity in
biological membranes. As with hydraphiles, these compounds, seen in Figure 5.3, were
thought to be able to exhibit antimicrobial activity and were thus tested for this
characteristic. The limited solubility of these aplosspans in ethanol led to the use of
dimethyl sulfoxide as a solvent. As with ethanol, all assays using test compounds were
compared to cultures grown in the presence of solvent alone. The solutions were prepared
to yield a high end 64 μM concentration in-culture, with dilutions down to 1 μM. Limited
solubility precluded the preparation of a 128 μM in-culture concentration for any of the
compounds.

Figure 5.3 Aplosspan molecules tested with antimicrobial activity in E. coli shown.

Unfortunately, none of the aplosspans effected growth inhibition in E. coli. To
confirm the negative results, the experiment was repeated using compound 1 as a positive
control, with the same conditions used in the assay. Additionally, the optical density at
600 nm (OD600, discussed in greater detail below) was measured for each of the cultures to
ensure that no degree of growth inhibition occurred at the higher end of the concentration
range. If growth is present in a culture, any differences in the amount of growth are
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indiscernible to the naked eye, so visible light spectroscopy is necessary to ensure that no
antimicrobial activity is observed. With the exception of the first set of compounds (2-9),
which includes the known internal positive control compound, 2, this confirmation
procedure is used for all of the antimicrobial assays performed.
While 10-12, like hydraphiles, have cation transport and channel functionality, the
lack of antimicrobial activity can be attributed to the inherent solubility issues. Unaided,
the compounds may not be able to pass both of the bilayer membranes present in E. coli.
If they are able to insert into both the cell wall and plasma membrane, they may not be
present in concentrations significant enough to exhibit cation transport activity due to selfaggregation in solution.
A series of synthetic anion channels was investigated for their antimicrobial
activity.

Heptapeptides 13 and 14, seen in Figure 5.4, are members of the well-

characterized class of compounds known as Synthetic Anion Transporter (SATs).
Whereas compound 13 has established chloride transport ability and channel
functionality,20 compound 14 is cationic. Cationic peptides such as Polymyxin B21 and
synthetic lipopeptides characterized by Shai et al.22 have shown antimicrobial activity due
to membrane disruption and cell necrosis. These compounds selectively target membranes
that are rich in anionic phospholipids—a characteristic common to both Gram positive and
Gram negative bacteria,23 as well as a number of fungi,24 but is atypical of mammalian
cells.
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Figure 5.4 Heptapeptide synthetic anion transporters (SATs) 13 and 14 investigated for
antimicrobial activity in E. coli.
As with the aplosspans discussed above, no antimicrobial activity is observed for
compounds 13 and 14 in E. coli. The anion channel functionality of these compounds in
biological model systems suggest that ion homeostasis can be disrupted in natural systems.
Previous studies with airway epithelial cells confirm that they are, in fact, active in natural
systems.25 However, the composition of bacterial membranes—particularly the higher
proportion of anionic phospholipids—may preclude membrane activity in E. coli.
Complexation with anionic phospholipid head-groups would presumably lower chloride
transport rate. Although membrane disruption, such as seen with the previously-mentioned
Polymyxin B and lipopeptides, could occur, this does not appear to be the case, even with
the cationic heptapeptide 14.

Finally, the heptapeptide sequence, unlike the

antimicrobially-active hydraphile structure, is biotic in nature, and metabolism may occur
in situ, effectively destroying the applied transporter molecule. In an effort to circumvent
this latter drawback in using the heptapeptide SATs, only abiotic synthetic compounds
were tested for the remainder of the survey.
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The next three compounds studied for antimicrobial activity are members of the
pyrogallol[4]arene family of compounds detailed in Chapter 4—branched chain 2-propyl
(15) and 3-pentyl (16), as well as straight chain 1-undecyl (17), which has been shown to
exhibit channel functionality in asolectin black lipid membranes.26 These compounds, as
seen in Figure 5.5, do not exhibit antimicrobial activity when applied as either ethanolic or
DMSO solutions to inoculated growth cultures. Compound 16 precipitates from ethanol at
concentrations greater than 32 μM. The same holds true for compounds 15 and 17 at a
final concentration higher than 64 μM.

Figure 5.5 Pyrogallol[4]arenes 15-17 tested for antimicrobial activity in E. coli.

The potential for these compounds to act as antimicrobial agents seemed greater
due to the known channel functionality of 17 and their abiotic structural motif. However,
the limited solubility of the compounds in aqueous solution, particularly of 3-pentyl
compound 16, precluded membrane insertion rather than assisted in the process, as with
the dipicolinic dianilides. Chronologically, these studies were performed before those in
Chapter 4, so the understanding of the aggregation of 16 was not yet complete.
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In

retrospect, the strong intermolecular cogging interactions observed in the solid state,
expanded in the nanoscale, would prevent any significant interaction with membranes.

Compound
Solvent
MIC
Compound
Solvent
MIC
DMSO
>16 μM
DMSO
>128 μM
18
23
DMSO
>128 μM
DMSO
>128 μM
19
24
EtOH
>128 μM
DMSO
>128 μM
20
25
DMSO
>128 μM
DMSO
>128 μM
21
26
DMSO
>128 μM
DMSO
>128 μM
22
27
Figure 5.6 Synthetic anion receptors 18-27 detailed previously in Chapters 2 and 3 and
tested here for antimicrobial activity in E. coli. All of these compounds were applied to
growing cultures of bacteria using dimethyl sulfoxide as solvent. The solubility of these
compounds varied, though all were inactive at the highest concentrations that could be
tested.
A final set of compounds tested for antimicrobial activity includes the anion
receptors modeled, synthesized, and characterized in Chapters 2 and 3 of this work. The
anion-binding character of these compounds, seen in Figure 5.6, is similar to that of SATs
13 and 14. However, the abiotic composition of the compounds (excepting compound 20
with two glycine residues) suggests that they may be resistant to microbial metabolism.
As the observations show, however, these anion receptors, like the heptapeptide
SATs, elicit no antimicrobial activity.

As before, the anionic character of bacterial
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membranes may impede anion transport and preclude disruption of ion homeostasis,
lending no significant growth inhibition.

Growth curves of S. epidermidis in the presence of ion transporters

Figure 5.7 Synthetic anion receptors 23 and 24 detailed previously in Chapter 3 and
cation transporter 28 shown previously to elicit antimicrobial activity in Gram positive
bacteria.17
N,N’-Didodecyl-4,13-diaza-18-crown-6, compound 28, has been shown to have
antimicrobial activity against the Gram positive bacterium Bacillus subtilis. Presumably,
this activity results from the disruption of ion homeostasis due to transmembrane sodium
transport that is observed in phospholipid vesicles.17
With diaza-crown 28 being a known sodium transporter and 24 being a proven
chloride transporter,27 co-application of the two species may produce synergistic or
deleterious effects.

Compound 24 itself, as shown above, displays no antimicrobial

activity in Gram negative E. coli, but this study tests its effects on Staphylococcus
epidermidis, a Gram positive bacterium with significant differences in cell wall
composition and architecture. S. epidermidis is used as the target organism as it has not
been previously assessed for antimicrobial activity in our research group. Additionally, S.
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epidermidis is in the same genus as Staphylococcus aureus, a microbe known for
developing resistance to antibiotics. Antibiotic-resistant S. aureus infects an estimated
100,000 people, killing nearly 20,000 in the United States, annually.28
With a co-application of an anion and cation transporter, three results can be
expected:
1. Transporters of both chloride and sodium working in tandem would elicit a
synergistic effect that increases the antimicrobial activity of 28 alone. This
can be due to a more rapid disruption of ion homeostasis
2. Transport of sodium and chloride in tandem elicits a deleterious effect
wherein the antimicrobial activity of 28 is decreased.
3. The presence of a chloride transporter would not have any impact in
bacterial growth rates

Whereas the third result would show that no activity is implicated in this particular
biological system, either of the first two results would be a positive indication of activity in
biological systems. The lack of antimicrobial activity by 23 and 24 in the first section of
this chapter
To monitor the effects of the co-application of transporters, bacterial growth curves
were measured using spectrophotometric means (OD600) over a 24 hour growth period with
recordings made every 30 minutes. While the minimum inhibitory concentration (MIC)
and IC50 (or the concentration required for the inhibition of 50% of bacterial) can yield
quantitative results, they are determined at only one given time point and give no sense of
dynamic characteristics. Growth curves measure the optical density of cultures at regular
intervals—yielding an understanding of bacteriostatic activity that is present for a certain
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time frame. They can also give a better understanding of the interaction of two compounds
in a bacterial culture as more data is recorded over the time frame, providing more than the
“snapshot” afforded by antimicrobial assays.

29

The MIC of 28 was determined using the methods outlined above, showing a lethal
concentration of 16 μM. The growth curves of the three compounds alone are shown in
Figure 5.8 with 28 applied at a lethal concentration and 23 and 24 applied at 50 μM. The
growth curve of both 23 and 24 nearly overlap with the control, indicating that they elicit
no antimicrobial activity when applied alone.
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Figure 5.8 (Top) Growth curves of S. epidermidis grown with either 23, 24 and 28
compared to the control. (Bottom) Growth curves of 28 grown at a lethal concentration
(16 μM) and sub-lethal concentrations (2 and 4 μM) compared to the control.
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Figure 5.9 (Top) Growth curves of S. epidermidis grown with 2 μM of 28 applied alone
(dark boxes), with 50 μM of 23 (light down triangles) or with 50 μM of 24 (light up
triangles) compared to the control. (Bottom) Growth curves with co-application using 4
μM.
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One important facet of this dynamic study is the length of lag time before the
cultures began to undergo mitosis and proliferate. The addition of stressors or beneficial
compounds can alter these lag times as the bacteria “mature” more slowly or more rapidly,
respectively.30 A summary of these results, focusing on the lag phase of the growth
cultures are seen in Table 5.1.
Anion
Transporter

Concentration
(μM)

Cation
Transporter

Concentration
(μM)

Lag Phase
(hours)

Final
OD600

None

0

None

0

3.0

>2.5

23

50

None

0

3.0

>2.5

24

50

None

0

3.0

>2.5

None

0

28

16

19.0a

0.1

None

0

28

4

19.0

1.0

23

50

28

4

17.5

>2.5

24

50

28

4

15.0

>2.5

None

0

28

2

13.5

>2.5

23

50

28

2

8.5

>2.5

24

50

28

2

3.0

>2.5

Table 5.1 Summary of the lag phase and final optical density after 24 hours of growth. A
higher OD600 signifies more growth at a given time while a shorter lag phase signifies
quicker growth. aDeviation from the baseline occurs at this time, but exponential growth
does not follow.
The co-application with the synthetic anion transporter, p-nitro substituted
dicipicolinic dianilide 24, with a cation transporter, C12 diazacrown 28, shows that a
significant deleterious effect is imposed on the antimicrobial activity of the latter. As
shown in Figure 5.9, the growth curve of this culture nearly overlaps with the control
culture, indicating that the antimicrobial activity of 28 is completely negated. When 28 is
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co-applied with the unsubstituted dianilide, 23, the lag phase of bacterial growth is roughly
5 hours shorter indicating that while 23 does not efficiently transport chloride in
phospholipid vesicles, and exhibits weaker chloride binding interactions, mitigation of the
antimicrobial activity of 28 is still seen. At the 4 μM concentration of 28, this mitigating
effect is still seen, but the presence of 24 does not completely negate the activity of 28, and
the difference in lag phase between co-application of 23 versus 24 is not as significant.

Development of antimicrobial resistance in E. coli to hydraphile, 1
The initial step in the antimicrobial resistance study was the confirmation of the
previously determined minimum inhibitory concentration (MIC) of hydraphile, 1, when
applied to E. coli. Four iterations of the assay yielded an average MIC of 10 μM—a value
that agrees with the established value of 9.4 μM.31 The superficial difference arises from
the fact that the previous studies produced dilution series by a mass to volume ratio,
whereas the current study factored in the molecular weight of the compound, resulting in
exact micromolar values.
O

O
N

N

N
O

N
O

O

O

O

O
N

O

O

O

1

O
N

From this initial MIC determination, a sub-MIC (i.e. “sub-lethal”) concentration of
8 μM (4/5 of the MIC) of 1, in ethanolic solution, as well as an ethanol blank, is applied to
stock E. coli in successive 24 hour growth periods, transferring a portion of the last growth
culture into fresh growth media, complete with the given concentration of 1. The non-
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transferred portion of each growth culture is then frozen and preserved for later assays.
This process is repeated in this study eleven additional times to yield 288 hours of growth
and 12 testable samples for both the control and sub-lethal application of 1.
The development of antibiotic resistance in the test organism is gauged using two
methods, the minimum inhibitory concentration assay32 and the spectrophotometric assay
of growth,33 both outlined previously. The former is a quick and easy estimation of
antibiotic activity, while the latter can yield more sensitive results by compiling and using
data from growth at all concentrations of antibiotic.

The data garnered from

spectrophotometric assays can be mathematically fit to a sigmoidal curve on a logarithmic
concentration scale to determine the IC50, or the concentration required for 50% inhibition
through interpolation.1
The studies detailed below have determined the MIC and IC50 for E. coli cultures
grown at both 8 μM and at 0 μM (blank) for up to 288 hours at each 24 hour interval, with
each assay performed in at least three and up to five replications at each relevant
concentration. For each iteration of spectrophotometric assays, results were normalized in
the following fashion: (1) The absorbance values for all spectrophotometric readings were
first adjusted by subtracting out the blank absorbance value—the optical density of
uninoculated culture in the presence of only ethanol (which is normalized to 0% survival).
(2) These results were then normalized by dividing by the adjusted optical density of
inoculated culture with only ethanol added (which is normalized to 100% survival) to yield
a percentage value. These adjusted, normalized, and averaged values were plotted against
their concentrations on a logarithmic scale. A sigmoidal curve was fit to the data, and the
concentration at which 50% inhibition of growth results can be interpolated from the
resulting equation as shown in Figure 5.10.
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Figure 5.10 Sigmoidal curve fit of the percent growth readings for the original stock
culture. The results for all replications are shown. A 50% survival (50% inhibition) line
is added to show the interpolative determination of the IC50 value from the curve. A
second dashed line intersecting the 50% growth line is added to show the approximate
IC50 concentration. The actual value is derived from the calculated equation.

Figure 5.11 Sigmoidal curve fit of the percent growth readings for the culture grown
continuously for 144 hrs in 8 μM of 1 and 1% ethanol (Test, down triangles) and with 1%
ethanol only (Control, open boxes). The results for all replications are shown. Vertical
dashed lines show the concentration differences in the IC50 values of the test and control.
The effective concentration of 1 at this time recording is the difference between the two
concentrations.
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MIC

IC50

Hours

Control

Test

Difference

Control

Test

Difference

0

10.0

10.0

0.0

3.2

3.2

0.0

24

12.0

13.0

1.0

5.0

5.9

0.9

48

14.0

20.0

6.0

7.2

10.5

3.3

72

15.2

22.4

7.2

8.8

12.1

3.3

96

16.0

24.0

8.0

8.7

13.3

4.6

120

18.7

26.7

8.0

9.5

14.7

5.1

144

17.6

27.2

9.6

9.4

16.0

6.6

168

17.3

26.7

9.3

8.9

16.6

7.7

192

16.0

24.0

8.0

9.9

16.2

6.3

216

17.6

27.2

9.6

10.5

17.4

6.9

240

18.7

26.7

8.0

10.7

15.9

5.3

264

16.0

26.7

10.7

9.8

17.9

8.1

288

17.6

27.2

9.6

9.3

16.2

7.0

Table 5.2 Average MICs of at least three independent trials for both control and test
cultures. IC50 values are interpolated from a curve fit to the normalized growth
percentages of the same trials used for determining MIC values.
These same methods and mathematical relationships can be applied to the other
samples taken from each culture. This has been done with cultures grown for every 24 h
interval up to 288 h. These results can all be compared to the original results from the
stock culture of E. coli, and a time-dependent trend can be established. To describe this
trend, the effects of the hydraphile alone must be differentiated from the effects of adding
ethanol to the growing cultures.

Thus, the activity values of the blank samples are

subtracted from the activity values of the test growth cultures to yield the effect of the
presence of hydraphile at the given concentration. MIC values can be subtracted from one
another to yield these results, and the differences in the interpolated values from the IC50
curves can be used for the effective activity. An example of this is shown in Figure 5.11
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with dashed lines showing where on the concentration coordinate the IC50 value for the test
and control cultures fall. The tests, blanks, and final results for both methods are
summarized in Table 5.2, IC50 curves fit to normalized measurements can be seen in
Appendix A and the final results are graphically represented in Figure 5.12.
The results show that while the concentration required to effect antimicrobial
activity increases with constant exposure to hydraphile, some portion of this increase can
be attributed to growth in the presence of 1% ethanol. After about 6 days, or 144 hours of
growth, this change in effective concentration plateaus, for both the test and control
cultures.
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Figure 5.12 (Top) Change in the measured MIC (left) and IC50 (right) over time for
cultures grown in the presence of hydraphile 1 and 1% ethanol (triangles, “sub lethal”)
and 1% ethanol only (squares, “control”). MIC error bars represent the range of
replicates recorded, IC50 error bars represent the standard deviation from the curve fit to
the data points at each time point. (Bottom) Difference in effective concentrations of the
MIC (open circles) and IC50 (open diamonds) between the control and test.
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Conclusions
The investigation of activity in biological systems is an overarching goal of
chemical biologists. The ability of a synthetic transmembrane ion transporting agent to
elicit antimicrobial activity is just one example of how this goal can be realized. As
demonstrated by these investigations, not all ion transport agents effect antimicrobial
activity. Compounds that exhibit ion transport activity in biological model systems, such
as phospholipid vesicles and phospholipid planar bilayer membranes, are, by definition,
membrane active. However, due to the heterogeneous character of natural systems with
membrane proteins and sugars, a wider variety of phospholipids,34 efflux proteins that
actively pump toxic substances out of the cell,35 and (in the case of E. coli and other Gram
negative organisms) a second bilayer membrane forming the bacterial cell wall,
complications can certainly arise. The fact that any of these compounds exhibit membrane
activity at all is surprising, given the complexity of these systems and their defenses.
While previous work has established that cation channels, as well as cation carriers,
can effect antimicrobial activity, the compounds surveyed in the present study show that
neither anion channels nor anion carriers can reproduce the effect.

Conceivably, the

disruption of the balance of anions within a target system would impair growth or cause
apoptosis. However, the anionic nature of bacterial membranes can impede the ability of
anion carriers and channels to effect their intended chloride transport purpose in bacteria.
The co-application with the synthetic anion transporter, p-nitro substituted
dicipicolinic dianiline 24 with a cation transporter, C12 diazacrown 28, shows that the
antimicrobial activity of the latter is completely negated when applied at 2 μM. As shown
in Chapter 3, the unsubstituted dianilide, 23, does not bind chloride as strongly or transport
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chloride as efficiently in phospholipid vesicles, but the antimicrobial activity of 28 is
likewise mitigated in the presence of 23, albeit to a lesser extent. The simultaneous
transport of chloride and sodium by each species is implicated in the negation of the
antimicrobial activity of 28. Presumably, the disruption of the sodium gradient by 28 is
eliminated as an environmental stressor by the presence of 24 as a chloride transporter or
as a transport blocker, interacting directly with 28.
Finally, these studies show that E. coli evolve resistance to C12 benzyl channel,
compound 1, over extended periods of constant exposure to a sub-lethal concentration, but
the development of resistance does not continue to develop after an initial time period.
Using either the MIC or IC50 as a gauge, E. coli has developed only a two-fold resistance to
compound 1 over 288 h. The assays also show that resistance develops continuously until
about 144 h, or 6 days of growth, and then begin to plateau. This characteristic is
promising as the individuals that are resistant to the effects of the antibiotic are not being
selected for, and application of a high enough concentration of hydraphile 1 continues to
elicit bactericidal function even after a continuous application of high, but sub-lethal,
concentrations of the drug.
The sensitivity of the MIC assays used in the original antimicrobial studies is
improved by utilizing intercalated two-fold dilutions. The IC50 spectrophotometric assays
show a level of sensitivity that is not reached with the stepped threshold levels seen in the
MIC assays and better precision is more readily attained.
These spectrophotometric assay methods can be applied to both standard antibiotics
or other hydraphiles for a relevant comparison. If C12 benzyl channel performs better over
continued sub-MIC exposure times than standard antibiotics, then there may be some
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advantage that the compound and related structures possess that circumvent the downfalls
of other antibiotics.

Experimental

General
All UV-Vis absorbance spectra were recorded on a Beckman Coulter DU 7400
Spectrophotometer. All microbiological assays are performed using sterile technique. All
equipment and growth media solutions are autoclaved to 121°C with sterilizing conditions
confirmed by autoclave tape. Equipment that is prepackaged as sterile is not similarly
sterilized and assumed usable as delivered.

All transfers are performed with sterile

equipment that is flamed (passed over a Bunsen burner a number of times in rapid
succession) before and after transfers, and all unique transfers use a new micropipette tip.
Before each liquid transfer or inoculation, the liquid is vortexed for at least 3 seconds to
ensure proper mixing and even distribution of nutrients, agents, and/or bacteria. To ensure
accuracy and reproducibility, all assays are replicated from 3 to 5 times at each relevant
concentration.
The study tests the viability of Escherichia coli DH5α cells with a plasmid
expressing ampicillin resistance.

Unless otherwise noted, all inoculations are of the

standard inoculum size of 5 x 10 5 CFU ml-1. This is measured as an approximate optical
density of 0.5 at 600nm compared to growth media blank. Cultures grown from frozen
stock are thus grown to an optical density of between 0.45 and 0.55.
The growth media used in all experiments is LB Miller broth, which contains 10g
L-1 casein peptone, 10 g L-1 sodium chloride, and 5 g L-1 yeast extract. The growth media
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is made selective for ampicillin resistance by the addition of 50μM ampicillin, and is pH
balanced at 7.0 by 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
buffer.

Compounds Studied

Compound 1
This compound was synthesized by Dr. Wei Wang and was used as received. Synthetic
details are reported in the literature. 36
Compounds 2-9
These compounds were synthesized by Dr. Wei Wang and were used as received.
Synthetic details are reported in the literature.2
Compounds 10-11
These compounds were synthesized by Dr. Wei Wang and were used as received.
Synthetic details are reported.37
Compound 12
This compound was synthesized by Dr. Wei Wang and was used as received. Synthetic
details are reported in the literature.38
Compound 13
This compound was synthesized by Dr. Lei You and was used as received. Synthetic
details are reported in the literature.39
Compound 14
This compound was synthesized by Dr. Lei You and was used as received. Synthetic
details are reported in the literature.40
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Compounds 15-17
These compounds were synthesized by Dr. Oleg Kulikov and were used as received.
Synthetic details are reported in the literature.41
Compounds 18-17
These compounds were synthesized by me, as detailed in Chapter 2 of this work.
Compounds 23-27
These compounds were synthesized by me, as detailed in Chapter 3 of this work.
Compound 28
This compound was synthesized by Dr. Wei Wang and was used as received. Synthetic
details are reported in the literature. 42

Serial Dilutions
The compound of interest is dissolved in either ethanol or DMSO at a concentration
one hundred times the desired in-culture concentration. A volume of 20 μL is added to
each culture, which in total has a volume of 2000μL. Two-fold serial dilutions of the test
antibiotic are established using either the macrobroth dilution method or the stock solution
dilution method. The latter entails diluting the stock solution down a series of solutions
containing the solvent used for the antibiotic. These pre-diluted solutions are then each
added to the series of growth media. The macrobroth method involves the same dilution
aspect, but is performed with pre-inoculated liquid media in each culture tube.

Two

different series of dilutions can be used to establish two series of intercalated
concentrations. In most experimental replications, the macrobroth dilution method is used
to create two intercalated series for testing, though for at least one replication of each assay
the stock solution dilution method is used to validate both the macrobroth method and
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statistical distribution. The standard dilution concentrations for the intercalated series are 2
μM and its two-fold multiples (128, 64, 32, 16, 8, 4, 2, 1, 0.5) and 3 μM and its two-fold
multiples (96, 48, 24, 12, 6, 3, 1.5, 0.75).

Minimum Inhibitory Concentration
The minimum inhibitory concentration (MIC) is determined using a modification
of the methods outlined by the NCCLS.32 The modification entails using two intercalated
series of serial two-fold dilutions of a given antibiotic instead of the standard single series.
The use of intercalated series is expected to yield more sensitive results. The MIC is
determined by inoculating each test tube in the series with a standard inoculum size and
growing at 37°C, while agitating at 200 rpm for 16 hours. The MIC is determined by a
visual inspection of turbidity. An antibiotic concentration at which the resulting solution is
cloudy (turbid) is one in which growth has not been inhibited. A concentration at which
the resulting solution is transparent is a concentration at which growth is inhibited. The
lowest concentration at which this latter scenario is true is thus determined as the MIC. If
growth is present at the highest concentration at both series, the MIC is listed as higher
than that concentration and, for all intents and purposes, the compound is inactive.

Spectrophotometric Assays
Using the same dilution and growth procedures as used for MICs (the same grown
cultures can be used, as well), the optical density (absorbance) at 600nm is measured for
each dilution using a UV/Vis spectrophotometer. All readings are compared to a blank
consisting of uninoculated growth media with the test compound present.
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The spectrophotometric data were normalized by subtracting the absorbance of
uninoculated culture and 1% ethanol as the blank for all values before dividing by the
blank-adjusted absorbance of an inoculated culture grown with 1% ethanol to yield the
adjusted and normalized growth percentages. Using the graphing software GraphPad, data
points from all of the replications were plotted against the logarithmic concentration of 1
and, using non-linear regression analysis with equation 1, fit to a variable-slope sigmoidal
dose-response curve as previously described.1

(eq.1)
Values are fit to equation 1 where “Y” equals the percentage of growth, “X” equals
log[hydraphile] of each dilution, “Top” is the maximal growth (100%), normalized to the
results of the ethanol blank and “Bottom” is the minimum growth (or 0%). The resulting
value, “LogEC50,” is converted to a micromolar concentration for reporting in Table 5.3
and Figure 5.12.

Continuous Growth
E. coli from stock culture is used to inoculate two growth cultures—one containing
a sub-MIC concentration (8 μM) of C12 benzyl channel hydraphile, 1, in ethanol and one
containing a blank with only ethanol added (1% present in culture). Each culture, with
compound solution and inoculum added, has a volume of 2mL. This first generation is
incubated for 24h at 37°C while agitating at 200 rpm.
After one 24h cycle, an 100 μL inoculum (5% of volume) is transferred from the
first generation culture to fresh growth media with the appropriate amount of compound
present. The concentrations for growth after the first cultures are adjusted to be additive
with compound already present in previous growth that is transferred over with the
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inoculum so that a constant 8 μM is present. This second set of growth cultures is again
incubated for 24 h at 37°C while agitating at 200 rpm, and the process is repeated for a
total of twelve sets of growth cultures.
Meanwhile, the remnants of these growth cultures (1900 μL) are frozen to –80°C
using glycerol added to yield 15% volume as a cryoprotectant. A portion of these frozen
cultures are revived at a later date by adding 50 μL of thawed culture to fresh growth
media. These are grown out to mid-logarithmic phase (OD600 = 0.5) and used to inoculate
cultures grown for the MIC and IC50 studies, using a different thawed culture for each
replication.

Growth Curves
The methodology for this investigation uses a modified procedure from an earlier
study comparing antibiotics and investigating synergistic effects.29 Using regular (nonselective) growth media without ampicillin, S. epidermidis was grown from stock culture
to mid-logarithmic phase, and is subsequently used to inoculate ten growth cultures. Three
cultures were grown containing only diaza-crown 28 at three concentrations: 16 μM, 4 μM
and 2 μM—the first being the pre-determined MIC of 16 μM in S. epidermidis and the
latter two below the MIC.

Two cultures were grown containing either dipicolinic

dianilide 23 or 24 alone, each at 50 μM.

Six cultures were grown containing a

combination of 23 or 24 (at 50 μM) and diaza-crown 28 at the three tested concentrations.
For cultures with only one type of transporter present, the solvent used for the other
transporter type is thus added to eliminate experimental differences. Finally, a control
culture was grown with no compounds present in 0.5% DMSO and 0.5% ethanol.
Each culture was measured for growth by the optical density at 600 nm assay
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method. Absorbance readings above 2.5 approach higher deviation from linearity and can
be thought of as “full growth” for this purpose.
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